10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 1, 2012

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to            

Commission file number: 001-13279

Intermec, Inc.

(Exact name of registrant as specified in its charter)

Delaware	95-4647021
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
6001 36th Avenue West, Everett, WA	98203-1264
(Address of principal executive offices)	(Zip Code)

(425) 348-2600

(Registrant’s telephone number, including area code)

[None]

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨  (Do not check if a smaller reporting company)	Smaller reporting company filer	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange

Act).     Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class	Outstanding at August 1, 2012
Common Stock, $0.01 par value per share	60,237,626 shares

INTERMEC, INC.

TABLE OF CONTENTS

		Page Number
PART I. FINANCIAL INFORMATION
ITEM 1.	Financial Statements
	Condensed Consolidated Balance Sheets (Unaudited) as of July 1, 2012 and December 31, 2011		3
	Condensed Consolidated Statements of Operations (Unaudited)  for the Three and Six Months Ended July 1, 2012, and July 3, 2011		4
	Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)  for the Three and Six Months Ended July 1, 2012 and July 3, 2011		5
	Condensed Consolidated Statements of Cash Flows (Unaudited)  for the Six Months Ended July 1, 2012 and July 3, 2011		6
	Notes to Condensed Consolidated Financial Statements (Unaudited)		7-20
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		21
ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk		33
ITEM 4.	Controls and Procedures		33
PART II. OTHER INFORMATION
ITEM 1.	Legal Proceedings		34
ITEM 1A.	Risk Factors		34
ITEM 6.	Exhibits		35
Signature			36

INTERMEC, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands)

	July 1, 2012			December 31, 2011
ASSETS
Current assets:
Cash and cash equivalents	$	74,711		$	95,108
Short-term investments		181			170
Accounts receivable, net		132,172			139,737
Inventories		97,944			103,622
Current deferred tax assets, net		8,158			84,541
Other current assets		28,908			24,226
Total current assets		342,074			447,404
Deferred tax assets, net		7,379			141,064
Goodwill		101,996			143,510
Intangible assets, net		52,610			61,996
Property, plant and equipment, net		42,977			47,086
Other assets, net		19,546			28,230
Total assets	$	566,582		$	869,290
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	70,833		$	92,607
Payroll and related expenses		26,711			32,540
Deferred revenue		60,074			47,234
Accrued expenses		26,727			35,118
Total current liabilities		184,345			207,499
Long-term debt		85,000			85,000
Pension and other postretirement benefits liabilities		126,309			124,058
Long-term deferred revenue		28,883			28,960
Other long-term liabilities		15,975			15,344
Commitments and contingencies
Shareholders’ equity:
Common stock (250,000 shares authorized, 63,419 and 62,956 shares issued and 60,113 and 59,717 outstanding)		639			636
Additional paid-in capital		701,111			697,597
Accumulated deficit		(489,939	)		(210,327	)
Accumulated other comprehensive loss		(85,741	)		(79,477	)
Total shareholders’ equity		126,070			408,429
Total liabilities and shareholders’ equity	$	566,582		$	869,290

See accompanying notes to condensed consolidated financial statements.

3

INTERMEC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share amounts)

	Three Months Ended						Six Months Ended
	July 1, 2012			July 3, 2011			July 1, 2012			July 3, 2011
Revenues:
Product	$	158,357		$	177,751		$	294,828		$	319,487
Service		42,594			43,331			85,801			80,113
Total revenues		200,951			221,082			380,629			399,600
Costs and expenses:
Cost of product revenues		99,973			106,441			191,312			194,239
Cost of service revenues		21,781			23,325			44,195			45,752
Research and development		20,431			22,858			40,440			40,674
Selling, general and administrative		61,412			66,052			127,419			120,295
Impairment of goodwill		26,589			—			41,514			—
Gain on sale of assets		(1,255	)		—			(2,655	)		—
Acquisition costs		—			373			—			5,211
Restructuring costs		5,598			5,111			5,598			5,111
Total costs and expenses		234,529			224,160			447,823			411,282
Operating loss		(33,578	)		(3,078	)		(67,194	)		(11,682	)
Interest income		80			306			201			403
Interest expense		(882	)		(883	)		(1,632	)		(1,393	)
Loss before income taxes		(34,380	)		(3,655	)		(68,625	)		(12,672	)
Income tax expense (benefit)		3,142			141			210,987			(2,798	)
Net loss	$	(37,522	)	$	(3,796	)	$	(279,612	)	$	(9,874	)
Loss per common share:
Basic loss per share	$	(0.62	)	$	(0.06	)	$	(4.65	)	$	(0.16	)
Diluted loss per share	$	(0.62	)	$	(0.06	)	$	(4.65	)	$	(0.16	)
Shares used in computing:
Basic loss per share		60,251			59,784			60,140			60,070
Diluted loss per share		60,251			59,784			60,140			60,070

See accompanying notes to condensed consolidated financial statements.

4

INTERMEC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(In thousands)

	Three Months Ended						Six Months Ended
	July 1, 2012			July 3, 2011			July 1, 2012			July 3, 2011
Net loss:	$	(37,522	)	$	(3,796	)	$	(279,612	)	$	(9,874	)
Other comprehensive loss:
Foreign currency translation adjustments		(5,525	)		2,716			(2,014	)		7,636
Unrealized gain (loss) on investment		(9	)		(1	)		(9	)		(3	)
Amortization of benefit plan costs		(2,119	)		562			(4,237	)		1,182
Income tax on other comprehensive income		(4	)		(202	)		(4	)		(425	)
Total other comprehensive income		(7,657	)		3,075			(6,264	)		8,390
Total comprehensive loss	$	(45,179	)	$	(721	)	$	(285,876	)	$	(1,484	)

See accompanying notes to condensed consolidated financial statements.

5

INTERMEC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

	Six Months Ended
	July 1, 2012			July 3, 2011
Cash and cash equivalents at beginning of the period	$	95,108		$	221,467
Cash flows from operating activities:
Net loss		(279,612	)		(9,874	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		18,015			12,815
Deferred taxes		211,321			(6,810	)
Stock-based compensation		3,125			4,376
Impairment of goodwill		41,514			—
Gain on sale of assets		(2,655	)		—
Gain on company owned life insurance		(1,174	)		—
Change in pension and other postretirement plans		(1,963	)		(608	)
Changes in operating assets and liabilities:
Accounts receivable		7,363			(4,321	)
Inventories		5,032			(1,507	)
Other current assets		(4,703	)		(3,948	)
Accounts payable		(21,151	)		2,607
Payroll and related expenses		(5,736	)		1,777
Accrued expenses		(7,984	)		(8,551	)
Deferred revenue		13,041			5,365
Other operating activities		(1,232	)		1,514
Net cash used in operating activities		(26,799	)		(7,165	)
Cash flows from investing activities:
Acquisitions, net of cash acquired		—			(200,810	)
Additions to property, plant and equipment		(4,551	)		(11,534	)
Proceeds from sale of assets		2,359			—
Proceeds from company owned life insurance		8,962			—
Other investing activities		(346	)		(699	)
Net cash provided by (used in) investing activities		6,424			(213,043	)
Cash flows from financing activities:
Proceeds from issuance of debt		—			97,000
Repayment of debt		—			(20,000	)
Stock repurchase		—			(10,014	)
Stock options exercised and other		1,034			1,097
Net cash provided by financing activities		1,034			68,083
Effect of exchange rate changes on cash and cash equivalents		(1,056	)		6,098
Net change in cash and cash equivalents		(20,397	)		(146,027	)
Cash and cash equivalents at end of the period	$	74,711		$	75,440
Cash paid during the period for income taxes	$	(7,091	)	$	(4,317	)
Cash paid during the period for interest		(1,008	)		(1,443	)

See accompanying notes to condensed consolidated financial statements.

6

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 1. Basis of Presentation

Our interim financial periods are based on a thirteen-week internal accounting calendar. In our opinion, the accompanying balance sheets, statements of operations, statements of cash flows and statements of comprehensive income (loss) include all adjustments, consisting mainly of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated financial statements include the accounts of Intermec and its subsidiaries. Intercompany transactions and balances have been eliminated. Preparing our financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and financial data included in the accompanying notes to the financial statements. Actual results and outcomes may differ from our estimates and assumptions.

Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2011 (the “2011 Form 10-K”).

Recently Adopted Accounting Pronouncements

Fair Value Measurement - In May 2011, the Financial Accounting Standards Board (“FASB”) issued guidance which generally provides a consistent definition of fair value and ensures that the fair value measurement and disclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. The guidance changes certain fair value measurement principles and enhances the disclosure requirements, particularly for Level 3 fair value measurements. This guidance was effective for interim and annual reporting periods beginning after December 15, 2011 and was applied on a prospective basis. The Company adopted the guidance on January 1, 2012, as required. There was no material impact on the Consolidated Financial Statements resulting from the adoption, see Note 3 Fair Value Measurements for additional disclosures related to this pronouncement.

Comprehensive Income - In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income,” (“ASU 2011-05”). ASU 2011-05 eliminates the option to report other comprehensive income (loss) and its components in the statement of changes in equity and requires that all nonowner changes in stockholders’ equity be presented in either a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB issued ASU 2011-12, “Comprehensive Income — Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in ASU 2011-05,” to defer the effective date to present items that are reclassified out of accumulated other comprehensive income to net income alongside their respective components of net income and other comprehensive income. All other provisions of this update, which are to be applied retrospectively, are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. We adopted this guidance in the first quarter of 2012 and applied it retrospectively. To implement this standard we have added a separate statement labeled Condensed Consolidated Statement of Comprehensive Income (Loss).

Intangibles – Goodwill and Other - In September 2011, the FASB issued ASU No. 2011-08, “Intangibles – Goodwill and Other (Topic 350) (“ASU 2011-08”). The amendments in this update will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendments include a number of events and circumstances for an entity to consider in conducting the qualitative assessment. This new guidance was adopted and applied in January 2012. The adoption of this accounting standard update did not have an impact on our financial position, results of operations, cash flows, or comprehensive income as it is intended to potentially simplify the assessment for goodwill impairment.

Reclassification

Certain reclassifications have been made to prior periods to conform to the present year presentation. Specifically, for the three and six months ended July 3, 2011 we have reclassified certain costs that were in cost of service revenues to cost of product revenues in the amount of $0.8 and $1.7 million, respectively. This reclassification has no impact on previously reported earnings from operations or net income. In addition, we have reclassified change in pension and other postretirement plans, net, previously reported in other operating activities into its own line item on the condensed consolidated statement of cash flows.

Offsetting of Financial Assets and Financial Liabilities

The Company has taken out policy loans from an insurance company on life insurance policies it owns and offsets these loans against the cash surrender values associated with the company owned life insurance policies. There is no intention to repay the loans prior to maturity or cancellation, and the company owned life insurance policies allow the right to offset the loan against the proceeds received on maturity or cancellation of the policies. The gross amount of the cash surrender values was $22.9 and $26.1 million at July 1, 2012 and December 31, 2011 respectively. The gross amount of the policy loans was $21.4 million and $16.0 million at July 1, 2012 and December 31, 2011 respectively. The net amounts of $1.5 million and $10.1 million at July 1, 2012 and December 31, 2011 respectively are included in our condensed consolidated balance sheets in Other assets, net.

Note 2: Revolving Credit Facility

Effective March 3, 2011, we amended our unsecured revolving credit facility with Wells Fargo Bank, National Association (the “Bank”) to convert the facility to a three-year, $100 million, secured revolving credit facility, which originally matured on March 3, 2014 (the “Revolving Facility”). The unsecured revolving credit facility was initiated on September 27, 2007. On

7

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

December 21, 2011, we amended the Revolving Facility to expand our borrowing capacity to $150 million and extended the maturity date to December 31, 2014. On February 2, 2012, we amended the Revolving Facility to modify certain financial covenants relating to net income. Effective March 30, 2012, we amended the Revolving Facility to remove certain financial covenants, to add a new covenant related to minimum adjusted EBITDA and to add a new financial covenant for permitted acquisitions. We were in compliance with all financial and non-financial covenants of the Revolving Facility at July 1, 2012.

In addition to financing the acquisition of Vocollect in 2011, the Revolving Facility is used for general corporate purposes. The Revolving Facility includes financial covenants and is secured by pledges of equity in certain assets of our domestic subsidiaries and guaranties of payment obligations from certain of our domestic subsidiaries. At July 1, 2012, after considering the financial covenant requirements, we had borrowing capacity of $7.3 million under the Revolving Facility with borrowings of $85 million and $1.5 million of letters of credit outstanding. The amount outstanding under the Revolving Facility bears interest at a variable rate equal to LIBOR plus a margin ranging from 1.25% to 1.75%. For the three and six months ended July 1, 2012, the weighted average interest rate on borrowed funds under the Revolving Facility was 2.23% and 2.26%, respectively.

At July 1, 2012, scheduled principal payments on long-term debt were as follows (in thousands):

	Total
2012-2013	$	—
2014		85,000
Total principal payments	$	85,000

The key terms of the Revolving Facility are as follows following the most recent amendment:

• Loans bear interest at a variable rate equal to (at our option) (i) LIBOR plus the applicable margin, which ranges from 1.25% to 1.75%, or (ii) the Bank’s prime rate, less the applicable margin, which ranges from 0.25% to 1.00%. If an event of default occurs and is continuing, then the interest rate on all obligations under the Revolving Facility may be increased by 2.0% above the otherwise applicable rate, and the Bank may declare any outstanding obligations under the Revolving Facility to be immediately due and payable. In addition, the Bank may exercise its security interest in our equity interests in the assets of certain of our domestic subsidiaries, and it may call the guaranties of payment obligations made by certain of our domestic subsidiaries.

• A fee ranging from 0.60% to 1.00% on the maximum amount available to be drawn under each letter of credit that is issued and outstanding under the Revolving Facility. The fee on the unused portion of the Revolving Facility ranges from 0.15% to 0.25%.

• Certain of our domestic subsidiaries have guaranteed the Revolving Facility.

• The Revolving Facility contains various restrictions and covenants, including restrictions on our ability and the ability of our subsidiaries to consolidate or merge, make acquisitions, create liens, incur additional indebtedness or dispose of assets.

• The Revolving Facility includes covenants requiring us to meet certain minimum financial performance thresholds, including:

• A ratio of maximum funded debt to EBITDA allowed (as defined in the Revolving Facility) of not more than 2.5 to 1.

• An Asset Coverage Ratio of not less than 1 to 1 for debt to margined assets. For this purpose, a certain percentage of our accounts receivable and inventory balances are included in margined assets.

• The minimum adjusted EBITDA allowed (as defined in the Revolving Facility) for the trailing twelve months is $25 million for the second quarter of 2012, $35 million for the third quarter of 2012, and $45 million for all subsequent quarters.

We expect to be in compliance with our covenants for the next twelve months.

8

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 3. Fair Value Measurements

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Our financial assets and liabilities subject to fair value measurement provisions as of July 1, 2012 comprised the following (in thousands):

	Level 1		Level 2			Level 3		Fair Value at July  1, 2012
Money market funds	$	39,561	$	—		$	—	$	39,561
Stock		181		—			—		181
Derivative instruments – assets		—		1,317			—		1,317
Total assets at fair value	$	39,742	$	1,317		$	—	$	41,059
	Level 1		Level 2			Level 3		Fair Value at July 1, 2012
Derivative instruments – liabilities	$	—	$	(575	)	$	—	$	(575	)
Total liabilities at fair value	$	—	$	(575	)	$	—	$	(575	)

Our financial assets and liabilities subject to fair value measurement provisions as of December 31, 2011 comprised the following (in thousands):

	Level 1		Level 2			Level 3		Fair Value at December 31, 2011
Money market funds	$	15,275	$	—		$	—	$	15,275
Certificates of deposit		—		3,555			—		3,555
Stock		170		—			—		170
Derivative instruments – assets		—		985			—		985
Total assets at fair value	$	15,445	$	4,540		$	—	$	19,985
	Level 1		Level 2			Level 3		Fair Value at December 31, 2011
Derivative instruments – liabilities	$	—	$	(1,801	)	$	—	$	(1,801	)
Total liabilities at fair value	$	—	$	(1,801	)	$	—	$	(1,801	)

Our Level 1 financial instrument values are based on quoted market prices for identical assets in active markets. Our Level 2 financial instrument values are based on quoted prices in active markets for similar assets, which we use to value our certificates of deposit, or comparable sales, such as quoted market rates for similar contracts. Specifically, we obtain current pricing from the issuing bank for identical items purchased on the last business day of our reporting period. Level 3 financial instrument values refer to fair values using unobservable inputs that are not corroborated by market data.

There were no transfers between Level 1 and Level 2 assets and liabilities in the three and six months ended July 1, 2012 and July 3, 2011.

Fair Value of Financial Instruments

The estimated fair values of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, and payroll and related expenses at July 1, 2012 and December 31, 2011, approximate their carrying values due to their short-term nature. The fair value of long-term debt at July 1, 2012 approximates its carrying value.

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

All other nonfinancial assets and liabilities measured at fair value in the financial statements on a nonrecurring basis are subject to fair value measurements and disclosures. Nonfinancial assets and liabilities included in our condensed consolidated balance sheets and measured on a nonrecurring basis consist of goodwill and long-lived assets, including other acquired intangibles. Goodwill and long-lived assets are measured at fair value to test for and measure impairment, if any, at least annually for goodwill or when necessary for both goodwill and long-lived assets. See Note 16 – Goodwill and other Long-Lived Assets for details of our impairment analysis.

9

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

The following fair value hierarchy table presents information about our goodwill assets that were measured at fair value on a non-recurring basis at July 1, 2012 (in thousands):

Goodwill	Level 1		Level 2		Level 3		Fair Value at July 1, 2012
Voice solutions supply chain reporting unit	$	—	$	—	$	89,993	$	89,993
Voice solutions healthcare reporting unit		—		—		8,655		8,655
Intermec global solutions reporting unit		—		—		3,348		3,348
Total goodwill at fair value	$	—	$	—	$	101,996	$	101,996

The following fair value hierarchy table presents information about our goodwill assets that were measured at fair value on a non-recurring basis at December 31, 2011(in thousands):

Goodwill	Level 1		Level 2		Level 3		Fair Value at December 31, 2011
Voice solutions supply chain reporting unit	$	—	$	—	$	130,682	$	130,682
Voice solutions healthcare reporting unit						9,480		9,480
Intermec global solutions reporting unit						3,348		3,348
Total goodwill at fair value	$	—	$	—	$	143,510	$	143,510

A goodwill impairment was recorded in the amount of $26.6 and $41.5 million for the three and six months ended July 1, 2012, respectively, against the Voice Solutions Supply Chain (“VSC”) and Voice Solutions Healthcare (“VHS”) reporting units.

The following table presents qualitative information with respect to Level 3 fair value measurements for assets and liabilities measured at fair value on a non-recurring basis at July 1, 2012:

Reporting Unit	Fair Value		Valuation Technique(s)	Unobservable Input(s)
Voice Solutions Supply Chain
Goodwill	$	89,993	Income Approach	Financial Forecast
				Terminal Growth Rate
				Weighted Average Cost of Capital
				Expected Cash Flow
			Market Approach	Public Company Multiples
Voice Solutions Healthcare
Goodwill	$	8,655	Income Approach	Financial Forecast
				Terminal Growth Rate
				Weighted Average Cost of Capital
Intermec Global Solutions
Goodwill	$	3,348	Income Approach	Financial Forecast
				Terminal Growth Rate
				Weighted Average Cost of Capital
Total Goodwill	$	101,996

Note 4. Derivative Instruments

Due to our global operations, we are exposed to foreign currency exchange rate fluctuations in the normal course of our business. Our treasury policies provide for risk mitigation of the effects of certain foreign currency exposures through the purchase of foreign exchange forward contracts. Our policy prohibits speculation in financial instruments for profit on the exchange rate price fluctuation. We enter into foreign exchange forward contracts primarily to economically hedge the impact of fluctuations of foreign exchange arising from intercompany inventory sales made to our subsidiaries that are denominated primarily in

10

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Euros or British Pounds, customer receivables of our foreign subsidiaries denominated primarily in U.S. Dollars and Euros and intercompany loans denominated in Euros, Swedish Krona, Norwegian Kroner, Danish Krone and Canadian Dollar. Our foreign exchange forward contracts are not designated as hedging instruments for accounting purposes; accordingly, we record these contracts at fair value on our consolidated balance sheets, with changes in fair value recognized in earnings in the period of the change. The aggregate notional amounts of the forward contracts we held for foreign currencies were $129.0 million as of July 1, 2012. Principal currencies we economically hedged include the Euro, British Pound, Brazilian Real, Canadian Dollar, Mexican Peso, Singapore Dollar, Swedish Krona, Norwegian Kroner and Danish Krone. These contracts do not contain any credit-risk-related contingent features.

We attempt to manage the counterparty risk associated with these foreign exchange forward contracts by limiting transactions to counterparties with which we have an established banking relationship. In addition, these contracts generally settle in approximately 30 days. See Note 3, Fair Value Measurements, for information on the fair value of these contracts.

The net loss (gain) resulting from these contracts recorded in selling, general and administrative expense was approximately $2.4 and $1.5 million for the three and six months ended July 1, 2012, and $0.5 and $1.1 million for the three and six months ended July 3, 2011, respectively. We recorded a net (liability) asset of $0.7 and $(0.8) million in other current assets or accounts payable and accrued expenses as of ended July 1, 2012 and December 31, 2011, respectively.

Note 5. Accounts Receivable, Net

Accounts receivable, net, consisted of the following (in thousands):

	July 1, 2012		December 31, 2011
Accounts receivable, gross	$	138,132	$	146,682
Less:
Allowance for sales returns		4,185		4,423
Allowance for doubtful accounts		1,775		2,522
Accounts receivable, net	$	132,172	$	139,737

Our allowance for sales returns includes estimated customer returns and other incentives that are recorded as a reduction of sales. Price exceptions globally are recorded directly to the customers’ accounts instead of an allowance to gross receivables. One customer, ScanSource, our largest distributor, accounted for 26% and 19% of our accounts receivable as of July 1, 2012 and December 31, 2011, respectively.

One distributor, ScanSource Inc., accounted for more than 10% of our revenues. Total sales to this distributor were $41.1 and $71.9 million for the three months and six months ended July 1, 2012, respectively, and $28.1 and $68.7 million for the three and six months ended July 3, 2011, respectively

Note 6. Inventories

Inventories consisted of the following (in thousands):

	July 1, 2012		December 31, 2011
Raw materials	$	27,739	$	30,485
Service parts		14,651		13,412
Work in process		550		316
Finished goods		55,004		59,409
Inventories	$	97,944	$	103,622

In addition to the inventories described above, we have service parts inventories totaling $4.3 and $4.3 million at July l, 2012 and December 31, 2011, respectively, which are included in our condensed consolidated balance sheets in Other assets, net.

11

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 7. Intangibles

The following table presents the gross carrying amount and accumulated amortization of intangible assets as of July 1, 2012 (in thousands):

	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Weighted Average Useful Life
Developed technology	$	40,200	$	16,053	$	24,147		5 years
In-process research and development		1,900		138		1,762		7 years
Customer relationships		17,600		1,948		15,652		11 years
Trademarks		5,200		519		4,681		10 years
Lease agreements		2,600		463		2,137		8 years
Total acquired intangible assets from Vocollect acquisition:		67,500		19,121		48,379
Other intangibles		14,459		10,228		4,231		5 years
Total	$	81,959	$	29,349	$	52,610

The following table presents the gross carrying amount and accumulated amortization of intangible assets as of December 31, 2011 (in thousands):

	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Weighted Average Useful Life
Developed technology	$	40,200	$	9,416	$	30,784		5 years
In-process research and development		1,900		—		1,900		7 years
Customer relationships		17,600		623		16,977		11 years
Trademarks		5,200		303		4,897		10 years
Lease agreements		2,600		245		2,355		8 years
Total acquired intangible assets from Vocollect acquisition:		67,500		10,587		56,913
Other intangibles		14,459		9,376		5,083		5 years
Total	$	81,959	$	19,963	$	61,996

Total amortization expense on intangibles for the three and six months ended July 1, 2012 was $4.7 and $9.4 million, respectively, and $3.3 and $4.3 million, for the three and six months ended July 3, 2011, respectively. Estimated future amortization expense for intangible assets for the next five years is as follows (in thousands):

Year	Amount
2012	$	18,558
2013		16,367
2014		8,865
2015		6,005
2016		3,482

Note 8. Provision for Income Taxes

In the second quarter, we recorded a tax provision of $1.7 million on foreign earnings and no tax benefit for earnings in the United States, Singapore and Japan due to losses in those jurisdictions. We also provided $1.4 million for deferred taxes on projected future repatriation from certain foreign subsidiaries which are not permanently reinvested. The tax provision for the three months ended April 1, 2012 included a net $206.9 million non-cash charge to record a valuation allowance against our U.S. deferred tax assets.

12

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Currently, we record valuation allowances in the following jurisdictions: United States, Singapore and Japan. Under GAAP, a valuation allowance against our deferred tax assets is appropriate if based on the available evidence, it is more likely than not (defined as a likelihood of more than 50%) that the value of such assets will not be realized in the future. The valuation of deferred tax assets requires judgment in assessing a number of factors, including the likely future tax consequences of events we expect to recognize in our financial statements and tax returns, as well as our historical performance. Key factors we considered include our results for the quarter ended April 1, 2012; we recorded a pre-tax loss and significantly underperformed relative to our forecast. We also revised our forecast downward in the first quarter of 2012 for our U.S. and global operations for the remainder of 2012. We concluded that it was more likely than not that the value of such assets would not be realized, and we recorded a valuation allowance for our U.S. entities representing the full balance of these assets.

A sustained period of profitability in our U.S. operations is required before we would change our judgment regarding the need for a full valuation allowance against our U.S. deferred tax assets. In the event that we determine in the future that we expect to benefit from our deferred income tax assets in excess of the net balance at that time, we will make an adjustment to the deferred tax asset valuation allowance. This will reduce the provision for income taxes in that period. Until such time, we will offset U.S. profits against our deferred tax assets and will reduce the overall level of deferred tax assets subject to valuation allowance as a result.

For the jurisdictions where we did not record a valuation allowance, our tax provision includes an estimated annual effective tax rate from continuing operations of approximately 31%. Our effective tax rate from continuing operations in those jurisdictions is lower than the U.S. statutory rate of 35% due primarily to lower tax rates and tax incentives in those jurisdictions.

Note 9. Shares Used in Computing Earnings (Loss) per Share

Basic earnings (loss) per share are calculated using the weighted average number of common shares issued and outstanding for the applicable period. Diluted loss per share is computed using basic weighted average shares issued and outstanding plus the dilutive effect of unvested restricted stock and outstanding stock options using the “treasury stock” method.

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Weighted average shares - basic		60,251,466		59,784,479		60,140,033		60,070,394
Dilutive effect of unvested restricted shares and stock options		—		—		—		—
Weighted average shares - diluted		60,251,466		59,784,479		60,140,033		60,070,394

Our employees and directors held options to purchase 3,950,272 and 3,844,272 shares of our common stock for the three and six months ended July 1, 2012, respectively, and 3,451,713 and 3,078,769 shares of our common stock for the three and six months ended July 3, 2011, respectively, that were not included in weighted average shares diluted calculation because they were anti-dilutive to the diluted loss per share computation. These options would become dilutive in future periods if the average market price of our common stock exceeds the exercise price of the outstanding options and we report net earnings.

Note 10. Stock-Based Compensation

A summary of stock-based compensation expense related to director and employee stock options, Restricted Stock Units (“RSU”), Performance Stock Units (“PSU”), and Employee Stock Purchase Plan (“ESPP”) for the three and six months ended July 1, 2012 and July 3, 2011 is as follows (in thousands):

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Cost of revenue	$	63	$	63	$	126	$	126
Selling, general and administrative		421		2,152		2,999		4,299
Total	$	484	$	2,215	$	3,125	$	4,425

Stock compensation expense for the three and six months ended July 1, 2012 was reduced by $1.9 million primarily due to forfeitures related to the departure of our former CEO.

13

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

For the three and six months ended July 1, 2012, we granted 572,855 and 586,855 options, respectively, to employees with a weighted-average grant-date fair value of $2.71 and $2.72 per option, respectively, which will vest annually in substantially equal quantities over three years from the date of grant.

Note 11. Segment Reporting

Our chief operating decision maker is our Chief Executive Officer. Based on the evaluation of our financial information our reportable segments are comprised of Intermec-branded products, Intermec-branded services and Voice solutions. The Intermec-branded product segment generates revenue from the design, development, manufacture, sale and resale of mobile computing products, bar code scanners, wired and wireless bar code printers and label media products, and RFID products and license fees. Our Intermec-branded service segment generates revenue from managed services, customer support, product maintenance and professional services related to products and systems integration. The Voice solutions segment is comprised of voice data, collection terminals and professional services related to these products. Our statements of operations separately disclose revenues and costs related to our products and services on a consolidated basis.

Our chief operating decision maker evaluates revenue performance of product lines, both domestically and internationally. However, operating, strategic and resource allocation decisions are based primarily on the overall performance of our operating segments. The accounting policies of our three reportable segments are the same as those used to prepare our consolidated financial statements. Performance and resource allocation are primarily measured by sales and standard gross profit. All other earnings, costs and expenses are aggregated and reported on a consolidated basis. It is not practicable to segregate total assets by segment. Total assets at July 1, 2012 and December 31, 2011 were $566.6 and $869.3 million, respectively.

The following table sets forth our revenues and gross profit by reportable segment (in thousands):

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Revenues:
Intermec-branded products	$	135,618	$	153,329	$	252,951	$	287,183
Intermec-branded services		34,747		37,301		69,696		72,162
Voice solutions		30,586		30,452		57,982		40,255
Total	$	200,951	$	221,082		380,629	$	399,600
Gross profit:
Intermec-branded products	$	47,348	$	60,998	$	84,162	$	112,467
Intermec-branded services		14,237		13,234		28,017		25,814
Voice solutions		17,612		17,084		32,943		21,328
Total	$	79,197	$	91,316	$	145,122	$	159,609

The following table sets forth our revenues by product lines (in thousands):

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Revenues:
Intermec branded:
Systems and solutions	$	96,924	$	108,664	$	178,730	$	199,045
Printer and media		38,694		44,665		74,221		88,138
Service		34,747		37,301		69,696		72,162
Voice solutions		30,586		30,452		57,982		40,255
Total	$	200,951	$	221,082	$	380,629	$	399,600

14

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 12. Product Warranties

The following table summarizes our warranty liability activity included in current liabilities, for the six month period ended July 1, 2012 and the year ended December 31, 2011, respectively (in thousands):

	July 1, 2012			December 31, 2011
Beginning balance	$	4,853		$	2,555
Vocollect addition at acquisition		—			948
Payments or parts usage		(2,645	)		(5,867	)
Additional provision		3,060			7,217
Ending balance	$	5,268		$	4,853

Note 13. Commitments and Contingencies

We have entered into a variety of agreements with third parties that include indemnification clauses, both in the ordinary course of business and in connection with our divestitures of certain product lines. These clauses require us to compensate these third parties for certain liabilities and damages that may be incurred by them. Fair value of guarantees is required to be recorded as a liability. We do not believe that we have any significant exposure related to such guarantees and therefore have not recorded a liability as of July 1, 2012 or December 31, 2011. We have not made any significant indemnification payments as a result of these clauses.

In the three and six months ended July 1, 2012, we recorded $0.5 and $1.9 million in engineering fees related to take or pay purchase commitment agreements. We expect to make these payments by the end of 2012.

We currently, and from time to time, are subject to disputes, claims and lawsuits arising in the ordinary course of business. With the exception of certain cases involving intellectual property described below, the external legal costs incurred in these matters are expensed. These matters include claims by third parties against us for amounts allegedly owed to them as well as counterclaims against us in cases where we have made claims against third parties. Resolution of these disputes could result in the write down or write off of accounts receivable or the payment of damages. The ultimate resolution of such matters is inherently subject to uncertainty. An adverse outcome in certain of these matters could result in a material charge in the period in which the matter is resolved. However, we currently do not expect the ultimate resolution of pending proceedings and disputes to have a material effect on our business, financial condition, results of operations or liquidity. In the second quarter of 2012, we settled a pending lawsuit against us in the amount of $1.2 million. This amount is recorded in Selling, general and administrative expenses on our condensed consolidated statement of operations.

One of our pending lawsuits involves the defense of our patents; the external legal costs incurred in this matter are capitalized. We capitalize external legal costs incurred in the defense of our patents when we believe that there is an evident increase in the value of the patent and that the successful outcome of the legal action is probable. During the course of any legal action, the court where the case is pending makes decisions and issues rulings of various kinds, which may be favorable or unfavorable. We monitor developments in the legal action, the legal costs incurred and the anticipated outcome of the legal action, and assess the likelihood of a successful outcome based on the entire action. If changes in the anticipated outcome occur that reduce the likelihood of a successful outcome to less than probable, the capitalized costs would be charged to expense in the period in which the change is determined. As of July 1, 2012 and December, 31, 2011, $7.5 and $7.4 million of legal patent costs have been capitalized, respectively. All of these amounts relate to the case Alien Technologies Corporation v. Intermec, Inc., et al., Civil Action No. 3:06-cv-0051, United States District Court for the District of North Dakota, Southeastern Division (the “Alien Case”). The capitalized legal patent costs are recorded in other assets on our condensed consolidated balance sheets.

15

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 14. Pension and Other Postretirement Benefits Liabilities

The components of net pension and postretirement periodic benefit cost (income) for the three and six months ended July 1, 2012 and July 3, 2011, were as follows (in thousands):

	U.S. Defined Benefit Plans						Non U.S. Defined Benefit Plans						Other Postretirement Benefit Plans
	2012			2011			2012			2011			2012			2011
Three Months Ended July 1, 2012, and July 3, 2011:
Interest cost	$	2,983		$	3,029		$	495		$	528		$	34		$	40
Expected return on plan assets		(2,592	)		(2,689	)		(532	)		(517	)		—			—
Amortization and deferrals:
Transition asset		—			—			(34	)		(33	)		—			—
Actuarial loss		888			563			163			163			—			—
Prior service cost		—			—			—			—			(41	)		(40	)
Net pension and postretirement periodic benefit cost (income)	$	1,279		$	903		$	92		$	141		$	(7	)	$	—

	U.S. Defined Benefit Plans						Non U.S. Defined Benefit Plans						Other Postretirement Benefit Plans
	2012			2011			2012			2011			2012			2011
Six Months Ended July 1, 2012, and July 3, 2011:
Interest cost	$	5,965		$	6,059		$	994		$	1,057		$	69		$	80
Expected return on plan assets		(5,183	)		(5,377	)		(1,069	)		(1,035	)		—			—
Amortization and deferrals:
Transition asset		—			—			(68	)		(66	)		—			—
Actuarial loss		1,776			1,126			328			326			—			—
Prior service cost		—			—			—			—			(83	)		(79	)
Net pension and postretirement periodic benefit cost (income)	$	2,558		$	1,808		$	185		$	282		$	(14	)	$	1

Our pension and other postretirement benefit plan contributions for the three and six months ended July 1, 2012, were as follows (in thousands):

	Three Months Ended July 1, 2012		Six Months Ended July 1, 2012
U.S. defined benefit postretirement benefit plans	$	2,122		3,117
Matching contributions to 401(k) plan		1,087		2,322
Foreign pension plans		956		1,770
Total	$	4,165		7,209

Benefits paid pertaining to our other postretirement benefit plans were not material for the three and six months ended July 1, 2012.

We expect to contribute an additional $10.7 million to these plans during the remainder of 2012, including $4.8 million of contributions to our U.S. pension plan, $2.3 million of benefit payments for our unfunded U.S. defined benefit plans, $1.9 million in matching contributions to our 401(k) plan, and $1.7 million in contributions to our foreign pension plans.

Note 15. Acquisitions

On March 3, 2011, we completed our acquisition of Vocollect Inc. by acquiring all of the outstanding shares of capital stock of Vocollect and all in-the-money options to purchase shares of common stock of Vocollect for an aggregate purchase price of approximately $197 million in cash, net of cash acquired. Vocollect provides voice-centric solutions for mobile workers in distribution, warehouse and healthcare environments worldwide through design, manufacture and sale of voice data collection terminals and related software. This acquisition is part of our strategy to expand our warehouse and mobility solutions.

16

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

We have included the financial results of Vocollect in our condensed consolidated financial statements from the date of acquisition. Vocollect acquisition and related costs of approximately $0.3 and $5.2 million were recorded as an expense for the three and six months ended July 3, 2011, respectively, and are included in the total acquisition costs of $5.2 million in our condensed consolidated statement of operations. Acquisition related costs include direct integration costs, transaction fees and professional services.

The allocation of the purchase price to Vocollect’s assets acquired and liabilities assumed, net of cash acquired, is as follows (in thousands):

	At Acquisition March 3, 2011 (Adjusted)
Accounts receivable (gross contractual receivables total of $21,461)	$	20,569
Inventories		7,520
Net deferred tax assets		7,880
Other current assets		7,353
Goodwill (including $7.9 million for assembled workforce)		140,162
Intangible assets		67,500
Property, plant and equipment		9,123
Other assets		137
Accounts payable		(6,818	)
Payroll and related expenses		(8,812	)
Deferred revenue		(10,936	)
Accrued expenses		(8,739	)
Deferred tax liabilities		(22,570	)
Long-term deferred revenue		(4,282	)
Other long-term liabilities		(1,370	)
Total net assets acquired	$	196,717

Goodwill recognized is attributable primarily to the expected synergies and the assembled workforce of Vocollect and is not deductible for income tax purposes. Goodwill associated with the Vocollect acquisition has been allocated to the Voice solutions reportable segment.

Unaudited Pro Forma Financial Information

The unaudited pro forma financial information in the table below summarizes the combined results of operations for Intermec and Vocollect as though the acquisition occurred at the beginning of fiscal 2011. The pro forma financial information presented below is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisitions and any borrowings undertaken to finance the acquisition had taken place at the beginning of fiscal 2011.

(in thousands)	Three Months Ended July 3, 2011			Six Months Ended July 3, 2011
Total revenues	$	221,082		$	417,911
Net loss		(3,796	)		(7,006	)

Note 16. Goodwill and Other Long-Lived Assets

Goodwill

We assign goodwill to our reporting units based on the expected benefit from the growth and synergies arising from each acquisition. We have three reportable segments: Intermec-branded products, Intermec-branded services and Voice solutions.

17

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Intermec-branded services and Voice solutions each comprise two reporting units. Intermec-branded services are divided into: Core Service and Intermec Global Solutions (“IGS”). Voice solutions contains the Supply Chain (“VSC”) and Healthcare (“VHS”) reporting units.

The following table represents changes in goodwill (amounts in thousands):

Reportable Segment	Reporting Unit	Goodwill balance at 12/31/2011		Goodwill impairment			Goodwill balance at 7/1/2012
Intermec-branded services:	Intermec Global Solutions	$	3,348	$	—		$	3,348
Voice solutions:	Supply chain		130,682		(40,689	)		89,993
	Healthcare		9,480		(825	)		8,655
	Total:	$	143,510	$	(41,514	)	$	101,996

Goodwill impairment charges of $26.6 and $41.5 million were recognized during the three and six months ended July 1, 2012, respectively. There were no goodwill impairment charges for the similar periods in 2011.

Q1 2012 goodwill impairment analysis

During the first quarter of 2012, two events occurred that triggered an analysis of the carrying value of goodwill and resulted in the estimated write down of goodwill of $14.9 million. Specifically, operating income was less than our forecast, primarily due to an $19 million loss on operations in the first quarter principally in the Intermec-branded products and services segments. In addition, our financial results negatively impacted the price per share of Intermec stock, causing the market capitalization of the Company to be significantly below its net book value. These triggering events were indicators that it was more likely than not the fair value of the Company’s goodwill was less than its book value.

We prepared a Step 1 goodwill impairment analysis to determine the fair values of all three reporting units with goodwill (Intermec Global Solutions, Healthcare, and Supply Chain). To calculate the fair values we used the discounted cash flow method and market approach. We made significant assumptions and estimates about the extent and timing of future cash flows, growth rates, and discount rates that represent unobservable inputs into our valuation methodologies used to calculate fair value. The cash flows were estimated over a significant future period of time, which made those estimates and assumptions subject to a high degree of uncertainty. Where available and as appropriate, comparative market multiples and the quoted market price of our common stock were used to corroborate the results of the discounted cash flow method and market approach. Assumptions used in our analysis that have the most significant effect on the estimated fair values of our reporting units include:

• Our estimated weighted-average cost of capital (WACC); and

• Our estimated long-term growth

• Market mutiples

Once we had determined our assumptions, we calculated the fair value of each reporting unit and compared it to the carrying value of the reporting unit. After performing our Step 1 analysis for the reporting units, we determined that the carrying value of the Supply Chain reporting unit exceeded its fair value by $14.9 million and recognized an estimated impairment charge in the first quarter. Due to the timing and complexity of this analysis, Step 2 of the impairment test was substantially completed in the second quarter of 2012. After performing that test we determined we had an additional goodwill impairment of $25.8 million associated with our Supply Chain reporting unit. The additional impairment was the result of an increase in the fair value of developed and in process technology intangible assets within the Supply Chain reporting unit. The increase in the intangible assets reduced the implied fair value of the goodwill, and we recognized a $40.7 million cumulative impairment of the Supply Chain reporting unit goodwill for the six months ended July 1, 2012.

Determining the fair value of goodwill for the Supply Chain reporting unit for Step 2 was judgmental in nature and involved the use of significant estimates and assumptions to calculate a hypothetical fair value of the assets and liabilities within the reporting unit. Our analysis utilized the income approach to calculate the implied fair value of goodwill of the Supply Chain reporting unit. The key inputs we used in the income approach included our forecast of revenue and expenses, a migration curve of developed and in-process technology, tax rate, discount rates, customer retention rates, useful lives, and contributory charge rates. These key inputs, for the income approach, are classified as Level 3 within the fair value hierarchy; see Note 3 Fair Value Measurements.

18

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Q2 2012 goodwill impairment analysis

During the three months ended July 1, 2012, we changed the composition of key senior management at the reporting units and also changed our Chief Executive Officer. Additionally, we evaluated certain market trends and specific changes in our marketplace including, macro and micro economic conditions, expected government spending and industry data. As a result of the changes and evaluations, a review was performed over all areas in which we engage in business. Upon conclusion of the review, key operational and investment decisions were made which resulted in changes in the amount and timing of receipts and expenditures. Specifically, forecasts of revenue, research and development costs, capital expenditures, and other inputs to operations were revised, and the result was reduced cash flow forecasts across the three reporting units with goodwill. Consequently, a triggering event occurred to evaluate impairment of goodwill, specific to facts and circumstances during the three months ended July 1, 2012.

We prepared a Step 1 goodwill impairment analysis to determine the fair values of all three reporting units with goodwill (Intermec Global Solutions, Healthcare, and Supply Chain). To calculate the fair values we used the discounted cash flow method and market approach. We utilized the same methods listed above in Q1 2012 goodwill impairment analysis to perform our Step 1 analysis for the three months ended July 1, 2012. Once we had determined our assumptions we calculated the fair value of each reporting unit and compared it to the carrying value of the reporting unit.

After performing our Step 1 analysis, for the reporting units, we determined that the carrying value of the Healthcare reporting unit exceeded its fair value, so we then performed a Step 2 analysis. Based on our preliminary Step 2 analysis we determined we had an estimated goodwill impairment of $0.8 million associated with our Healthcare reporting unit. This impairment was primarily the result of a reduction in our long term business forecast specifically related to expected government spending in the skilled nursing area, the likely impact on capital investments in that market and the timing of the launch of new products for our Healthcare reporting unit. Due to the timing and complexity of this Step 2 analysis, we will finalize it in the third quarter of 2012 and the impairment amount may change at that time.

Determining the fair value of goodwill for the Healthcare reporting unit for Step 2 is judgmental in nature and involves the use of significant estimates and assumptions to perform a hypothetical fair value of the assets and liabilities within the reporting unit. Our analysis utilized the income approach to calculate the implied fair value of goodwill of the Healthcare reporting unit. The key inputs we used in the income approach included our forecast of revenue and expenses, a migration curve of developed and new technology, tax rate, discount rates, customer retention rates, useful lives, and contributory charge rates. These key inputs, for the income approach, are classified as Level 3 within the fair value hierarchy. See Note 3 Fair Value Measurements to our Condensed Consolidated Financial Statements for further detail.

Future goodwill impairments that may be material could be recognized should the recent economic uncertainty continue, our equity price declines on a sustained basis, global economies enter in another recession, or industry growth stagnates further. Our fair value estimates for event-driven impairment tests assume the achievement of future financial results contemplated in our forecasted cash flows and there can be no assurance that we will realize that value. The estimates and assumptions used are subject to significant uncertainties, many of which are beyond our control, and there is no assurance that anticipated financial results will be achieved.

Valuation of Long-Lived Assets

Long-lived assets, such as property, plant, and equipment, and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of asset groups to be held and used is measured by a comparison of the carrying amount of an asset group to estimated undiscounted future cash flows expected to be generated by the asset group. If the carrying amount of an asset group exceeds its estimated future cash flows, an impairment charge is recognized in our statement of operations and as a reduction to the asset group to the extent that the fair market value of the asset group is less than its carrying value. Due to the same circumstances that required the interim goodwill impairment test above, we evaluated our long lived assets for impairment for the quarters ended April 1, 2012 and July 1, 2012. We determined that the carrying amount of our long-lived assets did not exceed their estimated undiscounted future cash flows, and thus our long-lived assets are not impaired as of April 1, 2012 and July 1, 2012.

Note 17. Restructuring

After revising our 2012 business forecast to reflect current economic and other expectations, we committed to a business restructuring plan on June 12, 2012 that was intended to better align our cost structure with our current and anticipated needs by lowering costs primarily in North America and Europe. These reductions were primarily intended to lower our service and supply chain overhead and general and administrative support costs, with lesser impacts to Research and Development and Sales and Marketing. Under the business restructuring plan, we are reducing our work force primarily in the United States and Europe by approximately 160 employees, which represent approximately 7% of our current total global work force. We implemented this restructuring plan beginning in June of 2012 and expect to complete it over the remainder of fiscal year 2012.

19

INTERMEC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

The total restructuring costs for this plan are expected to be $6.4 million, including employee termination costs of $5.9 million and $0.5 million of other associated costs. We recorded $5.9 million of these charges in the second quarter of 2012. We expect to record the majority of the remaining charge throughout 2012. We anticipate that substantially all of the severance-related and periodic other associated costs will be cash expenditures. These costs are recorded on our condensed consolidated statement of operations in restructuring charges.

The reconciliation of accrued restructuring charges as of July 1, 2012 is summarized in the table below (in millions):

	Accrued Employee Termination Costs per Contract			Accrued Other Costs			Total Accrued Restructuring Charges
Balance at December 31, 2011	$	1.0		$	1.2		$	2.2
Restructuring charges for 2012 plan		5.9			—			5.9
Utilization of restructuring plans		(1.1	)		(0.2	)		(1.3	)
Reversal of prior year restructuring charges		(0.3	)		—			(0.3	)
Balance at July 1, 2012	$	5.5		$	1.0		$	6.5

Note 18. Accumulated Other Comprehensive Loss

At July 1, 2012 and December 31, 2011, accumulated other comprehensive income comprised the following (in thousands):

	July 1, 2012			December 31, 2011
Foreign currency translation adjustment	$	(6,563	)	$	(4,546	)
Unamortized benefit plan costs		(78,861	)		(74,623	)
Unrealized loss on investments		(317	)		(308	)
Accumulated other comprehensive loss	$	(85,741	)	$	(79,477	)

20

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

FORWARD-LOOKING STATEMENTS AND RISK FACTORS; SAFE HARBOR

Statements made in this filing and any related statements that express Intermec’s or our management’s intentions, hopes, indications, beliefs, expectations, guidance, estimates, forecasts or predictions of the future constitute forward-looking statements, as defined by the Private Securities Litigation Reform Act of 1995, and relate to matters that are not historical facts. They include, without limitation statements about: our view of general economic and market conditions; our revenue, expense, earnings, tax attributes or financial outlook for the current or any other period; our compliance with covenants under our secured credit facility; our analysis of deferred tax valuation allowances, impairment analysis, and cost reduction plans; our ability to develop, produce, market or sell our products, either directly or through third parties, to reduce or control expenses, to improve efficiency, to realign resources, to successfully integrate acquired companies, or to continue operational improvement and year-over-year or sequential growth; our management succession; and the applicability of accounting policies used in our financial reporting. When used in this document and in documents it refers to, the words “anticipate,” “believe,” “will,” “intend,” “project” and “expect” and similar expressions as they relate to us or our management are intended to identify such forward-looking statements. These statements represent beliefs and expectations only as of the date they were made. We may elect to update forward-looking statements but we expressly disclaim any obligation to do so, even if our beliefs and expectations change.

Actual results may differ from those expressed or implied in our forward-looking statements. Such forward-looking statements involve and are subject to certain risks and uncertainties, which may cause our actual results to differ materially from those discussed in a forward-looking statement. These include, but are not limited to, risks and uncertainties described more fully in our reports filed or to be filed with the Securities and Exchange Commission including, but not limited to, our 2011 Form 10-K, current reports on Form 8-K, and quarterly reports on Form 10-Q, which are available on our website at www.intermec.com.

You are encouraged to review the Risk Factors portion of Item 1A of Part II of this filing which discusses the risk factors associated with our business.

Overview

Intermec is a global business that designs, develops, integrates, sells and resells wired and wireless automated identification and data collection (“AIDC”) products and related services. Our products and services are used by businesses of all sizes, throughout the world, and are particularly suited for challenging or harsh environments where mobility, reliability and durability are important. Our products include mobile computers, barcode scanners, printers, label media, radio frequency identification (“RFID”) products and related software. With our acquisition of Vocollect in March 2011, our products now include wearable voice data collection devices and related software. We also offer a variety of services related to our product offerings. Refer to Item 1 Business, in our 2011 Form 10-K, for detail about our products and services. Most of our revenue is currently generated through sales of mobile computers, wearable voice data capture devices and related software, printers and repair services.

Our strategy is to provide mobile business solutions that help our customers improve workflow performance, increase revenues, lower costs and improve customer satisfaction and loyalty. As part of that strategy, we seek to strengthen our position as “a Solutions Company” in the AIDC industry through vertical market expertise, a solutions orientation and customer and partner intimacy. We also seek to grow our business by targeting vertical markets, increasing our marketing activities, expanding our channel, adding more software and managed services to our offerings and introducing innovative new products.

Total revenue declined on a year-over-year basis predominantly from the segments of our business that are most comparable to our business as it existed prior to the acquisitions in March 2011. This decline was more pronounced in our Intermec-branded products segment, predominately in Europe, Middle East and Africa (“EMEA”) and to a lesser extent in North America, Asia Pacific (“ASIAPAC”) and Latin America (“LATAM”) geographic regions. We believe that our revenue decline reflects a decrease in enterprise spending globally and competitive pressure, particularly in Europe. We believe that many of our end customers completed projects in 2011 that had previously been started, but have taken a more cautious approach in 2012. These declines were partially offset by businesses that we acquired last year, specifically, the inclusion of a full six months of results from the Vocollect acquisition, compared to the inclusion of approximately four months results in the first six months of 2011 following the acquisition date of March 3, 2011, and the inclusion of a full six months of Enterprise Mobile results, compared to three and one half months of results included in the first six months of the prior year following the acquisition date of March 15, 2011.

For the three months ended July 1, 2012, worldwide revenues decreased 9% over the prior-year quarter. International revenues declined 12% over the prior-year quarter reflecting the negative impact of foreign currency exchange rates, significantly lower sales in EMEA, partially offset by growth in ASIAPAC and LATAM. Revenues in North America decreased 6% due primarily to declines in Intermec-branded product sales and a reduction in sales to the U.S. government. Within our Intermec-branded product categories, Systems and solutions revenues declined 11%, and Printer and media revenue declined 14%, partially mitigated by a smaller decline in our Intermec-branded services and a small increase in our Voice solutions businesses.

21

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

For the six months ended July 1, 2012, worldwide revenues decreased 5% over the prior-year quarter and decreased 11% when revenue from businesses acquired during the first quarter of 2011 are excluded. International revenues declined 12% over the prior-year quarter reflecting the negative impact of foreign currency exchange rates, significantly lower sales in EMEA, partially offset by the benefit of acquired revenues in those geographies. Revenues in North America increased due to the positive effects of revenue from Vocollect and Enterprise Mobile, partially offset by declines in Intermec-branded product sales. Within our Intermec-branded product categories, Systems and solutions revenues declined 10%, and Printer and media revenue declined 16%. Intermec-branded service revenue decreased 4% as compared with the prior-year period, largely due to the related lower product sales, and was down 9% when revenues from acquired businesses are excluded.

Total gross profit margin for the three months ended July 1, 2012 were 39.4%, as compared to 41.3% in the prior-year quarter, reflecting increased discounts on Intermec-branded products, reduced sales leverage on fixed costs, negative foreign currency exchange impacts and certain engineering fee payments.

Total gross profit margins for the six months ended July 1, 2012 were 38.1%, as compared to 39.9% in the prior year quarter, reflecting increased discounts on Intermec-branded products, negative foreign currency exchange impacts and reduced sales, partially offset by higher margins on our Voice-solutions segment which included a full six months of results, and a full six months results for Enterprise Mobile which was included in the Intermec-branded services segment. Additionally, in the first six months of 2012 we had several unusual charges and expenses that we do not anticipate will recur, including a $1.9 million charge for non-recurring engineering fees for volume buy pay outs on minimum purchase commitments and a $0.9 million charge for royalties based on the outcome of a software vendor audit.

Our financial reporting currency is the U.S. dollar, and changes in exchange rates can significantly affect our financial trends and reported results. Overall, as compared to the first six months of 2011, currency exchange rates negatively affected revenues by $8.5 million and $11.4 million in the first three and six months of 2012, respectively. Our consolidated revenues and operating expenses are subject to the fluctuations of foreign exchange rates; however, our cost of revenue is primarily denominated in U.S. dollars, and therefore, is less affected by changes in foreign exchange rates. If the U.S. dollar weakens year-over-year relative to currencies in our international locations, our consolidated revenues, costs of revenues and operating expenses will be higher than if currencies had remained constant. A weaker U.S. dollar typically results in improved gross margin yields as the increase in revenue would normally exceed the corresponding increase in costs. If the U.S. dollar strengthens year-over-year relative to currencies in our international locations, our consolidated revenues, operating expenses and to a certain extent cost of revenues will be lower than if currencies had remained constant. A stronger U.S. dollar typically results in diminished gross margin yields as the decreased revenue would normally outpace the corresponding reduction in costs. We believe it is important to evaluate our growth rates before and after the effect of foreign currency changes.

On June 12, 2012, we committed to a business restructuring plan intended to better align our cost structure with our current and anticipated needs by lowering costs in North America and Europe. These reductions are intended to lower our general and administrative support costs. Under the business restructuring plan, we will reduce our work force primarily in the United States and Europe by approximately 160 employees, which represent approximately 7% of our current total global workforce. We implemented this restructuring plan beginning later in the second quarter of 2012 and expect to complete it over the remainder of fiscal year 2012.

The total restructuring costs for this plan are expected to be approximately $6.4 million, including employee termination costs of $5.9 million and $0.5 million of other associated costs. We recorded $5.9 million of these charges in both the three and six months ended July 1, 2012. We expect to record the majority of the remaining charge throughout 2012. We anticipate that substantially all of the severance-related and periodic other associated costs will be cash expenditures. These costs are recorded on our condensed consolidated statement of operations in restructuring costs.

22

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Results of Operations

The following compares our results of operations and percentages of revenues for the three and six months ended July 1, 2012 and July 3, 2011 (in millions, except for per share data):

	Three Months Ended						Six Months Ended
	July 1, 2012			July 3, 2011			July 1, 2012			July 3, 2011
	Amounts			Amounts			Amounts			Amounts
Revenues	$	201.0		$	221.1		$	380.6		$	399.6
Costs and expenses:
Cost of revenues		121.8			129.8			235.6			240.0
Research and development		20.4			22.8			40.4			40.7
Selling, general and administrative		61.4			66.1			127.4			120.3
Impairment of goodwill		26.6			—			41.5			—
Gain on sale of assets		(1.3	)		—			(2.7	)		—
Acquisition costs		—			0.4			—			5.2
Restructuring charges		5.6			5.1			5.6			5.1
Total costs and expenses		234.5			224.2			447.8			411.3
Operating loss		(33.5	)		(3.1	)		(67.2	)		(11.7	)
Interest, net		(0.8	)		(0.6	)		(1.4	)		(1.0	)
Loss before income taxes		(34.3	)		(3.7	)		(68.6	)		(12.7	)
Income tax (benefit) expense		3.2			0.1			211.0			(2.8	)
Net loss	$	(37.5	)	$	(3.8	)	$	(279.6	)	$	(9.9	)
Basic loss per share	$	(0.62	)	$	(0.06	)	$	(4.65	)	$	(0.16	)
Diluted loss per share	$	(0.62	)	$	(0.06	)	$	(4.65	)	$	(0.16	)
	Percent of Revenues			Percent of Revenues			Percent of Revenues			Percent of Revenues
Costs and expenses:
Cost of revenues		60.6	%		58.7	%		61.9	%		60.1	%
Research and development		10.1			10.3			10.6			10.2
Selling, general and administrative		30.5			29.9			33.5			30.1
Impairment of goodwill		13.2			—			10.9			—
Gain on sale of assets		(0.6	)		—			(0.7	)		—
Acquisition costs		—			0.2			—			1.3
Restructuring charges		2.8			2.3			1.5			1.3
Total costs and expenses		116.7			101.4			117.7			102.9
Operating loss		(16.7	)		(1.4	)		(17.7	)		(2.9	)
Interest, net		(0.4	)		(0.3	)		(0.4	)		(0.3	)
Loss before income taxes		(17.1	)		(1.7	)		(18.0	)		(3.2	)
Income tax expense (benefit)		1.6			0.0			55.4			(0.7	)
Net loss		(18.7	)%		(1.7	)%		(73.5	)%		(2.5	)%

23

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Revenues (in millions)

Revenues by category and geographic region and as a percentage of total revenues for the three months ended July 1, 2012, and July 3, 2011, as well as the same three months revenue changes were as follows (in millions):

	Three Months Ended
	July 1,		Percent of			July 3,		Percent of						Percentage
	2012		Revenues			2011		Revenues			Change			Change
Revenues by category:
Intermec-branded:
Systems and solutions	$	96.9		48.2	%	$	108.6		49.1	%	$	(11.7	)		(10.8	)%
Printer and media		38.7		19.3			44.7		20.2			(6.0	)		(13.4	)
Services		34.8		17.3			37.3		16.9			(2.5	)		(6.7	)
Voice solutions		30.6		15.2			30.5		13.8			0.1			0.3
Total revenues	$	201.0		100.0	%	$	221.1		100.0	%	$	(20.1	)		(9.1	)%
	Three Months Ended
	July 1,		Percent of			July 3,		Percent of						Percentage
	2012		Revenues			2011		Revenues			Change			Change
Revenues by geographic region:
North America	$	101.2		50.3	%	$	107.2		48.5	%	$	(6.0	)		(5.6	)%
Europe, Middle East and Africa (EMEA)		55.9		27.8			70.0		31.7			(14.1	)		(20.1	)
Latin America and Mexico (LATAM)		26.7		13.3			26.4		11.9			0.3			1.1
Asia Pacific (ASIAPAC)		17.2		8.6			17.5		7.9			(0.3	)		(1.7	)
Total revenues	$	201.0		100.0	%	$	221.1		100.0	%	$	(20.1	)		(9.1	)%

Revenue for the three months ended July 1, 2012, decreased $20.1 million, or 9.1%, compared to the prior year period. This decrease is substantially due to declines in sales in our Systems and solutions and Printer and media segments in our EMEA region primarily due to economic uncertainty in the region, increased competitive pressure and an $8.5 million unfavorable change in foreign currencies as compared to the prior year currency rates across all regions. The majority of the unfavorable change in foreign currencies is due to currency rates of the Euro, Peso and Real.

Within the Intermec-branded product segment, Systems and solutions and Printer and media revenue for the three months ended July 1, 2012 decreased $17.7 million from the prior year comparable period primarily due to declines in sales in EMEA which reflect economic uncertainty in the region and competitive pressure and, to a lesser extent, a decline in sales of our Printer and media product line in North America.

Intermec-branded service revenues of $34.8 million for the quarter ended July 1, 2012, declined compared to the corresponding prior-year period. Service revenue declined in the three months ended July 1, 2012 as compared to the prior-year period. This decline is primarily attributable to reduced product sales that drive service revenues and a lower average price per unit under contract due to mix of lower cost product sales and competitive pricing.

Voice solutions revenue of $30.6 million for the three months ended July 1, 2012 increased $0.1 million, or 0.3%, compared to the corresponding prior-year period. Sales were lower than expected primarily due to delays in closing business as a result of turnover in our voice sales team in North America. We also anticipate reduced government program reimbursements related to customers of our Voice solution Healthcare (“VHS”) reporting unit of Voice Solutions, which may impact revenues going forward.

Revenues varied across the geographic regions for the quarter ended July 1, 2012. North America revenues decreased $6.0 million, or 5.6%. The decrease in North America revenues was attributable primarily to a decline in Intermec-branded printer and media sales. EMEA revenues decreased $14.1 million, or 20.1%, over the corresponding prior-year period. The decrease in EMEA revenues was mainly attributable to lower sales in our Intermec-branded product revenues driven by a slowing of large deals compared to the prior-year period, competitive pressure and economic conditions in that region. Foreign currency conversion rates unfavorably impacted EMEA revenue by $4.7 million, or 6.7%. LATAM revenues grew slightly, up $0.3 million from the prior year quarter. ASIAPAC revenues decreased $0.3 million, or 1.7% primarily due to a strong comparable quarter in 2011. Across all regions the impact of foreign currency rates as compared to the foreign currency rates in the prior-year period was $8.5 million, or 3.9%, unfavorable to revenue.

24

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Revenues by category and geographic region and as a percentage of total revenues for the six months ended July 1, 2012, and July 3, 2011, as well as the same six months revenue changes were as follows (in millions):

	Six Months Ended
	July 1, 2012		Percent of Revenues			July 3, 2011		Percent of Revenues			Change			Percentage Change
Revenues by category:
Intermec-branded:
Systems and solutions	$	178.7		47.0	%	$	199.0		49.8	%	$	(20.3	)		(10.2	)%
Printer and media		74.2		19.5			88.1		22.0			(13.9	)		(15.8	)
Services		69.7		18.3			72.2		18.1			(2.5	)		(3.5	)
Voice solutions		58.0		15.2			40.3		10.1			17.7			43.9
Total revenues	$	380.6		100.0	%	$	399.6		100.0	%	$	(19.0	)		(4.8	)%
	Six Months Ended
	July 1, 2012		Percent of Revenues			July 3, 2011		Percent of Revenues			Change			Percentage Change
Revenues by geographic region:
North America	$	192.8		50.7	%	$	185.6		46.4	%	$	7.2			3.9	%
Europe, Middle East and Africa (EMEA)		110.5		29.0			135.9		34.0			(25.4	)		(18.7	)
Latin America and Mexico (LATAM)		46.5		12.2			46.3		11.6			0.2			0.4
Asia Pacific (ASIAPAC)		30.8		8.1			31.8		8.0			(1.0	)		(3.1	)
Total revenues	$	380.6		100.0	%	$	399.6		100.0	%	$	(19.0	)		(4.8	)%

Revenue for the six months ended July 1, 2012, decreased $19.0 million, or 4.8%, due largely to an $11.4 million unfavorable change in foreign currencies as compared to the prior year currency rates across all regions. The decline in sales in our Systems and solutions and Printer and media segments in our EMEA region were primarily due to a slowing of large deals, competitive pressure and economic uncertainty in the region. These declines were partially offset by modest growth in and the inclusion of a full six months of the operations of Vocollect and Enterprise Mobile. These operations increased revenues by $21.7 million over the prior year.

Within the Intermec-branded product segment, Systems and solutions and Printer and media revenue for the six months ended July 1, 2012 decreased $34.2 million from the prior year comparable period primarily due to the declines in sales in EMEA which we believe reflects a slowing of large deals, competitive pressure and uncertainty in the economy and, to a lesser extent, a decline in sales of our Printer and media product line in North America.

Intermec-branded service revenues of $69.7 million for the six months ended July 1, 2012, declined compared to the corresponding prior-year period. Intermec-branded service revenues for the six months ended July 1, 2012, includes $7.1 million of revenue from Enterprise Mobile, acquired in 2011, which represents growth of $4.0 million from the $3.1 million of comparable revenues for the first six months of 2011. The decline is primarily attributable to reduced product sales and a lower average price per unit under contract due to mix of lower cost product sales and competitive pricing.

Voice solutions revenue of $58.0 million for the six months ended July 1, 2012, increased $17.7 million, or 43.9%, compared to the corresponding prior-year period, due to the inclusion of a full six months results from the Vocollect acquisition, compared to the inclusion of the results from acquisition date, March 3, 2011, in the first six months of 2011.

Revenues varied across the geographic regions for the six months ended July 1, 2012. North America revenues increased $7.2 million or 3.9%. The increase in North America revenues was attributable to $16.4 million for the inclusion of a full six months results of entities acquired in March, 2011, offset by a decline in Intermec-branded printer and media sales. EMEA revenues decreased $25.4 million, or 18.7%, over the corresponding prior-year period. The decrease in EMEA revenues was mainly attributable to lower sales in our Intermec-branded product revenues driven by a slowing of large deals compared to the prior-year period and economic conditions in that region. Foreign currency conversion rates unfavorably impacted EMEA revenue by $6.7 million, or 4.9%. These decreases in EMEA were partially offset by the inclusion of a full six months of Vocollect results, which increased $4.6 million over the prior year. LATAM revenues remained fairly steady from the prior year’s period. ASIAPAC revenues decreased $1.0 million, or 3.1% primarily due to a particularly strong first six months in 2011. Across all regions the impact of foreign currency rates as compared to the foreign currency rates in the prior-year period

25

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

was $11.4 million, or 2.9%, unfavorable to revenue. Operations of acquired entities positively contributed $16.4, $4.6 and $0.4 million of the total change in revenues in North America, EMEA, and LATAM, respectively, for the six months ended July 1, 2012.

Gross Profit and Gross Margin

Gross profit and gross margin by revenue category for the three and months ended July 1, 2012 and July 3, 2011, were as follows (in millions):

	Three Months Ended										Six Months Ended
	July 1, 2012					July 3, 2011					July 1, 2012					July 3, 2011
	Gross Profit		Gross Margin			Gross Profit		Gross Margin			Gross Profit		Gross Margin			Gross Profit		Gross Margin
Intermec-branded products	$	47.3		34.9	%	$	61.0		39.8	%	$	84.2		33.3	%	$	112.5		39.2	%
Intermec-branded service		14.2		41.0	%		13.2		35.5	%		28.0		40.2	%		25.8		35.8	%
Voice solutions		17.6		57.6	%		17.1		56.1	%		32.9		56.8	%		21.3		52.9	%
Total	$	79.1		39.4	%	$	91.3		41.3	%	$	145.1		38.1	%	$	159.6		39.9	%

Total gross profit for the three months and six months ended July 1, 2012, decreased by $12.2 and $14.5 million, respectively, as compared to the corresponding prior-year period. These decreases in total gross profit were primarily attributable to increases pricing discounts on Intermec-branded products, reduced sales, negative foreign currency exchange impacts and engineering fees related to Intermec branded products and services. The gross profit decline for the six months ended July 1, 2012 was partially offset by the inclusion of a full six months of the Voice solutions segment.

Intermec-branded product gross profit decreased $13.7 and $28.3 million for the three and six months ended July 1, 2012, respectively, compared to the corresponding prior-year period primarily due to certain pricing discounts, reduced sales and the impact of foreign currency conversion rates.

The increase in Intermec-branded service gross profit for the three and six months ended July 1, 2012, from the corresponding prior-year periods was attributable to the inclusion of results for a full period from the Enterprise Mobile acquisition and reduced costs, partially offset by reduced sales in our traditional services business, largely in EMEA.

The increase in Voice solutions gross profit for the three and six months ended July 1, 2012, from the corresponding prior-year periods was attributable to a favorable sales mix. The increase for the six months ended July 1, 2012 was also attributable to the inclusion of a full six months of the Voice solutions results.

Operating Expenses and Interest Expense (in millions)

	Three Months Ended
	July 1, 2012			July 3, 2011			Change
Research and development expense	$	20.4		$	22.9		$	(2.5	)
Selling, general and administrative expense		61.4			66.1			(4.7	)
Impairment of goodwill		26.6			—			26.6
Gain on sale of assets		(1.3	)		—			(1.3	)
Acquisition costs		—			0.4			(0.4	)
Restructuring costs		5.6			5.1			0.5
Interest, net		(0.8	)		(0.6	)		(0.2	)
	Six Months Ended
	July 1, 2012			July 3, 2011			Change
Research and development expense	$	40.4		$	40.7		$	(0.3	)
Selling, general and administrative expense		127.4			120.3			7.1
Impairment of goodwill		41.5			—			41.5
Gain on sale of assets		(2.7	)		—			(2.7	)
Acquisition costs		—			5.2			(5.2	)
Restructuring costs		5.6			5.1			0.5
Interest, net		(1.5	)		(1.0	)		(0.5	)

26

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Research and Development Expenses - The total research and development (“R&D”) expenses were $20.4 and $40.4 for the three and six months ended July 1, 2012, respectively, compared to R&D expenses of $22.9 and $40.7 million for the corresponding prior-year periods. The decrease for the three months ended July 1, 2012 was primarily due to decreases in bonus and salary expense. The decrease for the six months ended July 1, 2012 was due to decreases in bonus expense partially offset by the inclusion of a full six months of Vocollect financial results compared to four months in 2011.

Selling, General and Administrative Expenses - Total selling, general and administrative (“SG&A”) expenses were $61.4 and $127.4 million for the three and six months ended July 1, 2012, compared to SG&A expenses of $66.1 and $120.3 million, respectively, for the corresponding prior-year period. The decrease in SG&A expenses for the three months ended July 1, 2012 as compared to the three months ended July 3, 2011, was primarily attributable to decreases in bonus expense, lower commissions on reduced sales, and stock compensation forfeitures related primarily to the departure of the former CEO. This decrease was partially offset by severance pay for our former CEO and a lawsuit settlement and payment. The increase in SG&A expenses for the six months ended July 1, 2012 was due to the inclusion of a full six months of expenses related to businesses acquired in March 2011 and severance pay for our former CEO, partially offset by a decrease in bonus expense, lower commissions on reduced sales, stock compensation forfeitures related primarily to the departure of the former CEO, and a gain on the sale of a small business entity.

Impairment of Goodwill - Impairment of goodwill during the three and six months of 2012 totaled $26.6 and $41.5 million, respectively, representing a partial write-off of previously acquired goodwill. The impairment was a result of a number of factors that existed during the first six months of 2012, and primarily reflects our business performance versus our prior forecast and the Company’s current and recent lower market capitalization. See Note 16 to the Condensed Consolidated Financial Statements Goodwill and Other Long-Lived Assets for further discussion. We had no similar expense related to impairment of goodwill or other long-lived assets in the first three and six months ended July 3, 2011.

Gain on sale of assets - The gain on the sale of assets for the three and six months ended July 1, 2012 represents a $1.3 million gain on the sale of a small European based reseller business. The six months ended July 1, 2012 included an additional $1.4 million net gain from the sale of certain patents. There were no similar transactions for the comparable periods in 2011.

Acquisition Costs - The acquisition costs of $0.4 and $5.2 million for the three and six months ended July 3, 2011 relate to the acquisitions made in the first quarter of 2011.

Restructuring Costs. The increase in restructuring costs of $0.5 and $0.5 million for the three and six months ended July 1, 2012, respectively, as compared to the corresponding prior-year periods, was mainly due to the restructuring program announced in June 2012 to lower general and administrative support costs as compared to the restructuring program announced in May 2011 to restructure our non-US service group. Details of these programs are as follows:

The total pre-tax restructuring costs for the restructuring plan announced in June 2012 are expected to be approximately $6.4 million, including employee termination costs of approximately $5.9 million, and $0.5 million of other transitional costs. We recorded $5.9 million of the restructuring costs in the second quarter of 2012, and expect to record the remainder in the balance of the year. Substantially all of the severance-related and periodic transitional costs were cash expenditures. The net expense of $5.6 million in the quarter includes a small reduction of the estimates recorded for the 2011 restructuring plan.

The total pre-tax restructuring costs for the restructuring plan announced in May 2011 were expected to be approximately $5.9 million, including employee termination costs of approximately $5.1 million, and $0.8 million of other transitional costs. We recorded $5.1 million of the restructuring costs in the second quarter of 2011, and recorded the remainder over the balance of the year. Substantially all of the severance-related and periodic transitional costs were cash expenditures. A small reduction to these costs was recorded in the second quarter of 2012 as noted in the paragraph immediately above.

Interest, Net - Net interest (income) expense was $0.8 and $1.5 million for the three and six months ended July 1, 2012, compared to net interest expense of $0.6 and $1.0 million for the corresponding prior-year periods. The increase in net interest expense was mainly due to the addition of interest paid on a full three months of borrowings under our Revolving Credit Facility, which was used to finance a portion of the Vocollect acquisition in March, 2011.

Income tax (benefit) expense (in millions)

	Three Months Ended						Six Months Ended
	July 1,		July 3,		Change from		July 1,		July 3,			Change from
	2012		2011		prior year		2012		2011			prior year
Income tax (benefit) expense	$	3.1	$	0.1	$	3.0	$	211.0	$	(2.8	)	$	213.8

27

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In the second quarter, we recorded a tax provision of $1.7 million on foreign earnings and no tax benefit for earnings in the United States, Singapore and Japan due to losses in those jurisdictions. We also provided $1.4 million for deferred taxes on projected future repatriation from certain foreign subsidiaries which are not permanently reinvested. The tax provision for the three months ending April 1, 2012 includes a net $206.9 million non-cash charge to record a valuation allowance against our U.S. deferred tax assets.

Currently, we record valuation allowances in the following jurisdictions: United States, Singapore and Japan. Under GAAP, a valuation allowance against our deferred tax assets is appropriate if based on the available evidence, it is more likely than not (defined as a likelihood of more than 50%) that the value of such assets will not be realized in the future. The valuation of deferred tax assets requires judgment in assessing a number of factors, including the likely future tax consequences of events we expect to recognize in our financial statements and tax returns, as well as our historical performance.

Key factors we considered include our results for the quarter ended April 1, 2012; we recorded a pre-tax loss and significantly underperformed relative to our forecast. We also revised our forecast downward in the first quarter of 2012 for our U.S. and global operations for the remainder of 2012. We concluded that it was more likely than not that the value of such assets would not be realized and we recorded a valuation allowance for our U.S. entities representing the full balance of these assets. A sustained period of profitability in our U.S. operations is required before we would change our judgment regarding the need for a full valuation allowance against our U.S. deferred tax assets. In the event that we determine in the future that we expect to benefit from our deferred income tax assets in excess of the net balance at that time, we will make an adjustment to the deferred tax asset valuation allowance. This will reduce the provision for income taxes in that period. Until such time, we will offset U.S. profits against our deferred tax assets and will reduce the overall level of deferred tax assets subject to valuation allowance as a result.

For the jurisdictions where we did not record a valuation allowance, our tax provision includes an estimated annual effective tax rate from continuing operations of approximately 31%. Our effective tax rate from continuing operations in those jurisdictions is lower than the U.S. statutory rate of 35% due primarily to lower tax rates and tax incentives in those jurisdictions.

Liquidity and Capital Resources

Our principal sources of liquidity are our cash, cash equivalents and short-term investments, as well as cash flow that we expect to generate from our operations. In addition, we have a secured Revolving Credit Facility as described in the Capital Resources section below (in millions). Our cash flows are summarized in the following table:

	Six Months Ended
(in millions)	July 1, 2012			July 3, 2011
Net cash used in operating activities	$	(26,799	)	$	(7,165	)
Net cash provided by (used in) investing activities		6,424			(213,043	)
Net cash provided by financing activities		1,034			68,083

Cash Flow Summary

At July 1, 2012, cash, cash equivalents and short-term investments totaled $74.9 million, a decrease of $20.4 million compared to the December 31, 2011 balance of $95.3 million. The decrease in cash is primarily due to cash used in operations described below, offset by proceeds from our company owned life insurance policies.

Cash used in operating activities of $26.8 million in the first six months of 2012 was primarily due to a net loss of $279.6 million, adjusted for a non-cash deferred tax valuation allowance and goodwill impairment charges of $254.4 million and decreases in accounts payable and payroll partially offset by a reduction in accounts receivable. Cash used in operating activities of $7.2 million in the first half of 2011 was primarily due to a net loss of $9.9 million offset by an increase in amortization and deferred tax related to acquisitions.

For the six months ended July 1, 2012, investing activities provided $6.4 million of cash primarily due to proceeds from loans against and the cash surrender of certain executive life insurance programs of $9.0 million and the sale of intellectual property of $1.4 million, offset by capital expenditures of $4.6 million. For the six months ended July 3, 2011, investing activities used $213.0 million of cash primarily due to the acquisition of Vocollect and Enterprise Mobile and capital expenditures of $11.5 million.

28

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Financing activities for the six months ended July 1, 2012, provided cash of $1.0 million primarily related to the vesting of restricted stock units. Financing activities for the six months ended July 3, 2011, provided cash of $68.1 million primarily related to incurring debt of $97.0 million, offset by a $20.0 million repayment of this debt and $10.0 million of stock repurchased.

Capital Resources

Our principal capital resources include cash, cash equivalents and short-term investments. In addition, we have a secured Revolving Credit Facility (the “Revolving Facility”). Effective March 3, 2011, we amended our unsecured revolving credit facility with Wells Fargo Bank, National Association (the “Bank”) to convert the facility to a three-year, $100 million, secured revolving credit facility, which matures on March 3, 2014 (the “Revolving Facility”). The unsecured revolving credit facility was initiated on September 27, 2007. On December 21, 2011, we amended the Revolving Facility to expand our borrowing capacity to $150 million and extended the maturity date to December 31, 2014. On February 2, 2012, we amended the Revolving Facility to modify certain financial covenants relating to net income. Effective March 30, 2012, we amended the Revolving Facility to remove certain financial covenants, to add a new covenant related to minimum adjusted EBITDA and to add a new financial covenant for permitted acquisitions. We were in compliance with all financial and non-financial covenants of the Revolving Facility at July 1, 2012.

During the three and six months ended July 1, 2012, our average borrowings outstanding were $86.5 and $85.7 million, respectively. At July 1, 2012, after considering the financial covenant requirements, we had borrowing capacity of $7.3 million under the Revolving Facility, borrowings of $85.0 million and $1.5 million of letters of credit outstanding under the Revolving Facility. After giving effect to the February 2, 2012 and March 30, 2012 amendments, we were in compliance with the financial covenants of the Revolving Facility at July 1 2012. The key terms of the Revolving Facility are as follows following the amendments:

• Loans bear interest at a variable rate equal to (at our option) (i) LIBOR plus the applicable margin, which ranges from 1.25% to 1.75%, or (ii) the Bank’s prime rate, less the applicable margin, which ranges from 0.25% to 1.00%. If an event of default occurs and is continuing, then the interest rate on all obligations under the Revolving Facility may be increased by 2.0% above the otherwise applicable rate, and the Bank may declare any outstanding obligations under the Revolving Facility to be immediately due and payable. In addition, the Bank may exercise its security interest in our equity interests in the assets of certain of our domestic subsidiaries, and it may call the guaranties of payment obligations made by certain of our domestic subsidiaries.

• A fee ranging from 0.60% to 1.00% on the maximum amount available to be drawn under each letter of credit that is issued and outstanding under the Revolving Facility. The fee on the unused portion of the Revolving Facility ranges from 0.15% to 0.25%.

• Certain of our domestic subsidiaries have guaranteed the Revolving Facility.

• The Revolving Facility contains various restrictions and covenants, including restrictions on our ability and the ability of our subsidiaries to consolidate or merge, make acquisitions, create liens, incur additional indebtedness or dispose of assets.

• The Revolving Facility includes covenants requiring us to meet certain minimum financial performance thresholds, including:

• A ratio of maximum funded debt to EBITDA allowed (as defined in the Revolving Facility) of not more than 2.5 to 1.

• An Asset Coverage Ratio of not less than 1 to 1 for debt to margined assets. For this purpose, a certain percentage of our accounts receivable and inventory balances are included in margined assets.

• The minimum adjusted EBITDA allowed(as defined in the Revolving Facility) for the trailing twelve months is $25 million for the second quarter of 2012, $35 million for the third quarter of 2012, and $45 million for all subsequent quarters.

We expect to be in compliance with our covenants for the next twelve months. A number of factors, including (without limitation) general macroeconomic and competitive conditions, increase the risk and uncertainty relating to achieving the levels of financial performance we expect and that would be required to remain in compliance with the financial covenants in the Revolving Facility, particularly the EBITDA-related covenants. If our financial performance does not meet our expectations we could fail to be in compliance with the financial covenants in the Revolving Facility. For example, with regard to the EBITDA-related covenants, a decline in revenue from expected levels would negatively affect our ability to comply with these covenants.

If we were to determine that we are or expect to be out of compliance with the financial covenants of the Revolving Facility, we believe that we could take steps available to us to avoid, mitigate or cure the breach, which may include, without limitation, steps such as: (i) seeking a waiver of compliance from the Bank and modifying the Revolving Facility in a manner satisfactory to the Bank, as we have done in the past, (ii) reducing the borrowings under the Revolving Facility using our existing cash to make payments to the Bank, or (iii) seeking other amendments or a restructuring or replacement of our Revolving Facility. We believe we can fund our ongoing working capital needs from operating cash flows and cash on hand.

For more information about risk factors related to the Revolving Facility and compliance with its covenants, and about risks related to our business performance, refer to our Risk Factors set forth in Part II, Item 1A. Risk Factors, of this Quarterly Report on Form 10-Q.

29

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

From time to time, we may look for potential acquisition targets for growth opportunities within our market, or to expand into new markets, which we believe can be funded with a combination of cash on hand, projected cash flows from operations and additional financing.

Depending on our assessment of the economic environment from time-to-time, we may decide to hold more cash than may be required to fund our future investment in working capital, capital expenditures and research and development and to implement changes in our cost structure. Projected cash flows from operations are largely based on our revenue estimates, cost estimates, and the related timing of cash receipts and cash disbursements. If actual performance differs from estimated performance, cash flows from operations could be positively or negatively impacted.

Contractual Obligations

Except for the Revolving Facility outlined in Capital Resources above, our contractual commitments as of July 1, 2012 have not changed materially from those disclosed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2011 Form 10-K.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual amounts could differ from those estimates under different assumptions or conditions. Our critical accounting policies and estimates are discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2011 Form 10-K.

Goodwill. The accounting for goodwill requires that we test the goodwill of our reporting units for impairment on an annual basis, or when an event occurs or circumstances change such that it is more likely than not that impairment may exist. Our annual testing date is in the fourth quarter. In assessing the existence of impairment, our considerations include the impact of significant adverse changes in market and economic conditions; the results of our operational performance and strategic plans; unanticipated changes in competition; market share; and the potential for the sale or disposal of all or a significant portion of our business or a reporting unit. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its fair value. Accounting rules require a two-step goodwill impairment test whereby the first step, used to identify potential impairment, compares the fair value of a reporting unit with its carrying amount, including goodwill. If the estimated fair value of a reporting unit is less than its carrying amount, goodwill of the reporting unit is potentially impaired, thus the second step of the goodwill impairment test is used to quantify the amount of any impairment that exists.

We assign goodwill to our reporting units based on the expected benefit from the synergies arising from each business combination. We have three reportable segments: Intermec-branded products, Intermec-branded services and Voice solutions. Intermec-branded services and Voice solutions each comprise two reporting units. Intermec-branded services are divided into: Core Service and Intermec Global Solutions (“IGS”). Voice solutions contains the Vocollect Supply Chain (“VSC”) and Vocollect Healthcare reporting units (“VHS”).

Q1 2012 goodwill impairment analysis

During the first quarter of 2012, two events occurred that triggered an analysis of the carrying value of goodwill and resulted in the estimated write down of goodwill of $14.9 million. Specifically, operating income was less than our forecast, primarily due to an $19 million loss on operations in the first quarter principally in the Intermec-branded products and services segments. In addition, our financial results negatively impacted the price per share of Intermec stock, causing the market capitalization of the Company to be significantly below its net book value. These triggering events were indicators that it was more likely than not the fair value of the Company’s goodwill was less than its book value.

We prepared a Step 1 goodwill impairment analysis to determine the fair values of all three reporting units with goodwill (Intermec Global Solutions, Healthcare, and Supply Chain). To calculate the fair values we used the discounted cash flow method and market approach. We made significant assumptions and estimates about the extent and timing of future cash flows, growth rates, and discount rates that represent unobservable inputs into our valuation methodologies used to calculate fair value. The cash flows were estimated over a significant future period of time, which made those estimates and assumptions subject to

30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF

OPERATIONS

a high degree of uncertainty. Where available and as appropriate, comparative market multiples and the quoted market price of our common stock were used to corroborate the results of the discounted cash flow method and market approach. Assumptions used in our analysis that have the most significant effect on the estimated fair values of our reporting units include:

• Our estimated weighted-average cost of capital (WACC); and

• Our estimated long-term growth

• Market multiples

Once we had determined our assumptions, we calculated the fair value of each reporting unit and compared it to the carrying value of the reporting unit. After performing our Step 1 analysis for the reporting units, we determined that the carrying value of the Supply Chain reporting unit exceeded its fair value by $14.9 million and recognized an estimated impairment charge in the first quarter. Due to the timing and complexity of this analysis, Step 2 of the impairment test was substantially completed in the second quarter of 2012. After performing that test, we determined we had an additional goodwill impairment of $25.8 million associated with our Supply Chain reporting unit. The additional impairment was the result of an increase in the fair value of developed and in-process technology intangible assets within the Supply Chain reporting unit. The increase in the intangible assets reduced the implied fair value of the goodwill, and we recognized a $40.7 million cumulative impairment of the Supply Chain reporting unit goodwill for the six months ended July 1, 2012.

Determining the fair value of goodwill for the Supply Chain reporting unit for Step 2 was judgmental in nature and involved the use of significant estimates and assumptions to calculate a hypothetical fair value of the assets and liabilities within the reporting unit. Our analysis utilized the income approach to calculate the implied fair value of goodwill of the Supply Chain reporting unit. The key inputs we used in the income approach included our forecast of revenue and expenses, a migration curve of developed and in-process technology, tax rate, discount rates, customer retention rates, useful lives, and contributory charge rates. These key inputs, for the income approach, are classified as Level 3 within the fair value hierarchy, see Note 3 Fair Value Measurements.

Q2 2012 goodwill impairment analysis

During the three months ended July 1, 2012, we significantly changed the composition of key senior management at the reporting units and also changed our Chief Executive Officer. Additionally, we evaluated certain market trends and specific changes in our marketplace including, macro and micro economic conditions, expected government spending and industry data. As a result of the changes and evaluations, a review was performed over all areas in which we engage in business. Upon conclusion of the review, key operational and investment decisions were made which resulted in changes in the amount and timing of receipts and expenditures. Specifically, forecasts of revenue, research and development costs, capital expenditures, and other inputs to operations were revised, and the result was reduced cash flow forecasts across the three reporting units with goodwill. Consequently, a triggering event occurred to evaluate impairment of goodwill, specific to facts and circumstances during the three months ended July 1, 2012.

We prepared a Step 1 goodwill impairment analysis to determine the fair values of all three reporting units with goodwill (Intermec Global Solutions, Healthcare, and Supply Chain). To calculate the fair values we used the discounted cash flow method and market approach. We utilized the same methods listed above in Q1 2012 goodwill impairment analysis to perform our Step 1 analysis for the three months ended July 1, 2012. Once we had determined our assumptions, we calculated the fair value of each reporting unit and compared it to the carrying value of the reporting unit.

After performing our Step 1 analysis for the reporting units we determined that the carrying value of the Healthcare reporting unit exceeded its fair value, so we then performed a Step 2 analysis. Based on a preliminary Step 2 analysis we determined we had a estimated goodwill impairment of $0.8 million associated with our Healthcare reporting unit. This impairment was primarily the result of a reduction in our long term business forecast specifically related to expected government spending in the skilled nursing are, the likely impact on capital investments in that market and the timing of the launch of new products for our Healthcare reporting unit. Due to the complexity and timing of this Step 2 analysis we will finalize it in the third quarter of 2012 and the impairment amount may change at that time.

Determining the fair value of goodwill for the Healthcare reporting unit for Step 2 is judgmental in nature and involves the use of significant estimates and assumptions to perform a hypothetical fair value of the assets and liabilities within the reporting unit. Our analysis utilized the income approach to calculate the implied fair value of goodwill of the Healthcare reporting unit. The key inputs we used in the income approach included our forecast of revenue and expenses, a migration curve of developed and new technology, tax rate, discount rates, customer retention rates, useful lives, and contributory charge rates. These key inputs, for the income approach, are classified as Level 3 within the fair value hierarchy. See Note 3 Fair Value Measurements to our Condensed Consolidated Financial Statements for further detail.

Future goodwill impairments that may be material could be recognized should the recent economic uncertainty continue, our equity price declines on a sustained basis, global economies enter in another recession, or industry growth stagnates further. Our

31

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

fair value estimates for event-driven impairment tests assume the achievement of future financial results contemplated in our forecasted cash flows and there can be no assurance that we will realize that value. The estimates and assumptions used are subject to significant uncertainties, many of which are beyond our control, and there is no assurance that anticipated financial results will be achieved.

The fair value for the Intermec Global Services reporting unit and the Supply Chain reporting unit exceeded their carrying value by 8.5% and 8.2%, respectively and therefore are not impaired. Performance of our business operations could lag behind our forecast, which in turn could impact the fair value of our reporting units. In addition, based upon the results of our Step 1 test the margin between the fair value of the Intermec Global Services, Supply Chain and Healthcare reporting units and their carrying amounts are sensitive to changes in discount rate and forward operating results. An 100 bps increase in our discount rate may trigger an impairment when coupled with declining results of operations. In addition, a 5% decrease in the cash flows from operations may also yield recognition of impairment. Based upon the best information available, it does not appear more likely than not that either of these scenarios will occur.

Valuation of Long-Lived Assets. Long-lived assets, such as property, plant, and equipment, and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of asset groups to be held and used is measured by a comparison of the carrying amount of an asset group to estimated undiscounted future cash flows expected to be generated by the asset group. If the carrying amount of an asset group exceeds its estimated future cash flows, an impairment charge is recognized on our statement of operations and as a reduction to the asset group to the extent that the fair market value of the asset group is less than its carrying value. Assets to be disposed of would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no longer depreciated. The assets and liabilities of a disposal group classified as held for sale would be presented separately in the appropriate asset and liability sections of the balance sheet. Due to the same circumstances that required the interim goodwill impairment test above, we evaluated our long-lived assets for impairment for the quarters ended April 1, 2012 and July 1, 2012. We determined that the carrying amount of our long-lived assets does not exceed their estimated undiscounted future cash flow and therefore our long-lived assets are not impaired as of April 1, 2012 or July 1, 2012.

32

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As of July 1, 2012, there have been no material changes in the information provided in Item 7A of our 2011 Form 10-K, which contains a complete discussion of our material exposures to foreign currency exchange rate risk.

ITEM 4. CONTROLS AND PROCEDURES

Under the supervision and with the participation of management, including the Interim Chief Executive Officer, or CEO, and Chief Financial Officer, or CFO, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(e) as of the end of the period covered by this quarterly report. Based on that evaluation, management, including the CEO and CFO, has concluded that our disclosure controls and procedures as defined in Rule 13a-15(e) were effective as of July 1, 2012. There were no changes in our internal control over financial reporting during the quarter ended July 1, 2012, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

33

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We currently, and from time to time, are involved in claims, lawsuits and other proceedings, including, but not limited to, intellectual property, commercial, and employment matters, which arise in the ordinary course of business. We currently do not expect the ultimate resolution of pending matters (including the matters described below) to be material to Intermec in relation to our business, financial condition, results of operations or liquidity. With the exception of one of our cases, which involves the defense of our patents, the external legal costs incurred in these matters are expensed.

In the case Intermec Technologies Corporation v. Palm, Inc., Civil Action No. 1:05-cv-00147-SLR, United States District Court for the District of Delaware (the “Palm Case”), the parties entered into a confidential settlement agreement that ended the case before trial.

In the case Intermec, Inc. v. International Business Machines Corporation, Civil Action No. 2:11-cv-00165, United States District Court for the Western District of Washington (the “IBM Case”), there have been no material changes in the case during the second quarter of 2012 since those described in our Report on Form 10-Q for the period ended April 1, 2012. The trial in the IBM Case concluded on March 29, 2012, with a jury verdict in Intermec’s favor of $1.05 million, which was $0.7 million less than the receivable carried on our balance sheet. This $0.7 million was expensed in the first quarter of 2012. In the second quarter of 2012, IBM filed a Motion for Judgment Not Withstanding the Verdict and indicated that it intends to appeal the decision in the District Court, and Intermec asked the Court for a new trial or order on the issue whether pre-trial interest is owed to Intermec on the amount awarded by the jury.

In the case Alien Technologies Corporation v. Intermec, Inc., et al., Civil Action No. 3:06-cv-0051, United States District Court for the District of North Dakota, Southeastern Division (the “Alien Case”), Alien Technologies Corporation (“Alien”) sued Intermec in June 2006 for a declaratory judgment that Alien does not infringe certain Intermec patents relating to radio frequency identification technology (“RFID”) and that certain Intermec RFID patents are invalid; Alien’s case against Intermec does not assert any counterclaimed damages or loss against Intermec. Intermec counterclaimed against Alien for infringement related to certain of those patents. In the suit, Intermec is seeking a decision that its patents are valid and infringed by Alien. Both parties have requested reimbursement of legal fees. The Intermec patent remaining in the Alien Case after the District Court's summary judgment decisions has been the subject of proceedings in the U.S. Patent and Trademark Office (“USPTO”), which upheld the validity of most of the original claims as well as found new claims patentable upon reexamination. The reexamination decision was appealed by Alien to the Board of Patent Appeals and Interferences (“BPAI”) of the USPTO. On July 19, 2012, the BPAI issued a decision finding that the examiner erred in not considering certain grounds of rejection previously proposed by Alien. Intermec intends to continue reexamination proceedings for the patent claims at issue, including the submission of further evidence demonstrating that the possible new grounds of rejection should not be adopted by the examiner. The BPAI did not find error with the examiner’s decision not to adopt any other grounds of rejection originally proposed by Alien. The legal fees related to the defense of this case have been capitalized and reported on our Condensed Consolidated Balance Sheets as Other assets.

Refer to Commitments and Contingencies in Note 13 of the Notes to Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q, and to Capitalized Legal Patent Costs in Significant Accounting Policies in Note 1 and to Commitments and Contingencies in Note 13 of the Notes to Condensed Consolidated Financial Statements in our 2011 Form 10-K.

ITEM 1A. RISK FACTORS

You are encouraged to review the discussion of Forward Looking Statements and Risk Factors appearing in this report at Part I, “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

In addition to the other information set forth in this Report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2011 Form 10-K, and the factors discussed in this Part II, “Item 1A, Risk Factors” of this Quarterly Report on Form 10-Q for the quarter ended July 1, 2012 (the “Second Quarter Form 10-Q”) and in the First Quarter Form 10-Q, which could materially affect our business, financial condition, operating results, earnings or stock price, in various ways. The risks described in our 2011 Form 10-K and in the Second Quarter Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

The risk factor included in the 2011 Form 10-K under the caption “We have entered into a senior secured credit facility agreement that includes covenants, financial tests and ratios, which, if not met, may have an adverse effect on our business, financial condition, results of operations and cash flows” is restated in its entirety as follows:

• We have entered into a senior secured credit facility agreement that includes covenants, financial tests and ratios, which, if not met, may have an adverse effect on our business, financial condition, results of operations and cash flows. We maintain a senior secured credit facility that contains certain customary covenants to the Bank providing the credit facility, including financial covenants that require us to comply with specified financial ratios and tests. The credit facility is secured by pledges of equity in and assets of certain of our domestic subsidiaries, which have also guaranteed our payment obligations under the credit facility. We must take into account the requirements of these covenants in the conduct of our business. Depending on the circumstances under which we could fail to satisfy one or more of these covenants, we may need to make choices that limit some of our business or financing activities in order to comply with them. These choices may have an adverse effect on our results of operations and cash flows. Furthermore, we were not in compliance with certain of our debt covenants effective as of each of December 31, 2011, and April 1, 2012, but in each case the Bank agreed to amend the credit facility agreement to bring us back into compliance. However, if we fail to comply with the requirements of the credit facility in the future, we would be in default, and we may not be able to obtain the necessary amendments or waivers of an event of default. In that event, the Bank could declare all amounts outstanding, together with accrued interest, to be immediately due and payable. The Bank could also move to enforce its rights under its security interests in our assets and those of our subsidiaries. If at that time we were not able to repay any amounts borrowed under the credit facility using our existing cash, or to obtain sufficient financing from alternative sources to make the repayment, or if alternative financing is not available on favorable terms, or at all, our business and financial condition would be materially adversely affected. Such alternative financing, if available, may include increased costs or other terms affecting our business or assets. We could also incur substantial costs in pursuing such alternative financing arrangements. Financing arrangements that include the issuances of equity or other securities convertible into equity could cause our existing stockholders’ interests to be diluted.

34

ITEM 6. EXHIBITS

10.1	Director Compensation Program under the Company’s 2008 Omnibus Incentive Plan, as amended and restated as of June 14, 2012
10.2	Form of Employee Stock Option Grant Notice (For U.S. Optionees) and Stock Option Agreement under the Company’s 2008 Omnibus Incentive Plan, effective for awards granted on or after May 21, 2012
10.3	Form of Nonqualified Stock Option Grant Notice (Performance Vested for Senior Officers) and Stock Option Agreement under the Company’s 2008 Omnibus Incentive Plan, effective for awards granted on or after May 21, 2012
10.4	Clarification of Letter Agreement with Interim Chief Executive Officer, Dated June 18, 2012
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated as of August 9, 2012.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated as of August 9, 2012.
32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated as of August 9, 2012.
32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated as of August 9, 2012.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

35

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Intermec, Inc.
(Registrant)
	/s/ Robert J. Driessnack
	Robert J. Driessnack
	Senior Vice President and Chief Financial Officer
	August 9, 2012

36

EX-10.1

Exhibit 10.1

DIRECTOR COMPENSATION PROGRAM UNDER THE

INTERMEC, INC. 2008 OMNIBUS INCENTIVE PLAN

(Amended and Restated as of June 14, 2012)

The following provisions set forth the terms of the compensation program (the “Program”) for nonemployee directors of Intermec, Inc. (the “Company”) under the Intermec, Inc. 2008 Omnibus Incentive Plan (the “Plan”), as it may be amended from time to time. The following terms are intended to supplement, not alter or change, the provisions of the Plan, and in the event of any inconsistency between the terms contained herein and in the Plan, the Plan shall govern. All capitalized terms that are not defined herein shall be as defined in the Plan.

1. Eligibility

Each director of the Company elected or appointed to the Board who is not otherwise an officer or employee of the Company or a Related Company (a “Director”) shall be eligible to receive the Awards set forth in the Program.

2. Option Grants (Grants Prior to 2012)

(a) Timing and Number of Shares Subject to Option Grants

(i) Annual Option Grants. Immediately after the 2008 Annual Meeting of Stockholders and at each Annual Meeting of Stockholders thereafter, each Director shall automatically be granted a Nonqualified Stock Option to purchase shares of Common Stock with a Black-Scholes value of $80,000, with any fractional share rounded to the nearest whole share (0.5 to be rounded up) (each, an “Annual Option Grant”).

(ii) Initial Option Grants. Any person who becomes a Director at any time of the year other than the date of the Annual Meeting of Stockholders shall automatically be granted a Nonqualified Stock Option to purchase shares of Common Stock for a pro rata portion of the value of the most recent preceding Annual Option Grant, based on the time remaining in the one-year period following the date of the previous Annual Meeting of Stockholders, such grant to be effective on the date he or she becomes a Director (an “Initial Option Grant”).

(iii) Makeup Option Grants. Immediately after the 2008 Annual Meeting of Stockholders, each Director shall automatically be granted a Nonqualified Stock Option to purchase shares of Common Stock for a pro rata portion of the value of the Annual Option Grant made on the same date, based on the time between January 1, 2008 and the date of the 2008 Annual Meeting of Stockholders (each, a “Makeup Option Grant”).

(b) Exercise Price of Options.

Annual Option Grants, Initial Option Grants and Makeup Option Grants shall have a per share exercise price equal to the Fair Market Value of the Common Stock on the Grant Date of the Option.

(c) Option Vesting and Exercisability

Options granted at the Annual Meeting of Stockholders shall vest and become exercisable in four equal installments (subject to adjustment for fractional shares) on the first business day of each fiscal quarter of the Company, beginning on the Grant Date. Options granted on a day other than the date of the Annual Meeting of Stockholders shall vest and become exercisable in equal installments (subject to adjustment for fractional shares) on the Grant Date and the first business day of each fiscal quarter of the Company, if any, that occurs up to, and including, the first quarter of the year in which the next Annual Meeting of Stockholders occurs. Notwithstanding the forgoing, Makeup Option Grants made pursuant to Section 1(a)(iii) shall vest and become exercisable in three installments (subject to adjustment for fractional shares) on the first business day of each fiscal quarter of the Company, beginning on the Grant Date. The first installment will be equal to one half of the Makeup Option Grant; the second and third installments will be equal to one quarter of the Makeup Option Grant.

Page 1 of 7

(d) Term of Options

Each Option shall expire seven years from the Grant Date thereof, but shall be subject to earlier termination as follows:

(i) In the event that a Director ceases to be a Director of the Company for any reason other than the death of the Director, the unvested portion of any Option granted to the Director shall terminate immediately, and the vested portion of the option may be exercised by the Director only within three years after the date he or she ceases to be a Director of the Company or prior to the date on which the Option expires by its terms, whichever is earlier.

(ii) In the event of the death of a Director, the unvested portion of any Option granted to the Director shall become fully vested and exercisable, and the option may be exercised only within three years after the date of death of the Director or prior to the date on which the Option expires by its terms, whichever is earlier, by the personal representative of the Director’s estate, the person(s) to whom the Director’s rights under the option have passed by will or the applicable laws of descent and distribution, or any beneficiary designated pursuant to Section 13 of the Plan.

(e) Exercise of Options

Options shall be exercised by giving the required notice to the Company (or a brokerage firm designated or approved by the Company), stating the number of shares of Common Stock with respect to which the Option is being exercised, accompanied by payment in full for such Common Stock, which payment may be, to the extent permitted by applicable laws and regulations, in whole or in part, (a) in cash or check; (b) by having the Company withhold shares of Common Stock that would otherwise be issued on exercise of the Option that have an aggregate Fair Market Value equal to the aggregate exercise price of the shares being purchased under the Option; (d) by tendering (either actually or by attestation) shares of Common Stock owned by the Director that have an aggregate Fair Market Value equal to the aggregate exercise price of the shares being purchased under the Option; (e) if and so long as the Common Stock is registered under the Exchange Act, by delivery of a properly executed exercise notice, together with irrevocable instructions to a broker, to promptly deliver to the Company the amount of proceeds to pay the exercise price, all in accordance with the regulations of the Federal Reserve Board.

(f) No Options will be granted under the Program after 2011.

3. Restricted Deferred Stock Unit Grants (Grants Prior to 2012)

(a) Timing and Number of Restricted Deferred Stock Units

(i) Annual Restricted Deferred Stock Unit Grants. Immediately after the 2008 Annual Meeting of Stockholders, and at each Annual Meeting of Stockholders thereafter, each Director shall automatically be granted restricted deferred stock units with a value of $80,000, based on the Fair Market Value of the Common Stock on the Grant Date, with any fractional share rounded to the nearest whole share (0.5 to be rounded up) (each, an “Annual Restricted Deferred Stock Unit Grant”); provided, that any person who becomes a Director at any time of the year other than the date of the Annual Meeting of Stockholders shall receive a pro rata portion of the value of the most recent preceding Annual Restricted Deferred Stock Unit Grant, based on the time remaining in the one-year period following the date of the previous Annual Meeting of Stockholders, such grant to be effective on the date he or she becomes a Director.

(ii) Makeup Restricted Deferred Stock Unit Grant. Immediately after the 2008 Annual Meeting of Stockholders, each Director shall automatically receive a pro rata portion of the value of the Annual Restricted Deferred Stock Unit Grant made on the same date, based on the time between January 1, 2008 and the date of the 2008 Annual Meeting of Stockholders.

Page 2 of 7

(b) Mandatory Deferrals of Restricted Deferred Stock Units

All restricted deferred stock unit grants that Directors are entitled to receive under the Program shall automatically be deferred into and shall be subject to the terms and conditions of the Company’s Director Deferred Compensation Plan or any similar successor plan thereto (the “Deferred Compensation Plan”).

(c) Vesting of Restricted Deferred Stock Units

All restricted deferred stock unit awards granted under the Program shall be fully vested as of the date of the next Annual Meeting of Stockholders following the Grant Date, assuming the Director’s continued service on the Board during such period. In the event of a Director’s termination of service prior to the vesting of restricted deferred stock units, such units shall automatically be forfeited to the Company.

(d) No restricted deferred stock unit awards will be granted under the Program after 2011.

4. Restricted Stock Unit Grants (Grants After 2011)

(a) Timing and Number of Restricted Stock Units

Immediately after the 2012 Annual Meeting of Stockholders, and at each Annual Meeting of Stockholders thereafter, each Director shall automatically be granted restricted stock units (“RSUs”) with a value of $100,000 (“RSU Value”), based on the Fair Market Value of the Common Stock on the Grant Date, with any fractional share rounded to the nearest whole share (0.5 to be rounded up) (each, an “Annual RSU Award”); provided, that any person who becomes a Director at any time of the year other than the date of the Annual Meeting of Stockholders shall automatically be granted RSUs equal to a pro rata portion of the RSU Value, based on the time remaining in the one-year period following the date of the previous Annual Meeting of Stockholders, such grant to be effective on the date he or she becomes a Director and based on the Fair Market Value of the Common Stock on the Grant Date, with any fractional share rounded to the nearest whole share (0.5 to be rounded up) (a “Mid-Term RSU Award”).

(b) Voluntary Deferrals of Restricted Stock Units

All shares of Common Stock under RSU Awards that Directors are entitled to receive under the Program may be deferred into and shall be subject to the terms and conditions of the Deferred Compensation Plan, provided that the deferral election requirements of the Deferred Compensation Plan are met.

(c) Vesting of Restricted Stock Units

RSU Awards granted under the Program shall vest as follows:

(i) Annual RSU Awards shall vest in four equal installments (subject to adjustment for fractional shares as set forth below), with 25% of such Annual RSU Awards vesting on the first day of the calendar quarter that begins after the Annual Meeting of Stockholders occurs at which the Annual RSU Awards were granted and an additional 25% vesting on the first day of each of the three calendar quarters thereafter.

(ii) A Mid-Term RSU Award granted to a Director who commences service on the Board on or after January 1 of a calendar year but before the Annual Meeting of Stockholders for such calendar year will fully vest on the date of the Annual Meeting of Stockholders for such year.

(iii) A Mid-Term RSU Award granted to a Director who commences service on the Board after the Annual Meeting of Stockholders for a calendar year but before the end of the calendar year in which such Annual Meeting of Stockholders occurs will vest proportionately in accordance with the number of vesting dates remaining, as set forth in (i) above.

Page 3 of 7

(iv) In all cases, a Director’s continued service on the Board is required through each vesting date; provided, that unvested RSU Awards shall become fully vested in the event of a Director’s Termination of Service by reason of death or a Change of Control. In the event a Director ceases service on the Board prior to the vesting of his or her RSU Awards, such unvested RSU Awards shall automatically be forfeited to the Company. Vesting shall occur with respect to whole shares of Common Stock only, with any fractional shares carried forward to the final vesting date for a particular RSU Award.

(d) Form and Timing of Payment of Restricted Stock Units

(i) Subject to the terms of a deferral election made by a Director pursuant to Paragraph 4(b) hereof, upon full vesting of an Annual RSU Award or a Mid-Term RSU Award granted pursuant to Paragraph 4(c)(iii) above, such vested RSU Award shall be settled in shares of Common Stock upon the earlier to occur of the following (each, a “Settlement Date”): (A) the one-year anniversary of the Grant Date of the RSU Award (or with respect to a Mid-Term RSU Award granted pursuant to Paragraph 4(c)(iii), the one-year anniversary of the Grant Date of the most recently granted Annual RSU Awards) (provided that if such Settlement Date is not a business date, the Settlement Date shall be the immediately preceding business date) and (B) a Change of Control, provided such Change of Control also constitutes a “change in control” event within the meaning of Section 409A. Issuance of such shares shall occur within 30 days of the Settlement Date.

In the event a Change of Control is not a “change in control” event within the meaning of Section 409A, RSU Awards that are outstanding immediately prior to the effective date of such Change of Control shall remain an outstanding obligation of the Company or the Successor Company, as the case may be, and will be converted into a contractual right to receive a cash payment (a “Cash Payment Right”) in an amount equal to the Fair Market Value of the shares of Common Stock subject to the RSU Awards on the effective date of the Change of Control. After such conversion, no interest or dividend equivalents will be accrued, credited or paid with respect to a Cash Payment Right. The Cash Payment Right will be paid in accordance with the same schedule set forth in this Paragraph 4(d)(i) hereof, as applicable, with respect to RSU Awards.

(ii) Subject to the terms of a deferral election made by a Director pursuant to Paragraph 4(b) hereof, upon full vesting of a Mid-Term RSU Award granted pursuant to Paragraph 4(c)(ii) above, such vested RSU Award shall be settled in shares of Common Stock on the vesting date for such Mid-Term RSU Award, or if earlier, upon the Director’s Termination of Service by reason of death or a Change of Control. Issuance of such shares shall occur within 30 days thereof.

5. Terms and Conditions of Payment of Fees

(a) Retainer Fees

There shall automatically be granted each year to each Director retainer fees of $40,000. In addition, a non-executive Director serving as Chairman of the Board shall be paid an additional retainer of $150,000 for the twelve month period ending June 30, 2008 and $120,000 for the twelve month period thereafter ending June 30, 2009. During each of the foregoing periods, this additional retainer payable to the Chairman of the Board shall automatically be deferred into a stock account under the Deferred Compensation Plan. After June 30, 2009, a non-executive Director serving as Chairman of the Board shall be paid an additional annual retainer of $80,000. In addition, the Chairs of the Audit and Compliance Committee, Compensation Committee and Governance and Nominating Committee shall each be paid an additional annual retainer of $15,000, $10,000 and $10,000, respectively; provided that, during the period July 1, 2007 through June 30, 2009, the Chairman of the Board, when also acting in the capacity of the Chair of the Governance and Nominating Committee, shall not receive any additional retainer. For the avoidance of doubt, after June 30, 2009, the Chairman of the Board, when also acting in the capacity of the Chair of the Governance and Nominating Committee, shall also be eligible to receive the additional retainer for his or her service as Chair of such Committee.

Page 4 of 7

(b) Meeting Fees

Each Director shall automatically receive an attendance fee of $2,000 for his or her attendance at the following meetings:

(i) each physical or telephonic meeting of a committee of the Board of which that Director is a member;

(ii) each physical or telephonic meeting of the Board; and

(iii) each special meeting, physical or telephonic, of a committee of the Board of which that Director is not a member, if his or her attendance is required for the business of such meeting.

(c) Payment of Fees

Except as otherwise set forth above, all retainer fees and meeting fees shall be paid in cash quarterly, after the end of the quarter in which earned. Notwithstanding the foregoing and except as otherwise set forth above, Directors may elect to receive any retainer fees and meeting fees in shares of Common Stock in accordance with Section 4(d) below or may defer retainer fees and meeting fees into cash or stock accounts under the Deferred Compensation Plan.

(d) Share Election and Issuance of Shares

(i) Share Election. A Director may make a share election (“Share Election”) to receive in the form of Common Stock all of his or her retainer fees or meeting fees earned in each calendar year that are otherwise payable in cash. The shares of Common Stock (and cash in lieu of fractional shares) issuable pursuant to a Share Election shall be issued quarterly in accordance with Section 4(d)(ii). The Share Election must be in writing and delivered to the Secretary of the Company on or prior to December 31 of the calendar year preceding the calendar year in which the applicable retainer fees or meeting fees are to be earned; provided, however, that any Director who commences service on the Board on or subsequent to January 1 of a calendar year may make a Share Election during the 30-day period immediately following the commencement of his or her directorship. A Share Election, once made, shall be irrevocable for the calendar year with respect to which it is made and shall remain in effect for future calendar years, unless revoked in writing or modified by a subsequent Share Election with respect to future calendar years. Such subsequent Share Election must be made on or prior to December 31 of the calendar year preceding the calendar year in which such revocation shall take effect and in accordance with the provisions hereof.

(ii) Issuance of Shares. Shares of Common Stock issuable to a Director pursuant to this Section 4 shall be issued to such Director on the first business day following the end of each calendar quarter. The total number of shares of Common Stock to be issued shall be determined by dividing (x) the dollar amount of the Director’s retainer fees and meeting fees for the preceding calendar quarter to which a Share Election applies by (y) the Fair Market Value of the Common Stock on the date such retainer fees or meeting fees would otherwise have been paid in cash. In no event shall the Company be required to issue fractional shares. In the event that a fractional share of Common Stock would otherwise be required to be issued, an amount in lieu thereof shall be paid in cash based on the Fair Market Value of such fractional share on the last business day of the preceding calendar quarter.

(e) Retainer Fees and Meeting Fees for Non-Standing Committees.

Notwithstanding any other provision in the Program to the contrary, the Board may fix, by resolution, the retainer fee and meeting fee of any committee of the Board or subcommittee of a committee of the Board, other than the Audit and Compliance Committee, the Compensation Committee and the Governance and Nominating Committee (collectively, the “Standing Committees”); provided, however, that the retainer fee for the Chairman of such committee or subcommittee shall not exceed $5,000 per year and the meeting fees

Page 5 of 7

payable to the members of such committee or subcommittee shall not exceed $2,000 per individual meeting attended or, in the case of a retainer for meeting attendance in lieu of individual meeting fees, $4,000 per quarter. Any retainer fees or meeting fees (including a retainer paid in lieu of individual meeting fees) shall be subject to the provisions of subsections (c) and (d) of this section 5. Nothing in this subsection (e) shall require the Board to authorize compensation for any committee or subcommittee other than the Standing Committees.

6. Change of Control

Upon a Change of Control, (a) all Options outstanding as of the date of such Change of Control, and which are not then exercisable and vested, shall immediately become fully exercisable and vested; (b) the restrictions applicable to any restricted deferred stock unit shall lapse, and such restricted deferred stock unit grants shall become free of all restrictions and become fully vested and transferable; and (c) fees earned in respect of the calendar quarter in which the Change of Control occurs shall be paid in cash as soon as practicable. Upon a Change of Control, RSU Awards shall be treated as set forth in Paragraphs 4(c) and 4(d) of the Program.

7. Amendment

The Board may amend the provisions contained herein in such respects as it deems advisable. Any such amendment shall not, without the consent of the Director, impair or diminish any rights of a Director or any rights of the Company under an Award.

Provisions of the Plan (including any amendments) not discussed above, to the extent applicable to Directors, shall continue to govern the terms and conditions of Awards granted to Directors.

Page 6 of 7

ADDENDA TO THE DIRECTOR COMPENSATION PROGRAM UNDER THE

INTERMEC, INC. 2008 OMNIBUS INCENTIVE PLAN

AMENDMENT NO. 1

The Director Compensation Program under the Intermec, Inc. 2008 Omnibus Incentive Plan (the “Program”) is hereby amended by adding the following addendum:

Notwithstanding any other provision in the Program to the contrary, all retainer and meeting fees payable pursuant to the Program for services performed during the twelve-month period ending December 31, 2009 shall be reduced by ten percent.

In all other respects, the Program is hereby ratified and confirmed. The effective date of this amendment is January 1, 2009.

AMENDMENT NO. 2

The Director Compensation Program under the Intermec, Inc. 2008 Omnibus Incentive Plan (the “Program”) is hereby amended by adding the following addendum:

Notwithstanding any other provision in the Program to the contrary, the value of the Annual Option Grants made at the May 27, 2009 Annual Meeting of Stockholders in accordance with Section 2(a)(i) of the Program shall be $60,000, and the value of the Annual Restricted Deferred Stock Unit Grants made at the May 27, 2009 Annual Meeting of Stockholders in accordance with Section 3(a)(i) of the Program shall be $60,000.

In all other respects, the Program is hereby ratified and confirmed. The effective date of this amendment is May 26, 2009.

AMENDMENT NO. 3

The terms of AMENDMENT NO. 3, which was adopted July 16, 2009, are reflected in the restated document.

AMENDMENT NO. 4

The Director Compensation Program under the Intermec, Inc. 2008 Omnibus Incentive Plan (the “Program”) is hereby amended by adding the following addendum:

Notwithstanding any other provision in the Program to the contrary, the value of the Annual Option Grants made at the May 26, 2010 Annual Meeting of Stockholders in accordance with Section 2(a)(i) of the Program shall be $20,000.

In all other respects, the Program is hereby ratified and confirmed. The effective date of this amendment is May 26, 2010.

AMENDMENT NO. 5

The terms of AMENDMENT NO. 5, which was adopted January 19, 2012, are reflected in the restated document.

AMENDMENT NO. 6

The terms of AMENDMENT NO. 6, which was adopted June 14, 2012, are reflected in the restated document.

Page 7 of 7

EX-10.2

Exhibit 10.2

INTERMEC, INC.

2008 OMNIBUS INCENTIVE PLAN

(As Amended and Restated Effective May 25, 2011)

NONQUALIFIED STOCK OPTION GRANT NOTICE

(FOR U.S. OPTIONEES)

Intermec, Inc. (the “Company”) hereby grants to you an Option (the “Option”) to purchase shares of the Company’s Common Stock under the Company’s 2008 Omnibus Incentive Plan, as amended and restated effective May 25, 2011 (the “Plan”). The Option is subject to all the terms and conditions set forth in this Nonqualified Stock Option Grant Notice (this “Grant Notice”) and in the Nonqualified Stock Option Agreement (the “Stock Option Agreement”) and the Plan, which are incorporated into this Grant Notice in their entirety. Capitalized terms that are not defined herein shall have the meanings assigned to such terms in the Plan.

[NAME] [ADDRESS]	Option Number:	[OPTION_NUMBER]
	Option Plan:	2008
	Grant Date:	[OPTION_DATE]
	Option Shares:	[NUMBER]
	Exercise Price (per Share):	[PRICE]
	Type of Option:	Nonqualified Stock Option

Vesting and Exercisability Schedule: The Option shall, subject to the provisions of the Plan, become vested and exercisable in installments on the dates set forth below and shall remain cumulatively exercisable until the Option Expiration Date indicated, subject to earlier expiration in the event of your Termination of Service as set forth in the Stock Option Agreement:

Number of Shares	Date Option May First Be Exercised	Option Expiration Date
	[INSERT VESTING SCHEDULE]

Page 1 of 8

Additional Terms/Acknowledgement: You acknowledge receipt of, and understand and agree to, this Grant Notice and the Stock Option Agreement. You further acknowledge that as of the Grant Date, this Grant Notice, the Stock Option Agreement and the Plan set forth the entire understanding between you and the Company regarding the Option and supersede all prior oral and written agreements on the subject. You also acknowledge that you have received the Plan and the plan summary for the Plan. You are encouraged to review the Company’s most recent annual report and proxy statement, which may be found at www.intermec.com.

IN WITNESS WHEREOF, this Grant Notice has been executed by you and by the Company through its duly authorized officer, all as of the Grant Date indicated above.

	Intermec, Inc.
	By:
		[NAME] [TITLE]
	Participant:
IMPORTANT PLEASE ACCEPT ELECTRONICALLY OR SIGN AND RETURN PROMPTLY
	[NAME]

Page 2 of 8

INTERMEC, INC.

2008 OMNIBUS INCENTIVE PLAN

(As Amended and Restated Effective May 25, 2011)

NONQUALIFIED STOCK OPTION AGREEMENT

(FOR U.S. OPTIONEES)

Pursuant to your Nonqualified Stock Option Grant Notice (the “Grant Notice”) and this Nonqualified Stock Option Agreement (this “Agreement”), the Company has granted you an Option under its 2008 Omnibus Incentive Plan, as amended and restated effective May 25, 2011 (the “Plan”), to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice (the “Shares”) at the exercise price indicated in your Grant Notice.

Capitalized terms that are not defined herein shall have the meanings assigned to such terms in the Plan. The Plan shall control in the event there is any express conflict between the Plan and the Grant Notice or this Agreement and with respect to such matters as are not expressly covered herein.

The details of the Option are as follows:

1. Vesting and Exercisability. Subject to the limitations contained herein, the Option will vest and become exercisable as provided in your Grant Notice, provided that, unless otherwise provided in the Grant Notice or this Agreement, vesting will cease upon your Termination of Service and the unvested portion of the Option will terminate.

2. Securities Law Compliance. Notwithstanding any other provision of this Agreement, you may not exercise the Option unless the Shares issuable upon exercise are registered under the Securities Act or, if such Shares are not then so registered, the Company has determined that such exercise and issuance would be exempt from the registration requirements of the Securities Act. The exercise of the Option must also comply with other applicable laws and regulations governing the Option, and you may not exercise the Option if the Company determines that such exercise would not be in material compliance with such laws and regulations.

3. Independent Tax Advice. You should obtain independent tax advice prior to exercising the Option and prior to the disposition of any Shares. The Option is intended to be a Nonqualified Stock Option, as that term is defined in the Plan.

4. Methods of Exercise. Subject to the provisions of this Agreement, the vested portion of the Option may be exercised, in whole or in part, at any time during the term of the Option by giving written notice of exercise to the Company on the form furnished by the Company for that purpose or, to the extent applicable, by written notice to a brokerage firm designated or approved by the Company, specifying the number of Shares subject to the Option to be purchased.

Page 3 of 8

The exercise price for Shares to be purchased upon exercise of all or a portion of the Option shall be paid in any combination of the following:

(a) in cash in United States dollars (by certified or bank check or such other instrument payable to the order of “Intermec, Inc.” as the Company may accept);

(b) if permitted by the Committee, by having the Company withhold Shares that would otherwise be issued on exercise of the Option that have an aggregate Fair Market Value equal to the aggregate exercise price of the Shares being purchased under the Option;

(c) if permitted by the Committee, by tendering (either actually or by attestation) shares of Common Stock owned by you that have an aggregate Fair Market Value equal to the aggregate exercise price of the Shares being purchased under the Option;

(d) to the extent permitted by applicable law, by delivering a properly executed exercise notice, together with irrevocable instructions to a broker, to deliver promptly to the Company the aggregate amount of proceeds to pay the Option exercise price, and, if requested by you or required by law to be withheld by the Company, the amount of any federal, state, local and foreign withholding taxes, all in accordance with the regulations of the Federal Reserve Board; or

(e) by any other method permitted by the Committee.

5. Treatment upon Termination of Employment or Service Relationship.

(a) General Rule. In the event of your Termination of Service for any reason other than Disability, death or for Cause, you may thereafter exercise the Option, to the extent it was vested on the date of termination, for a period of three months from the date of such Termination of Service or until the Option Expiration Date, whichever period is shorter, provided that if you die within such three-month period, any unexercised Option held by you shall, notwithstanding the expiration of such three-month period, continue to be exercisable to the extent to which it was vested at the time of death for a period of 12 months from the date of such death or until the Option Expiration Date, whichever period is shorter.

(b) Disability. In the event of your Termination of Service by reason of Disability, the Option shall become fully vested and exercisable and you may thereafter exercise the Option for a period of three years from the date of such Termination of Service or until the Option Expiration Date, whichever period is shorter, provided that if you die within such period, any unexercised portion of the Option shall, notwithstanding the expiration of such period, continue to be exercisable for a period of 12 months from the date of such death or until the Option Expiration Date, whichever period is shorter. “Disability” means your permanent and total disability as more specifically defined in the Plan.

(c) Death. In the event of your Termination of Service by reason of death, the Option shall become fully vested and exercisable and may thereafter be exercised for a period of 12 months from the date of such death or until the Option Expiration Date, whichever period is shorter.

Page 4 of 8

(d) Cause. The Option, both the vested and unvested portion, will automatically expire at the time the Company first notifies you of your Termination of Service for Cause, unless the Committee determines otherwise. If your employment or service relationship is suspended pending an investigation of whether you will be terminated for Cause, all your rights under the Option likewise will be suspended during the period of investigation. If any facts that would constitute termination for Cause are discovered after your Termination of Service, any Option you then hold may be immediately terminated by the Committee.

(e) Other. Notwithstanding the foregoing provisions of this Paragraph 5, if exercise of the vested portion of the Option following your Termination of Service during the applicable time period above would be prohibited solely because the issuance of Shares upon exercise of the Option would violate the registration requirements under the Securities Act or the Company’s insider trading policy, then the Option shall remain exercisable until the later of the expiration of (i) the applicable time period set forth above and (ii) a three-month period during which exercise of the Option would not be a violation of the Securities Act or the Company’s insider trading policy requirements, but in no event later than the Option Expiration Date.

It is your responsibility to be aware of the date on which the Option terminates.

6. Limited Transferability. You may transfer all or a portion of the Option by way of gift to any family member, provided that any such transferee shall agree in writing with you (or any successor optionee) and the Company, as a condition to such transfer, to be bound by the provisions of all agreements and other instruments relating to the Option, including without limitation, the Plan, and shall agree in writing to such other terms as the Company may reasonably require to assure compliance with applicable federal and state securities and other laws. For purposes of the preceding sentence, “family member” shall include any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, any person sharing your household (other than a tenant or employee), a trust in which these persons have more than 50% of the beneficial interest, a foundation in which these persons (or the optionee) control the management of assets, and any other entity in which these persons (or the optionee) own more than 50% of the voting interests. The Option shall be exercisable, subject to the terms of the Plan, only by you, your guardian or legal representative, or any person to whom such Option is transferred pursuant to this paragraph, it being understood that the term “optionee” includes such guardian, legal representative and other trustee. If such transfer is made to a family member, there may be additional tax consequences at the time of transfer, and the Company will not be responsible for such tax consequences.

7. Change of Control. The effect of a Change of Control on the Option shall be governed by the terms of the Standard Change of Control Policy for the Plan (in which event, Section 2 of the Standard Change of Control Policy for the Plan shall govern).

8. Clawback Policy. The Option and any Shares issued thereunder shall be subject to potential cancellation, rescission, payback, recoupment or other action in accordance with the terms of the Company’s clawback policy (the “Policy”), as then in effect and as it may be amended from time to time, to the extent the Policy applies to the Option and any Shares issued thereunder (including a Policy implemented or amendments made thereto after the Grant Date for the Option). By accepting the Option, you agree to execute any additional documents to effect the Company’s application, implementation and enforcement of such Policy with respect to the Option and any Shares issued thereunder.

Page 5 of 8

9. Withholding Taxes. No later than the date as of which an amount first becomes includable in your gross income for federal income tax purposes or otherwise with respect to any portion of the Option, you shall pay to the Company or a Related Company, as applicable, or make arrangements satisfactory to the Company or a Related Company regarding the payment of, any federal, state or local, and foreign taxes of any kind required by law to be withheld by the Company or a Related Company with respect to such amount. If permitted by the Committee, the minimum amount of statutory withholding obligations may be settled with unrestricted shares of Common Stock having a Fair Market Value on the date of the exercise of the Option equal to the amount of taxes required by law to be withheld, including Shares otherwise issuable upon exercise of the Option. Tax withholding in excess of the statutory minimum amount may not be satisfied in shares of Common Stock but may, if desired, be paid in cash. The obligations of the Company under the Plan shall be conditional on such payment or arrangements having been made, and the Company and its Related Companies shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due you.

10. Stockholder Rights. No Shares subject to the Option shall be issued until full payment therefor, including applicable withholding taxes, has been made. You shall have all of the rights of a stockholder of the Company with respect to Shares subject to the Option (including, if applicable, the right to vote the Shares and the right to receive dividends, if any) when you have given written notice of exercise and have paid the exercise price and applicable withholding taxes in full for such Shares.

11. Adjustments. If, as a result of any adjustment to the number of Shares subject to this Agreement made pursuant to Section 14 of the Plan, any fractional share would be issuable under this Agreement, such fractional share shall be canceled without the payment of any consideration to you.

12. Voluntary Nature of Plan and Awards Granted Thereunder; No Employment or Service Contract. The Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless otherwise provided in the Plan and this Agreement. Grants of Options and other Awards under the Plan are made from time to time in the sole discretion of the Committee. The grant of the Option or other Award does not create any contractual or other right to receive future grants of Options, or benefits in lieu of Options, even if Options have been granted repeatedly in the past. You acknowledge that future grants under the Plan, if any, will be at the sole discretion of the Committee, including the timing of any grant, the number of shares subject to the Option, the vesting provisions, and the exercise price. The grant of an Option to you in any year shall give you neither any right to similar grants in future years nor any right to be retained in the employ or other service of the Company or a Related Company, such employment or service relationship being terminable to the same extent as if the Plan and this Agreement were not in effect. The right and power of the Company and its Related Companies to dismiss or discharge you is specifically and unqualifiedly unimpaired by this Agreement.

You acknowledge that your participation in the Plan is voluntary and the value of the Option is an extraordinary item that does not constitute compensation of any kind for services of any kind rendered to the Company or its Related Companies, and is outside the scope of any employment or other contract you may have, unless such contract specifically provides otherwise. As such, you understand that the Option is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-term service awards, pension or retirement benefits, or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or its Related Companies.

Page 6 of 8

13. Data Privacy Rights. If employed by a Related Company, you authorize and direct such Related Company or any agent of the Company or such Related Company administering the Plan or providing plan recordkeeping services to disclose to the Company or any of its Related Companies such information and data as it shall request in order to facilitate the grant of the Option and the administration of the Plan, and you waive any data privacy rights you may have with respect to such information. By accepting this Agreement, you authorize the Company and the Related Company by which you are employed, if applicable, to store and transmit such information in electronic form.

14. Option Expiration. It is the present practice of the Company to provide participants in the Plan, solely as a courtesy and not as a Company policy, with written or oral notification of the imminent expiration of any Option having monetary value. You acknowledge that the Company and its subsidiaries and agents shall have no liability or responsibility in the event you should fail to receive any such “courtesy notice” and the Option expires unexercised. You acknowledge that the obligation to monitor the schedule of exercisability and expiration of the Option evidenced by this Agreement, and to procure current quotations regarding the market value of the Shares, is solely your obligation and not that of the Company or any Related Company by which you are employed or the agents of either of them.

15. Notices. Each notice relating to this Agreement shall be in writing and delivered in person or by mail to the Company at its office, 6001 36th Avenue West, Everett, WA 98203-1264, to the attention of the Company’s Secretary, or at such other address as may be furnished to you in writing. All notices to you (or other person or persons then entitled to exercise any right pursuant to this Agreement) shall be delivered to the most recent address for you (or such other person) in the Company’s records or at such other address as you (or such other person) may specify in writing to the Secretary of the Company by a notice delivered in accordance with this paragraph.

16. Electronic Notices. The Company may, in its sole discretion, deliver any documents related to the Option, or future Options (if any) that may be granted under the Plan, by electronic means or request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.

17. Entire Agreement; Choice of Law and Venue. The terms and conditions of this Agreement and the Grant Notice and the Plan, both of which are incorporated by reference herein, comprise the whole terms and conditions between you and the Company with respect to the subject matter of the Grant Notice and this Agreement, and shall be governed by and construed in accordance with the laws of the State of Washington, U.S.A., without reference to principles of conflicts of law. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by the Grant Notice and this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of Washington, U.S.A., and agree that such litigation shall be conducted only in the courts of Washington, U.S.A., or the federal courts for the United States for the Western District of Washington, and no other courts where this grant is made and/or to be performed.

Page 7 of 8

The Company hereby reserves the right to alter, amend, modify, restate, suspend or terminate the Plan and the Grant Notice and this Agreement in accordance with Section 16 of the Plan, but, subject to the terms of the Plan, no such subsequent amendment, modification, restatement or termination of the Plan or the Grant Notice or this Agreement shall adversely affect in any material way your rights under the Grant Notice or this Agreement without your written consent. The Grant Notice and this Agreement shall be subject, without further action by the Company or you, to such amendment, modification or restatement.

The provisions of the Grant Notice and this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

18. Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon each successor of the Company and, to the extent specifically provided therein and in the Plan, shall inure to the benefit of and shall be binding upon your heirs, legal representatives, and successors and upon any person to whom a transfer of the Option permitted by Paragraph 6 of this Agreement has been made.

Page 8 of 8

EX-10.3

Exhibit 10.3

INTERMEC, INC.

2008 OMNIBUS INCENTIVE PLAN

(As Amended and Restated Effective May 25, 2011)

NONQUALIFIED STOCK OPTION GRANT NOTICE

(PERFORMANCE VESTED FOR SENIOR OFFICERS)

Intermec, Inc. (the “Company”) hereby grants to you an Option (the “Option”) to purchase shares of the Company’s Common Stock under the Company’s 2008 Omnibus Incentive Plan, as amended and restated effective May 25, 2011 (the “Plan”). The Option is subject to all the terms and conditions set forth in this Nonqualified Stock Option Grant Notice (this “Grant Notice”) and in the Nonqualified Stock Option Agreement (the “Stock Option Agreement”) and the Plan, which are incorporated into this Grant Notice in their entirety. Capitalized terms that are not defined herein shall have the meanings assigned to such terms in the Plan.

[NAME] [ADDRESS]	Option Number:
	Option Plan:	2008
	Grant Date:
	Option Shares:
	Exercise Price (per Share):
	Type of Option:	Nonqualified Stock Option
	Option Expiration Date:	[7 years from grant date]

Vesting and Exercisability Schedule: The Option shall, subject to the provisions of the Plan, become vested and exercisable in installments on the date(s) set forth below and, to the extent vested, shall remain cumulatively exercisable until the Option Expiration Date indicated above, subject to earlier expiration in the event of your Termination of Service as set forth in the Stock Option Agreement:

• Vesting is based on annual achievement of performance goals.

• The determination of the annual vesting percentage (if any) is made by the Committee in February after each performance year.

• The vesting percentage for a performance year becomes effective on the next following anniversary of the Grant Date (identified as a “Vesting Date” below), subject to continued employment.

• The vesting percentage set forth below is net of any prior years’ actual vesting percentage, if any.

Page 1 of 8

Performance Award Vesting Determination:

Goal BOP%* (as a percentage of revenue)	Vesting %	Vesting Date
FY 2012
If>    % of revenue	33%	[Grant anniversary 2013]
If<     %	Delay
FY 2013
If>     % of revenue	67%	[Grant anniversary 2014]
If<     %	Delay
FY 2014
If>   % of revenue	100%	[Grant anniversary 2015]
If<     %	Delay
FY 2015
If>    % of revenue	100%	[Grant anniversary 2016]
If<     %	Forfeit Unvested Options

* Business Operating Profit (BOP) as a percentage of Revenue. BOP attained is calculated to equate to what the Company reports as Adjusted Operating Profit, typically excluding charges related to: (i) restructuring costs, (ii) transaction costs, purchase accounting adjustments and/or intangible amortization from any current year business acquisitions, (iii) distressed asset impairments, and (iv) resolution of legal disputes.

Additional Terms/Acknowledgement: You acknowledge receipt of, and understand and agree to, this Grant Notice and the Stock Option Agreement. You further acknowledge that as of the Grant Date, this Grant Notice, the Stock Option Agreement and the Plan set forth the entire understanding between you and the Company regarding the Option and supersede all prior oral and written agreements on the subject. You also acknowledge that you have received the Plan and the plan summary for the Plan. You are encouraged to review the Company’s most recent annual report and proxy statement, which may be found at www.intermec.com.

IN WITNESS WHEREOF, this Grant Notice has been executed by you and by the Company through its duly authorized officer, all as of the Grant Date indicated above.

	Intermec, Inc.
	By:
		[NAME] [TITLE]
	Participant:
IMPORTANT PLEASE ACCEPT ELECTRONICALLY OR SIGN AND RETURN PROMPTLY
	[Name]

Page 2 of 8

INTERMEC, INC.

2008 OMNIBUS INCENTIVE PLAN

(As Amended and Restated Effective May 25, 2011)

NONQUALIFIED STOCK OPTION AGREEMENT

(PERFORMANCE VESTED FOR SENIOR OFFICERS)

Pursuant to your Nonqualified Stock Option Grant Notice (the “Grant Notice”) and this Nonqualified Stock Option Agreement (this “Agreement”), the Company has granted you an Option under its 2008 Omnibus Incentive Plan, as amended and restated effective May 25, 2011 (the “Plan”), to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice (the “Shares”) at the exercise price indicated in your Grant Notice.

Capitalized terms that are not defined herein shall have the meanings assigned to such terms in the Plan. The Plan shall control in the event there is any express conflict between the Plan and the Grant Notice or this Agreement and with respect to such matters as are not expressly covered herein.

The details of the Option are as follows:

1. Vesting and Exercisability. Subject to the limitations contained herein, the Option will vest and become exercisable as provided in your Grant Notice, provided that, unless otherwise provided in the Grant Notice or this Agreement, vesting will cease upon your Termination of Service and the unvested portion of the Option will terminate.

2. Securities Law Compliance. Notwithstanding any other provision of this Agreement, you may not exercise the Option unless the Shares issuable upon exercise are registered under the Securities Act or, if such Shares are not then so registered, the Company has determined that such exercise and issuance would be exempt from the registration requirements of the Securities Act. The exercise of the Option must also comply with other applicable laws and regulations governing the Option, and you may not exercise the Option if the Company determines that such exercise would not be in material compliance with such laws and regulations.

3. Independent Tax Advice. You should obtain independent tax advice prior to exercising the Option and prior to the disposition of any Shares. The Option is intended to be a Nonqualified Stock Option, as that term is defined in the Plan.

4. Methods of Exercise. Subject to the provisions of this Agreement, the vested portion of the Option may be exercised, in whole or in part, at any time during the term of the Option by giving written notice of exercise to the Company on the form furnished by the Company for that purpose or, to the extent applicable, by written notice to a brokerage firm designated or approved by the Company, specifying the number of Shares subject to the Option to be purchased.

Page 3 of 8

The exercise price for Shares to be purchased upon exercise of all or a portion of the Option shall be paid in any combination of the following:

(a) in cash in United States dollars (by certified or bank check or such other instrument payable to the order of “Intermec, Inc.” as the Company may accept);

(b) if permitted by the Committee, by having the Company withhold Shares that would otherwise be issued on exercise of the Option that have an aggregate Fair Market Value equal to the aggregate exercise price of the Shares being purchased under the Option;

(c) if permitted by the Committee, by tendering (either actually or by attestation) shares of Common Stock owned by you that have an aggregate Fair Market Value equal to the aggregate exercise price of the Shares being purchased under the Option;

(d) to the extent permitted by applicable law, by delivering a properly executed exercise notice, together with irrevocable instructions to a broker, to deliver promptly to the Company the aggregate amount of proceeds to pay the Option exercise price, and, if requested by you or required by law to be withheld by the Company, the amount of any federal, state, local and foreign withholding taxes, all in accordance with the regulations of the Federal Reserve Board; or

(e) by any other method permitted by the Committee.

5. Treatment upon Termination of Employment or Service Relationship.

(a) General Rule. In the event of your Termination of Service for any reason other than Disability, death or for Cause, you may thereafter exercise the Option, to the extent it was vested on the date of termination, for a period of three months from the date of such Termination of Service or until the Option Expiration Date, whichever period is shorter, provided that if you die within such three-month period, any unexercised Option held by you shall, notwithstanding the expiration of such three-month period, continue to be exercisable to the extent to which it was vested at the time of death for a period of 12 months from the date of such death or until the Option Expiration Date, whichever period is shorter.

(b) Disability. In the event of your Termination of Service by reason of Disability, the Option shall become fully vested and exercisable and you may thereafter exercise the Option for a period of three years from the date of such Termination of Service or until the Option Expiration Date, whichever period is shorter, provided that if you die within such period, any unexercised portion of the Option shall, notwithstanding the expiration of such period, continue to be exercisable for a period of 12 months from the date of such death or until the Option Expiration Date, whichever period is shorter. “Disability” means your permanent and total disability as more specifically defined in the Plan.

(c) Death. In the event of your Termination of Service by reason of death, the Option shall become fully vested and exercisable and may thereafter be exercised for a period of 12 months from the date of such death or until the Option Expiration Date, whichever period is shorter.

Page 4 of 8

(d) Cause. The Option, both the vested and unvested portion, will automatically expire at the time the Company first notifies you of your Termination of Service for Cause, unless the Committee determines otherwise. If your employment or service relationship is suspended pending an investigation of whether you will be terminated for Cause, all your rights under the Option likewise will be suspended during the period of investigation. If any facts that would constitute termination for Cause are discovered after your Termination of Service, any Option you then hold may be immediately terminated by the Committee.

(e) Other. Notwithstanding the foregoing provisions of this Paragraph 5, if exercise of the vested portion of the Option following your Termination of Service during the applicable time period above would be prohibited solely because the issuance of Shares upon exercise of the Option would violate the registration requirements under the Securities Act or the Company’s insider trading policy, then the Option shall remain exercisable until the later of the expiration of (i) the applicable time period set forth above and (ii) a three-month period during which exercise of the Option would not be a violation of the Securities Act or the Company’s insider trading policy requirements, but in no event later than the Option Expiration Date.

It is your responsibility to be aware of the date on which the Option terminates.

6. Limited Transferability. You may transfer all or a portion of the Option by way of gift to any family member, provided that any such transferee shall agree in writing with you (or any successor optionee) and the Company, as a condition to such transfer, to be bound by the provisions of all agreements and other instruments relating to the Option, including without limitation, the Plan, and shall agree in writing to such other terms as the Company may reasonably require to assure compliance with applicable federal and state securities and other laws. For purposes of the preceding sentence, “family member” shall include any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, any person sharing your household (other than a tenant or employee), a trust in which these persons have more than 50% of the beneficial interest, a foundation in which these persons (or the optionee) control the management of assets, and any other entity in which these persons (or the optionee) own more than 50% of the voting interests. The Option shall be exercisable, subject to the terms of the Plan, only by you, your guardian or legal representative, or any person to whom such Option is transferred pursuant to this paragraph, it being understood that the term “optionee” includes such guardian, legal representative and other trustee. If such transfer is made to a family member, there may be additional tax consequences at the time of transfer, and the Company will not be responsible for such tax consequences.

7. Change of Control. The effect of a Change of Control on the Option shall be governed by the terms of the Executive Change of Control Policy for the Plan (in which event, Section 2 of the Executive Change of Control Policy for the Plan shall govern).

8. Clawback Policy. The Option and any Shares issued thereunder shall be subject to the Company’s Policy for Recovery of Incentive Compensation (the “Recovery Policy”) adopted February 22, 2012. The Option and any Shares issued thereunder shall also be subject to potential cancellation, rescission, payback, recoupment or other action in accordance with the terms of any other Company clawback policy (a “Clawback Policy”), as then in effect and as it may be amended from time to time, to the extent the Clawback Policy applies to the Option and any Shares issued thereunder (including a Clawback Policy implemented or amendments made thereto after the Grant Date for the Option). By accepting

Page 5 of 8

the Option, you agree to execute any additional documents to effect the Company’s application, implementation and enforcement of the Recovery Policy or a Clawback Policy with respect to the Option and any Shares issued thereunder.

9. Withholding Taxes. No later than the date as of which an amount first becomes includable in your gross income for federal income tax purposes or otherwise with respect to any portion of the Option, you shall pay to the Company or a Related Company, as applicable, or make arrangements satisfactory to the Company or a Related Company regarding the payment of, any federal, state or local, and foreign taxes of any kind required by law to be withheld by the Company or a Related Company with respect to such amount. If permitted by the Committee, the minimum amount of statutory withholding obligations may be settled with unrestricted shares of Common Stock having a Fair Market Value on the date of the exercise of the Option equal to the amount of taxes required by law to be withheld, including Shares otherwise issuable upon exercise of the Option. Tax withholding in excess of the statutory minimum amount may not be satisfied in shares of Common Stock but may, if desired, be paid in cash. The obligations of the Company under the Plan shall be conditional on such payment or arrangements having been made, and the Company and its Related Companies shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due you.

10. Stockholder Rights. No Shares subject to the Option shall be issued until full payment therefor, including applicable withholding taxes, has been made. You shall have all of the rights of a stockholder of the Company with respect to Shares subject to the Option (including, if applicable, the right to vote the Shares and the right to receive dividends, if any) when you have given written notice of exercise and have paid the exercise price and applicable withholding taxes in full for such Shares.

11. Adjustments. If, as a result of any adjustment to the number of Shares subject to this Agreement made pursuant to Section 14 of the Plan, any fractional share would be issuable under this Agreement, such fractional share shall be canceled without the payment of any consideration to you.

12. Voluntary Nature of Plan and Awards Granted Thereunder; No Employment or Service Contract. The Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless otherwise provided in the Plan and this Agreement. Grants of Options and other Awards under the Plan are made from time to time in the sole discretion of the Committee. The grant of the Option or other Award does not create any contractual or other right to receive future grants of Options, or benefits in lieu of Options, even if Options have been granted repeatedly in the past. You acknowledge that future grants under the Plan, if any, will be at the sole discretion of the Committee, including the timing of any grant, the number of shares subject to the Option, the vesting provisions, and the exercise price. The grant of an Option to you in any year shall give you neither any right to similar grants in future years nor any right to be retained in the employ or other service of the Company or a Related Company, such employment or service relationship being terminable to the same extent as if the Plan and this Agreement were not in effect. The right and power of the Company and its Related Companies to dismiss or discharge you is specifically and unqualifiedly unimpaired by this Agreement.

Page 6 of 8

You acknowledge that your participation in the Plan is voluntary and the value of the Option is an extraordinary item that does not constitute compensation of any kind for services of any kind rendered to the Company or its Related Companies, and is outside the scope of any employment or other contract you may have, unless such contract specifically provides otherwise. As such, you understand that the Option is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-term service awards, pension or retirement benefits, or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or its Related Companies.

13. Data Privacy Rights. If employed by a Related Company, you authorize and direct such Related Company or any agent of the Company or such Related Company administering the Plan or providing plan recordkeeping services to disclose to the Company or any of its Related Companies such information and data as it shall request in order to facilitate the grant of the Option and the administration of the Plan, and you waive any data privacy rights you may have with respect to such information. By accepting this Agreement, you authorize the Company and the Related Company by which you are employed, if applicable, to store and transmit such information in electronic form.

14. Option Expiration. It is the present practice of the Company to provide participants in the Plan, solely as a courtesy and not as a Company policy, with written or oral notification of the imminent expiration of any Option having monetary value. You acknowledge that the Company and its subsidiaries and agents shall have no liability or responsibility in the event you should fail to receive any such “courtesy notice” and the Option expires unexercised. You acknowledge that the obligation to monitor the schedule of exercisability and expiration of the Option evidenced by this Agreement, and to procure current quotations regarding the market value of the Shares, is solely your obligation and not that of the Company or any Related Company by which you are employed or the agents of either of them.

15. Notices. Each notice relating to this Agreement shall be in writing and delivered in person or by mail to the Company at its office, 6001 36th Avenue West, Everett, WA 98203-1264, to the attention of the Company’s Secretary, or at such other address as may be furnished to you in writing. All notices to you (or other person or persons then entitled to exercise any right pursuant to this Agreement) shall be delivered to the most recent address for you (or such other person) in the Company’s records or at such other address as you (or such other person) may specify in writing to the Secretary of the Company by a notice delivered in accordance with this paragraph.

16. Electronic Notices. The Company may, in its sole discretion, deliver any documents related to the Option, or future Options (if any) that may be granted under the Plan, by electronic means or request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.

17. Entire Agreement; Choice of Law and Venue. The terms and conditions of this Agreement and the Grant Notice and the Plan, both of which are incorporated by reference herein, comprise the whole terms and conditions between you and the Company with respect to the subject matter of the Grant Notice and this Agreement, and shall be governed by and construed in accordance with the laws of the State of Washington, U.S.A., without reference to principles of conflicts of law. For purposes of litigating any dispute that arises directly or

Page 7 of 8

indirectly from the relationship of the parties evidenced by the Grant Notice and this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of Washington, U.S.A., and agree that such litigation shall be conducted only in the courts of Washington, U.S.A., or the federal courts for the United States for the Western District of Washington, and no other courts where this grant is made and/or to be performed.

The Company hereby reserves the right to alter, amend, modify, restate, suspend or terminate the Plan and the Grant Notice and this Agreement in accordance with Section 16 of the Plan, but, subject to the terms of the Plan, no such subsequent amendment, modification, restatement or termination of the Plan or the Grant Notice or this Agreement shall adversely affect in any material way your rights under the Grant Notice or this Agreement without your written consent. The Grant Notice and this Agreement shall be subject, without further action by the Company or you, to such amendment, modification or restatement.

The provisions of the Grant Notice and this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

18. Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon each successor of the Company and, to the extent specifically provided therein and in the Plan, shall inure to the benefit of and shall be binding upon your heirs, legal representatives, and successors and upon any person to whom a transfer of the Option permitted by Paragraph 6 of this Agreement has been made.

Page 8 of 8

EX-10.4

Exhibit 10.4

[COMPANY LETTERHEAD]

June 18, 2012

Allen J. Lauer

Dear Al:

The purpose of this letter is to clarify the intent and circumstances related to certain of the terms of your employment as Interim Chief Executive Officer and President (“Interim CEO”) of Intermec, Inc. (the “Company”), as set forth in the letter agreement, dated May 21, 2012, and effective as of April 30, 2012 (the “Employment Agreement”). In particular, we wish to affirm that, in view of the interim nature of the CEO position, it was not our expectation that you relocate to Washington State. Rather, we understand that you will determine the extent to which you should travel to the Company’s headquarters in Everett, WA in order to effectively fulfill your duties.

Accordingly, we propose the following revisions to the Employment Agreement:

Paragraph 1. Position is revised to read as follows:

1. Position. In your position as Interim CEO, you will report to the Company’s Board of Directors (the “Board”). The Interim CEO position is a full-time position. Although you will be expected to spend time in Everett at the Company’s headquarters, we anticipate that your travel plans may vary significantly week to week and you will work principally from your home office in California. While you render services to the Company as Interim CEO, you will not engage in any other employment, consulting or other business activity (whether full-time or part-time) that would create a conflict of interest with the Company; provided, however, that you may continue to serve on any boards of directors or committees thereof on which you served as of the Effective Date. By signing this Agreement, you confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company.

Paragraph 5. Expenses is revised to read as follows:

5. Expenses. The Company will reimburse you for all reasonable and necessary expenses incurred by you in connection with your performance of services as Interim CEO on behalf of the Company, in accordance with applicable Company policies and guidelines.

Except as revised in this letter, the terms of the Employment Agreement continue to apply.

Very truly yours,
INTERMEC, INC.
By:	/s/ Stephen P. Reynolds
	Stephen P. Reynolds
Title:	Lead Independent Director

I have read and agree with the above clarification
and amendment of the Employment Agreement.

/s/ Allen J. Lauer

Signature of Allen J. Lauer

Dated:

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Allen J. Lauer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Intermec, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

August 9, 2012

/s/ Allen J. Lauer

Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Robert J. Driessnack , Chief Financial Officer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Intermec, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

August 9, 2012

/s/ Robert J. Driessnack

Senior Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(SUBSECTIONS (a) AND (b) OF SECTION 1350,

CHAPTER 63 OF TITLE 18, UNITED STATES CODE)

In connection with the Quarterly Report on Form 10-Q of Intermec, Inc. (the “Company”) for the period ended July 1, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Allen J. Lauer, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. 1350, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 9, 2012

/s/ Allen J. Lauer

Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(SUBSECTIONS (a) AND (b) OF SECTION 1350,

CHAPTER 63 OF TITLE 18, UNITED STATES CODE)

In connection with the Quarterly Report on Form 10-Q of Intermec, Inc. (the “Company”) for the period ended July 1, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert J. Driessnack, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 9, 2012

/s/ Robert J. Driessnack

Senior Vice President and

Chief Financial Officer

XML

Accumulated Other Comprehensive Loss (Tables)

6 Months Ended

Jul. 01, 2012

Accumulated Other Comprehensive Income

At July 1, 2012 and December 31, 2011, accumulated other comprehensive income comprised the following (in thousands):

	July 1, 2012			December 31, 2011
Foreign currency translation adjustment	$	(6,563	)	$	(4,546	)
Unamortized benefit plan costs		(78,861	)		(74,623	)
Unrealized loss on investments		(317	)		(308	)
Accumulated other comprehensive loss	$	(85,741	)	$	(79,477	)

XML

Schedule Of Estimated Future Amortization Expense For Intangible Assets (Detail) (USD $) In Thousands, unless otherwise specified	Jul. 01, 2012
Intangibles [Abstract]
2012	$ 18,558
2013	16,367
2014	8,865
2015	6,005
2016	$ 3,482

XML

Schedule Of Accounts Receivable, Net (Detail) (USD $) In Thousands, unless otherwise specified	Jul. 01, 2012	Dec. 31, 2011
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 138,132	$ 146,682
Allowance for sales returns	4,185	4,423
Allowance for doubtful accounts	1,775	2,522
Accounts receivable, net	$ 132,172	$ 139,737

XML

Schedule Of Allocation Of Purchase Price To Assets Acquired And Liabilities Assumed, Net of Cash Acquired (Parenthetical) (Detail) (Adjusted Purchase Price, USD $) In Thousands, unless otherwise specified	Mar. 03, 2011
Adjusted Purchase Price
Schedule of Business Acquisitions, Purchase Price Allocation [Line Items]
Gross contractual receivables	$ 21,461
Goodwill for assembled workforce	$ 7,900

XML

Provision for Income Taxes - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended
	Apr. 01, 2012	Jul. 01, 2012
Tax Credit Carryforward [Line Items]
Tax provision on foreign earnings		$ 1.7
Deferred taxes from foreign subsidiaries		1.4
Valuation allowance increase	$ 206.9
Minimum likelihood of tax benefits being recognized upon ultimate settlement		50.00%
Effective tax rate for continuing operations		31.00%
U.S. statutory rate		35.00%

XML

Level 3 Fair Value Measurement for Assets and Liabilities Measured at Fair Value on Non-recurring Basis (Detail) (Goodwill, USD $)	6 Months Ended
	Jul. 01, 2012
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	$ 101,996
Voice Solutions Supply Chain Reporting Unit
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	89,993
Valuation Technique	Income Approach
Voice Solutions Healthcare Reporting Unit
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	8,655
Valuation Technique	Income Approach
Intermec Global Solutions Reporting Unit
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	$ 3,348
Valuation Technique	Income Approach

XML

Segment Reporting (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Revenues And Gross Profit By Reportable Segment

The following table sets forth our revenues and gross profit by reportable segment (in thousands):

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Revenues:
Intermec-branded products	$	135,618	$	153,329	$	252,951	$	287,183
Intermec-branded services		34,747		37,301		69,696		72,162
Voice solutions		30,586		30,452		57,982		40,255
Total	$	200,951	$	221,082		380,629	$	399,600
Gross profit:
Intermec-branded products	$	47,348	$	60,998	$	84,162	$	112,467
Intermec-branded services		14,237		13,234		28,017		25,814
Voice solutions		17,612		17,084		32,943		21,328
Total	$	79,197	$	91,316	$	145,122	$	159,609

Schedule Of Revenues By Product Lines

The following table sets forth our revenues by product lines (in thousands):

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Revenues:
Intermec branded:
Systems and solutions	$	96,924	$	108,664	$	178,730	$	199,045
Printer and media		38,694		44,665		74,221		88,138
Service		34,747		37,301		69,696		72,162
Voice solutions		30,586		30,452		57,982		40,255
Total	$	200,951	$	221,082	$	380,629	$	399,600

XML

Goodwill and Other Long-Lived Assets - Additional Information (Detail) (USD $)	3 Months Ended			6 Months Ended
	Jul. 01, 2012	Apr. 01, 2012 Segment	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Goodwill and Other Assets Disclosure [Line Items]
Impairment of goodwill	$ 26,589,000	$ 14,900,000		$ 41,514,000
Loss in operations	(33,578,000)	(19,000,000)	(3,078,000)	(67,194,000)	(11,682,000)
Number of reporting units with goodwill		3
Supply Chain
Goodwill and Other Assets Disclosure [Line Items]
Impairment of goodwill				40,700,000
Goodwill impairment charge		14,900,000
Goodwill impairment adjustment				25,800,000
Healthcare
Goodwill and Other Assets Disclosure [Line Items]
Goodwill impairment adjustment	$ 800,000

XML

Shares Used in Computing Earnings (Loss) per Share - Additional Information (Detail)	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock that were not included in weighted average shares diluted calculation	3,950,272	3,451,713	3,844,272	3,078,769

XML

Accumulated Other Comprehensive Income (Detail) (USD $) In Thousands, unless otherwise specified	Jul. 01, 2012	Dec. 31, 2011
Foreign currency translation adjustment	$ (6,563)	$ (4,546)
Unamortized benefit plan costs	(78,861)	(74,623)
Unrealized loss on investments	(317)	(308)
Accumulated other comprehensive loss	$ (85,741)	$ (79,477)

XML

Schedule Of Unaudited Pro Forma Financial Information (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended	6 Months Ended
	Jul. 03, 2011	Jul. 03, 2011
Pro forma
Total revenues	$ 221,082	$ 417,911
Net loss	$ (3,796)	$ (7,006)

XML

Basis of Presentation (Policies)

6 Months Ended

Jul. 01, 2012

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Fair Value Measurement - In May 2011, the Financial Accounting Standards Board (“FASB”) issued guidance which generally provides a consistent definition of fair value and ensures that the fair value measurement and disclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. The guidance changes certain fair value measurement principles and enhances the disclosure requirements, particularly for Level 3 fair value measurements. This guidance was effective for interim and annual reporting periods beginning after December 15, 2011 and was applied on a prospective basis. The Company adopted the guidance on January 1, 2012, as required. There was no material impact on the Consolidated Financial Statements resulting from the adoption, see Note 3 Fair Value Measurements for additional disclosures related to this pronouncement.

Comprehensive Income

Comprehensive Income - In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income,” (“ASU 2011-05”). ASU 2011-05 eliminates the option to report other comprehensive income (loss) and its components in the statement of changes in equity and requires that all nonowner changes in stockholders’ equity be presented in either a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB issued ASU 2011-12, “Comprehensive Income — Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in ASU 2011-05,” to defer the effective date to present items that are reclassified out of accumulated other comprehensive income to net income alongside their respective components of net income and other comprehensive income. All other provisions of this update, which are to be applied retrospectively, are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. We adopted this guidance in the first quarter of 2012 and applied it retrospectively. To implement this standard we have added a separate statement labeled Condensed Consolidated Statement of Comprehensive Income (Loss).

Goodwill

Intangibles – Goodwill and Other - In September 2011, the FASB issued ASU No. 2011-08, “Intangibles – Goodwill and Other (Topic 350) (“ASU 2011-08”). The amendments in this update will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendments include a number of events and circumstances for an entity to consider in conducting the qualitative assessment. This new guidance was adopted and applied in January 2012. The adoption of this accounting standard update did not have an impact on our financial position, results of operations, cash flows, or comprehensive income as it is intended to potentially simplify the assessment for goodwill impairment.

Reclassification

Reclassification

Certain reclassifications have been made to prior periods to conform to the present year presentation. Specifically, for the three and six months ended July 3, 2011 we have reclassified certain costs that were in cost of service revenues to cost of product revenues in the amount of $0.8 and $1.7 million, respectively. This reclassification has no impact on previously reported earnings from operations or net income. In addition, we have reclassified change in pension and other postretirement plans, net, previously reported in other operating activities into its own line item on the condensed consolidated statement of cash flow.

XML

Schedule Of Inventories (Detail) (USD $) In Thousands, unless otherwise specified	Jul. 01, 2012	Dec. 31, 2011
Inventories [Abstract]
Raw materials	$ 27,739	$ 30,485
Service parts	14,651	13,412
Work in process	550	316
Finished goods	55,004	59,409
Inventories	$ 97,944	$ 103,622

XML

Schedule Of Long-Term Debt Principal Payments (Detail) (USD $) In Thousands, unless otherwise specified	Jul. 01, 2012	Dec. 31, 2011
Revolving Credit Facility [Abstract]
2012-2013
2014	85,000
Total principal payments	$ 85,000	$ 85,000

XML

Schedule Of Reconciliation Of Accrued Restructuring Charges (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 5,598,000	$ 5,111,000	$ 5,598,000	$ 5,111,000
Accrued Employee Termination Costs Per Contract
Restructuring Cost and Reserve [Line Items]
Beginning Balance			1,000,000
Utilization of restructuring plans			(1,100,000)
Reversal of prior year restructuring charges			(300,000)
Ending Balance	5,500,000		5,500,000
Accrued Other Costs
Restructuring Cost and Reserve [Line Items]
Beginning Balance			1,200,000
Utilization of restructuring plans			(200,000)
Ending Balance	1,000,000		1,000,000
Total Accrued Restructuring Charges
Restructuring Cost and Reserve [Line Items]
Beginning Balance			2,200,000
Utilization of restructuring plans			(1,300,000)
Reversal of prior year restructuring charges			(300,000)
Ending Balance	6,500,000		6,500,000
2012 Restructuring Plan | Accrued Employee Termination Costs Per Contract
Restructuring Cost and Reserve [Line Items]
Restructuring charges			5,900,000
2012 Restructuring Plan | Total Accrued Restructuring Charges
Restructuring Cost and Reserve [Line Items]
Restructuring charges			$ 5,900,000

XML

Goodwill and Other Long-Lived Assets (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Changes In Goodwill

The following table represents changes in goodwill (amounts in thousands):

Reportable Segment	Reporting Unit	Goodwill balance at 12/31/2011		Goodwill impairment			Goodwill balance at 7/1/2012
Intermec-branded services:	Intermec Global Solutions	$	3,348	$	—		$	3,348
Voice solutions:	Supply chain		130,682		(40,689	)		89,993
	Healthcare		9,480		(825	)		8,655
	Total:	$	143,510	$	(41,514	)	$	101,996

XML

Schedule Of Gross Carrying Amount And Accumulated Amortization Of Intangible Assets (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended	12 Months Ended
	Jul. 01, 2012	Dec. 31, 2011
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 81,959	$ 81,959
Accumulated Amortization	29,349	19,963
Net Carrying Amount	52,610	61,996
Developed Technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	40,200	40,200
Accumulated Amortization	16,053	9,416
Net Carrying Amount	24,147	30,784
Weighted Average Useful Life, years	5 years	5 years
In-Process Research And Development
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,900	1,900
Accumulated Amortization	138
Net Carrying Amount	1,762	1,900
Weighted Average Useful Life, years	7 years	7 years
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	17,600	17,600
Accumulated Amortization	1,948	623
Net Carrying Amount	15,652	16,977
Weighted Average Useful Life, years	11 years	11 years
Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	5,200	5,200
Accumulated Amortization	519	303
Net Carrying Amount	4,681	4,897
Weighted Average Useful Life, years	10 years	10 years
Lease Agreements
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,600	2,600
Accumulated Amortization	463	245
Net Carrying Amount	2,137	2,355
Weighted Average Useful Life, years	8 years	8 years
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	14,459	14,459
Accumulated Amortization	10,228	9,376
Net Carrying Amount	4,231	5,083
Weighted Average Useful Life, years	5 years	5 years
Total Other Acquired Intangible Assets From Vocollect Acquisition
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	67,500	67,500
Accumulated Amortization	19,121	10,587
Net Carrying Amount	$ 48,379	$ 56,913

XML

Pension And Other Postretirement Benefits Liabilities - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Jul. 01, 2012
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Expected additional pension and other postretirement benefit contributions	$ 10.7
U.S. Defined Benefit Postretirement Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Expected additional pension and other postretirement benefit contributions	4.8
Unfunded Defined Benefit Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Expected additional pension and other postretirement benefit contributions	2.3
Matching Contributions To 401(k) Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Expected additional pension and other postretirement benefit contributions	1.9
Non U.S. Defined Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Expected additional pension and other postretirement benefit contributions	$ 1.7

XML

Schedule Of Revenues And Gross Profit By Reportable Segment (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Segment Reporting Information [Line Items]
Revenues	$ 200,951	$ 221,082	$ 380,629	$ 399,600
Gross profit	79,197	91,316	145,122	159,609
Intermec-Branded Products
Segment Reporting Information [Line Items]
Revenues	135,618	153,329	252,951	287,183
Gross profit	47,348	60,998	84,162	112,467
Intermec-Branded Services
Segment Reporting Information [Line Items]
Revenues	34,747	37,301	69,696	72,162
Gross profit	14,237	13,234	28,017	25,814
Voice Solutions
Segment Reporting Information [Line Items]
Revenues	30,586	30,452	57,982	40,255
Gross profit	$ 17,612	$ 17,084	$ 32,943	$ 21,328

XML

Derivative Instruments - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012 Day	Jul. 03, 2011	Dec. 31, 2011
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional amounts of the forward contracts	$ 129.0		$ 129.0
Foreign exchange forward contracts, settlement, period, in days			30
Net loss (gain) from forward contracts, recorded in selling, general and administrative expense	2.4	0.5	1.5	1.1
Net (liability) asset recorded in other current assets or accounts payable and accrued expenses	$ 0.7		$ 0.7		$ (0.8)

XML

Fair Value Measurements

6 Months Ended

Jul. 01, 2012

Fair Value Measurements

Note 3. Fair Value Measurements

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Our financial assets and liabilities subject to fair value measurement provisions as of July 1, 2012 comprised the following (in thousands):

	Level 1		Level 2			Level 3		Fair Value at July  1, 2012
Money market funds	$	39,561	$	—		$	—	$	39,561
Stock		181		—			—		181
Derivative instruments – assets		—		1,317			—		1,317
Total assets at fair value	$	39,742	$	1,317		$	—	$	41,059
	Level 1		Level 2			Level 3		Fair Value at July 1, 2012
Derivative instruments – liabilities	$	—	$	(575	)	$	—	$	(575	)
Total liabilities at fair value	$	—	$	(575	)	$	—	$	(575	)

Our financial assets and liabilities subject to fair value measurement provisions as of December 31, 2011 comprised the following (in thousands):

	Level 1		Level 2			Level 3		Fair Value at December 31, 2011
Money market funds	$	15,275	$	—		$	—	$	15,275
Certificates of deposit		—		3,555			—		3,555
Stock		170		—			—		170
Derivative instruments – assets		—		985			—		985
Total assets at fair value	$	15,445	$	4,540		$	—	$	19,985
	Level 1		Level 2			Level 3		Fair Value at December 31, 2011
Derivative instruments – liabilities	$	—	$	(1,801	)	$	—	$	(1,801	)
Total liabilities at fair value	$	—	$	(1,801	)	$	—	$	(1,801	)

Our Level 1 financial instrument values are based on quoted market prices for identical assets in active markets. Our Level 2 financial instrument values are based on quoted prices in active markets for similar assets, which we use to value our certificates of deposit, or comparable sales, such as quoted market rates for similar contracts. Specifically, we obtain current pricing from the issuing bank for identical items purchased on the last business day of our reporting period. Level 3 financial instrument values refer to fair values using unobservable inputs that are not corroborated by market data.

There were no transfers between Level 1 and Level 2 assets and liabilities in the three and six months ended July 1, 2012 and July 3, 2011.

Fair Value of Financial Instruments

The estimated fair values of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, and payroll and related expenses at July 1, 2012 and December 31, 2011, approximate their carrying values due to their short-term nature. The fair value of long-term debt at July 1, 2012 approximates its carrying value.

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

All other nonfinancial assets and liabilities measured at fair value in the financial statements on a nonrecurring basis are subject to fair value measurements and disclosures. Nonfinancial assets and liabilities included in our condensed consolidated balance sheets and measured on a nonrecurring basis consist of goodwill and long-lived assets, including other acquired intangibles. Goodwill and long-lived assets are measured at fair value to test for and measure impairment, if any, at least annually for goodwill or when necessary for both goodwill and long-lived assets. See Note 16 – Goodwill and other Long-Lived Assets for details of our impairment analysis.

The following fair value hierarchy table presents information about our goodwill assets that were measured at fair value on a non-recurring basis at July 1, 2012 (in thousands):

Goodwill	Level 1		Level 2		Level 3		Fair Value at July 1, 2012
Voice solutions supply chain reporting unit	$	—	$	—	$	89,993	$	89,993
Voice solutions healthcare reporting unit		—		—		8,655		8,655
Intermec global solutions reporting unit		—		—		3,348		3,348
Total goodwill at fair value	$	—	$	—	$	101,996	$	101,996

The following fair value hierarchy table presents information about our goodwill assets that were measured at fair value on a non-recurring basis at December 31, 2011(in thousands):

Goodwill	Level 1		Level 2		Level 3		Fair Value at December 31, 2011
Voice solutions supply chain reporting unit	$	—	$	—	$	130,682	$	130,682
Voice solutions healthcare reporting unit						9,480		9,480
Intermec global solutions reporting unit						3,348		3,348
Total goodwill at fair value	$	—	$	—	$	143,510	$	143,510

A goodwill impairment was recorded in the amount of $26.6 and $41.5 million for the three and six months ended July 1, 2012, respectively, against the Voice Solutions Supply Chain (“VSC”) and Voice Solutions Healthcare (“VHS”) reporting units.

The following table presents qualitative information with respect to Level 3 fair value measurements for assets and liabilities measured at fair value on a non-recurring basis at July 1, 2012:

Reporting Unit	Fair Value		Valuation Technique(s)	Unobservable Input(s)
Voice Solutions Supply Chain
Goodwill	$	89,993	Income Approach	Financial Forecast
				Terminal Growth Rate
				Weighted Average Cost of Capital
				Expected Cash Flow
			Market Approach	Public Company Multiples
Voice Solutions Healthcare
Goodwill	$	8,655	Income Approach	Financial Forecast
				Terminal Growth Rate
				Weighted Average Cost of Capital
Intermec Global Solutions
Goodwill	$	3,348	Income Approach	Financial Forecast
				Terminal Growth Rate
				Weighted Average Cost of Capital
Total Goodwill	$	101,996

XML

Schedule Of Revenues By Product Lines (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Segment Reporting Information [Line Items]
Revenues	$ 200,951	$ 221,082	$ 380,629	$ 399,600
Systems And Solutions
Segment Reporting Information [Line Items]
Revenues	96,924	108,664	178,730	199,045
Printer And Media
Segment Reporting Information [Line Items]
Revenues	38,694	44,665	74,221	88,138
Services
Segment Reporting Information [Line Items]
Revenues	34,747	37,301	69,696	72,162
Voice Solutions
Segment Reporting Information [Line Items]
Revenues	$ 30,586	$ 30,452	$ 57,982	$ 40,255

XML

Schedule Of Financial Assets And Liabilities Subject To Fair Value Measurement Provisions (Detail) (USD $) In Thousands, unless otherwise specified	Jul. 01, 2012	Dec. 31, 2011
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value	$ 41,059	$ 19,985
Total liabilities at fair value	(575)	(1,801)
Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value	39,561	15,275
Certificates of Deposit
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value		3,555
Stock
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value	181	170
Derivative Instruments - Assets
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value	1,317	985
Derivative Instruments - Liabilities
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value	(575)	(1,801)
Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value	39,742	15,445
Level 1 | Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value	39,561	15,275
Level 1 | Stock
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value	181	170
Level 2
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value	1,317	4,540
Total liabilities at fair value	(575)	(1,801)
Level 2 | Certificates of Deposit
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value		3,555
Level 2 | Derivative Instruments - Assets
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value	1,317	985
Level 2 | Derivative Instruments - Liabilities
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value	$ (575)	$ (1,801)

XML

Inventories (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Inventories

Inventories consisted of the following (in thousands):

	July 1, 2012		December 31, 2011
Raw materials	$	27,739	$	30,485
Service parts		14,651		13,412
Work in process		550		316
Finished goods		55,004		59,409
Inventories	$	97,944	$	103,622

XML

Accounts Receivable, Net (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Accounts Receivable, Net

Accounts receivable, net, consisted of the following (in thousands):

	July 1, 2012		December 31, 2011
Accounts receivable, gross	$	138,132	$	146,682
Less:
Allowance for sales returns		4,185		4,423
Allowance for doubtful accounts		1,775		2,522
Accounts receivable, net	$	132,172	$	139,737

XML

Schedule Of Computation Of Weighted Average Number Of Shares Issued And Outstanding (Detail)	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Schedule of Weighted Average Number of Diluted Shares Outstanding [Line Items]
Weighted average shares - basic	60,251,466	59,784,479	60,140,033	60,070,394
Dilutive effect of unvested restricted shares and stock options
Weighted average shares - diluted	60,251,466	59,784,479	60,140,033	60,070,394

XML

Schedule Of Goodwill Assets That Were Measured At Fair Value On Non-Recurring Basis (Detail) (Fair Value, Measurements, Nonrecurring, USD $) In Thousands, unless otherwise specified	Jul. 01, 2012	Dec. 31, 2011
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill, Fair Value	$ 101,996	$ 143,510
Voice Solutions Supply Chain Reporting Unit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill, Fair Value	89,993	130,682
Voice Solutions Healthcare Reporting Unit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill, Fair Value	8,655	9,480
Intermec Global Solutions Reporting Unit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill, Fair Value	3,348	3,348
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill, Fair Value	101,996	143,510
Level 3 | Voice Solutions Supply Chain Reporting Unit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill, Fair Value	89,993	130,682
Level 3 | Voice Solutions Healthcare Reporting Unit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill, Fair Value	8,655	9,480
Level 3 | Intermec Global Solutions Reporting Unit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill, Fair Value	$ 3,348	$ 3,348

XML

Intangibles (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Gross Carrying Amount And Accumulated Amortization Of Intangible Assets

The following table presents the gross carrying amount and accumulated amortization of intangible assets as of July 1, 2012 (in thousands):

	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Weighted Average Useful Life
Developed technology	$	40,200	$	16,053	$	24,147		5 years
In-process research and development		1,900		138		1,762		7 years
Customer relationships		17,600		1,948		15,652		11 years
Trademarks		5,200		519		4,681		10 years
Lease agreements		2,600		463		2,137		8 years
Total acquired intangible assets from Vocollect acquisition:		67,500		19,121		48,379
Other intangibles		14,459		10,228		4,231		5 years
Total	$	81,959	$	29,349	$	52,610

The following table presents the gross carrying amount and accumulated amortization of intangible assets as of December 31, 2011 (in thousands):

	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Weighted Average Useful Life
Developed technology	$	40,200	$	9,416	$	30,784		5 years
In-process research and development		1,900		—		1,900		7 years
Customer relationships		17,600		623		16,977		11 years
Trademarks		5,200		303		4,897		10 years
Lease agreements		2,600		245		2,355		8 years
Total acquired intangible assets from Vocollect acquisition:		67,500		10,587		56,913
Other intangibles		14,459		9,376		5,083		5 years
Total	$	81,959	$	19,963	$	61,996

Schedule Of Estimated Future Amortization Expense For Intangible Assets

Total amortization expense on intangibles for the three and six months ended July 1, 2012 was $4.7 and $9.4 million, respectively, and $3.3 and $4.3 million, for the three and six months ended July 3, 2011, respectively. Estimated future amortization expense for intangible assets for the next five years is as follows (in thousands):

Year	Amount
2012	$	18,558
2013		16,367
2014		8,865
2015		6,005
2016		3,482

XML

Shares Used in Computing Earnings (Loss) per Share (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Computation Of Weighted Average Number Of Shares Issued And Outstanding

Basic earnings (loss) per share are calculated using the weighted average number of common shares issued and outstanding for the applicable period. Diluted loss per share is computed using basic weighted average shares issued and outstanding plus the dilutive effect of unvested restricted stock and outstanding stock options using the “treasury stock” method.

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Weighted average shares - basic		60,251,466		59,784,479		60,140,033		60,070,394
Dilutive effect of unvested restricted shares and stock options		—		—		—		—
Weighted average shares - diluted		60,251,466		59,784,479		60,140,033		60,070,394

XML

Revolving Credit Facility

6 Months Ended

Jul. 01, 2012

Revolving Credit Facility

Note 2: Revolving Credit Facility

Effective March 3, 2011, we amended our unsecured revolving credit facility with Wells Fargo Bank, National Association (the “Bank”) to convert the facility to a three-year, $100 million, secured revolving credit facility, which originally matured on March 3, 2014 (the “Revolving Facility”). The unsecured revolving credit facility was initiated on September 27, 2007. On December 21, 2011, we amended the Revolving Facility to expand our borrowing capacity to $150 million and extended the maturity date to December 31, 2014. On February 2, 2012, we amended the Revolving Facility to modify certain financial covenants relating to net income. Effective March 30, 2012, we amended the Revolving Facility to remove certain financial covenants, to add a new covenant related to minimum adjusted EBITDA and to add a new financial covenant for permitted acquisitions. We were in compliance with all financial and non-financial covenants of the Revolving Facility at July 1, 2012.

In addition to financing the acquisition of Vocollect in 2011, the Revolving Facility is used for general corporate purposes. The Revolving Facility includes financial covenants and is secured by pledges of equity in certain assets of our domestic subsidiaries and guaranties of payment obligations from certain of our domestic subsidiaries. At July 1, 2012, after considering the financial covenant requirements, we had borrowing capacity of $7.3 million under the Revolving Facility with borrowings of $85 million and $1.5 million of letters of credit outstanding. The amount outstanding under the Revolving Facility bears interest at a variable rate equal to LIBOR plus a margin ranging from 1.25% to 1.75%. For the three and six months ended July 1, 2012, the weighted average interest rate on borrowed funds under the Revolving Facility was 2.23% and 2.26%, respectively.

At July 1, 2012, scheduled principal payments on long-term debt were as follows (in thousands):

	Total
2012-2013	$	—
2014		85,000
Total principal payments	$	85,000

The key terms of the Revolving Facility are as follows following the most recent amendment:

• Loans bear interest at a variable rate equal to (at our option) (i) LIBOR plus the applicable margin, which ranges from 1.25% to 1.75%, or (ii) the Bank’s prime rate, less the applicable margin, which ranges from 0.25% to 1.00%. If an event of default occurs and is continuing, then the interest rate on all obligations under the Revolving Facility may be increased by 2.0% above the otherwise applicable rate, and the Bank may declare any outstanding obligations under the Revolving Facility to be immediately due and payable. In addition, the Bank may exercise its security interest in our equity interests in the assets of certain of our domestic subsidiaries, and it may call the guaranties of payment obligations made by certain of our domestic subsidiaries.

• A fee ranging from 0.60% to 1.00% on the maximum amount available to be drawn under each letter of credit that is issued and outstanding under the Revolving Facility. The fee on the unused portion of the Revolving Facility ranges from 0.15% to 0.25%.

• Certain of our domestic subsidiaries have guaranteed the Revolving Facility.

• The Revolving Facility contains various restrictions and covenants, including restrictions on our ability and the ability of our subsidiaries to consolidate or merge, make acquisitions, create liens, incur additional indebtedness or dispose of assets.

• The Revolving Facility includes covenants requiring us to meet certain minimum financial performance thresholds, including:

• A ratio of maximum funded debt to EBITDA allowed (as defined in the Revolving Facility) of not more than 2.5 to 1.

• An Asset Coverage Ratio of not less than 1 to 1 for debt to margined assets. For this purpose, a certain percentage of our accounts receivable and inventory balances are included in margined assets.

• The minimum adjusted EBITDA allowed (as defined in the Revolving Facility) for the trailing twelve months is $25 million for the second quarter of 2012, $35 million for the third quarter of 2012, and $45 million for all subsequent quarters.

We expect to be in compliance with our covenants for the next twelve months.

XML

Stock-Based Compensation (Tables)

6 Months Ended

Jul. 01, 2012

Summary Of Stock-Based Compensation Expense

A summary of stock-based compensation expense related to director and employee stock options, Restricted Stock Units (“RSU”), Performance Stock Units (“PSU”), and Employee Stock Purchase Plan (“ESPP”) for the three and six months ended July 1, 2012 and July 3, 2011 is as follows (in thousands):

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Cost of revenue	$	63	$	63	$	126	$	126
Selling, general and administrative		421		2,152		2,999		4,299
Total	$	484	$	2,215	$	3,125	$	4,425

XML

Basis of Presentation - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended
	Jul. 03, 2011	Jul. 03, 2011	Jul. 02, 2012	Dec. 31, 2011
Product Information [Line Items]
Reclassified amount from cost of service revenues to cost of product revenues	$ 0.8	$ 1.7
Cash surrender values, Gross			22.9	26.1
Gross amount of policy loans			21.4	16.0
Cash surrender values, Net of policy loans			$ 1.5	$ 10.1

XML

Intangibles - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Finite-Lived Intangible Assets [Line Items]
Total amortization expense on other acquired intangibles	$ 4.7	$ 3.3	$ 9.4	$ 4.3

XML

Schedule Of Changes In Goodwill (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended				6 Months Ended
	Jul. 01, 2012	Apr. 01, 2012	Jul. 01, 2012	Jul. 01, 2012 Supply Chain	Jul. 01, 2012 Intermec-Branded Services Intermec Global Solutions	Dec. 31, 2011 Intermec-Branded Services Intermec Global Solutions	Jul. 01, 2012 Voice Solutions Supply Chain	Jul. 01, 2012 Voice Solutions Healthcare
Goodwill [Line Items]
Goodwill Beginning Balance		$ 143,510	$ 143,510		$ 3,348	$ 3,348	$ 130,682	$ 9,480
Goodwill impairment	(26,589)	(14,900)	(41,514)	(40,700)			(40,689)	(825)
Goodwill Ending balance	$ 101,996		$ 101,996		$ 3,348	$ 3,348	$ 89,993	$ 8,655

XML

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jul. 01, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 74,711	$ 95,108
Short-term investments	181	170
Accounts receivable, net	132,172	139,737
Inventories	97,944	103,622
Current deferred tax assets, net	8,158	84,541
Other current assets	28,908	24,226
Total current assets	342,074	447,404
Deferred tax assets, net	7,379	141,064
Goodwill	101,996	143,510
Intangible assets, net	52,610	61,996
Property, plant and equipment, net	42,977	47,086
Other assets, net	19,546	28,230
Total assets	566,582	869,290
Current liabilities:
Accounts payable	70,833	92,607
Payroll and related expenses	26,711	32,540
Deferred revenue	60,074	47,234
Accrued expenses	26,727	35,118
Total current liabilities	184,345	207,499
Long-term debt	85,000	85,000
Pension and other postretirement benefits liabilities	126,309	124,058
Long-term deferred revenue	28,883	28,960
Other long-term liabilities	15,975	15,344
Commitments and contingencies
Shareholders' equity:
Common stock (250,000 shares authorized, 63,419 and 62,956 shares issued and 60,113 and 59,717 outstanding)	639	636
Additional paid-in capital	701,111	697,597
Accumulated deficit	(489,939)	(210,327)
Accumulated other comprehensive loss	(85,741)	(79,477)
Total shareholders' equity	126,070	408,429
Total liabilities and shareholders' equity	$ 566,582	$ 869,290

XML

Fair Value Measurements - Additional Information (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Apr. 01, 2012	Jul. 01, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill impairment	$ 26,589	$ 14,900	$ 41,514

XML

Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011
Cash and cash equivalents at beginning of the period	$ 95,108	$ 221,467
Cash flows from operating activities:
Net loss	(279,612)	(9,874)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	18,015	12,815
Deferred taxes	211,321	(6,810)
Stock-based compensation	3,125	4,376
Impairment of goodwill	41,514
Gain on sale of assets	(2,655)
Gain on company owned life insurance	(1,174)
Change in pension and other postretirement plans	(1,963)	(608)
Changes in operating assets and liabilities:
Accounts receivable	7,363	(4,321)
Inventories	5,032	(1,507)
Other current assets	(4,703)	(3,948)
Accounts payable	(21,151)	2,607
Payroll and related expenses	(5,736)	1,777
Accrued expenses	(7,984)	(8,551)
Deferred revenue	13,041	5,365
Other operating activities	(1,232)	1,514
Net cash used in operating activities	(26,799)	(7,165)
Cash flows from investing activities:
Acquisitions, net of cash acquired		(200,810)
Additions to property, plant and equipment	(4,551)	(11,534)
Proceeds from sale of assets	2,359
Proceeds from company owned life insurance	8,962
Other investing activities	(346)	(699)
Net cash provided by (used in) investing activities	6,424	(213,043)
Cash flows from financing activities:
Proceeds from issuance of debt		97,000
Repayment of debt		(20,000)
Stock repurchase		(10,014)
Stock options exercised and other	1,034	1,097
Net cash provided by financing activities	1,034	68,083
Effect of exchange rate changes on cash and cash equivalents	(1,056)	6,098
Net change in cash and cash equivalents	(20,397)	(146,027)
Cash and cash equivalents at end of the period	74,711	75,440
Cash paid during the period for income taxes	(7,091)	(4,317)
Cash paid during the period for interest	$ (1,008)	$ (1,443)

XML

Stock-Based Compensation - Additional Information (Detail) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended	6 Months Ended
	Jul. 01, 2012	Jul. 01, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reduction in Stock compensation expense	$ 1.9	$ 1.9
Stock Options Granted To Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted	572,855	586,855
Stock options granted, weight-average grant-date fair value	$ 2.71	$ 2.72
Stock options granted, vesting period in years	3 years	3 years

XML

Pension and Other Postretirement Benefits Liabilities (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Components Of Net Pension And Postretirement Periodic Benefit Cost (Income)

The components of net pension and postretirement periodic benefit cost (income) for the three and six months ended July 1, 2012 and July 3, 2011, were as follows (in thousands):

	U.S. Defined Benefit Plans						Non U.S. Defined Benefit Plans						Other Postretirement Benefit Plans
	2012			2011			2012			2011			2012			2011
Three Months Ended July 1, 2012, and July 3, 2011:
Interest cost	$	2,983		$	3,029		$	495		$	528		$	34		$	40
Expected return on plan assets		(2,592	)		(2,689	)		(532	)		(517	)		—			—
Amortization and deferrals:
Transition asset		—			—			(34	)		(33	)		—			—
Actuarial loss		888			563			163			163			—			—
Prior service cost		—			—			—			—			(41	)		(40	)
Net pension and postretirement periodic benefit cost (income)	$	1,279		$	903		$	92		$	141		$	(7	)	$	—

	U.S. Defined Benefit Plans						Non U.S. Defined Benefit Plans						Other Postretirement Benefit Plans
	2012			2011			2012			2011			2012			2011
Six Months Ended July 1, 2012, and July 3, 2011:
Interest cost	$	5,965		$	6,059		$	994		$	1,057		$	69		$	80
Expected return on plan assets		(5,183	)		(5,377	)		(1,069	)		(1,035	)		—			—
Amortization and deferrals:
Transition asset		—			—			(68	)		(66	)		—			—
Actuarial loss		1,776			1,126			328			326			—			—
Prior service cost		—			—			—			—			(83	)		(79	)
Net pension and postretirement periodic benefit cost (income)	$	2,558		$	1,808		$	185		$	282		$	(14	)	$	1

Schedule Of Pension And Other Postretirement Benefit Plan Contributions

Our pension and other postretirement benefit plan contributions for the three and six months ended July 1, 2012, were as follows (in thousands):

	Three Months Ended July 1, 2012		Six Months Ended July 1, 2012
U.S. defined benefit postretirement benefit plans	$	2,122		3,117
Matching contributions to 401(k) plan		1,087		2,322
Foreign pension plans		956		1,770
Total	$	4,165		7,209

XML

Schedule Of Components Of Net Pension And Postretirement Periodic Benefit Cost (Income) (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
U.S. Defined Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 2,983	$ 3,029	$ 5,965	$ 6,059
Expected return on plan assets	(2,592)	(2,689)	(5,183)	(5,377)
Actuarial loss	888	563	1,776	1,126
Net pension and postretirement periodic benefit cost (income)	1,279	903	2,558	1,808
Non U.S. Defined Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Interest cost	495	528	994	1,057
Expected return on plan assets	(532)	(517)	(1,069)	(1,035)
Transition asset	(34)	(33)	(68)	(66)
Actuarial loss	163	163	328	326
Net pension and postretirement periodic benefit cost (income)	92	141	185	282
Other Postretirement Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Interest cost	34	40	69	80
Prior service cost	(41)	(40)	(83)	(79)
Net pension and postretirement periodic benefit cost (income)	$ (7)		$ (14)	$ 1

XML

Goodwill and Other Long-Lived Assets

6 Months Ended

Jul. 01, 2012

Goodwill and Other Long-Lived Assets

Note 16. Goodwill and Other Long-Lived Assets

Goodwill

We assign goodwill to our reporting units based on the expected benefit from the growth and synergies arising from each acquisition. We have three reportable segments: Intermec-branded products, Intermec-branded services and Voice solutions. Intermec-branded services and Voice solutions each comprise two reporting units. Intermec-branded services are divided into: Core Service and Intermec Global Solutions (“IGS”). Voice solutions contains the Supply Chain (“VSC”) and Healthcare (“VHS”) reporting units.

The following table represents changes in goodwill (amounts in thousands):

Reportable Segment	Reporting Unit	Goodwill balance at 12/31/2011		Goodwill impairment			Goodwill balance at 7/1/2012
Intermec-branded services:	Intermec Global Solutions	$	3,348	$	—		$	3,348
Voice solutions:	Supply chain		130,682		(40,689	)		89,993
	Healthcare		9,480		(825	)		8,655
	Total:	$	143,510	$	(41,514	)	$	101,996

Goodwill impairment charges of $26.6 and $41.5 million were recognized during the three and six months ended July 1, 2012, respectively. There were no goodwill impairment charges for the similar periods in 2011.

Q1 2012 goodwill impairment analysis

During the first quarter of 2012, two events occurred that triggered an analysis of the carrying value of goodwill and resulted in the estimated write down of goodwill of $14.9 million. Specifically, operating income was less than our forecast, primarily due to an $19 million loss on operations in the first quarter principally in the Intermec-branded products and services segments. In addition, our financial results negatively impacted the price per share of Intermec stock, causing the market capitalization of the Company to be significantly below its net book value. These triggering events were indicators that it was more likely than not the fair value of the Company’s goodwill was less than its book value.

We prepared a Step 1 goodwill impairment analysis to determine the fair values of all three reporting units with goodwill (Intermec Global Solutions, Healthcare, and Supply Chain). To calculate the fair values we used the discounted cash flow method and market approach. We made significant assumptions and estimates about the extent and timing of future cash flows, growth rates, and discount rates that represent unobservable inputs into our valuation methodologies used to calculate fair value. The cash flows were estimated over a significant future period of time, which made those estimates and assumptions subject to a high degree of uncertainty. Where available and as appropriate, comparative market multiples and the quoted market price of our common stock were used to corroborate the results of the discounted cash flow method and market approach. Assumptions used in our analysis that have the most significant effect on the estimated fair values of our reporting units include:

• Our estimated weighted-average cost of capital (WACC); and

• Our estimated long-term growth

• Market mutiples

Once we had determined our assumptions, we calculated the fair value of each reporting unit and compared it to the carrying value of the reporting unit. After performing our Step 1 analysis for the reporting units, we determined that the carrying value of the Supply Chain reporting unit exceeded its fair value by $14.9 million and recognized an estimated impairment charge in the first quarter. Due to the timing and complexity of this analysis, Step 2 of the impairment test was substantially completed in the second quarter of 2012. After performing that test we determined we had an additional goodwill impairment of $25.8 million associated with our Supply Chain reporting unit. The additional impairment was the result of an increase in the fair value of developed and in process technology intangible assets within the Supply Chain reporting unit. The increase in the intangible assets reduced the implied fair value of the goodwill, and we recognized a $40.7 million cumulative impairment of the Supply Chain reporting unit goodwill for the six months ended July 1, 2012.

Determining the fair value of goodwill for the Supply Chain reporting unit for Step 2 was judgmental in nature and involved the use of significant estimates and assumptions to calculate a hypothetical fair value of the assets and liabilities within the reporting unit. Our analysis utilized the income approach to calculate the implied fair value of goodwill of the Supply Chain reporting unit. The key inputs we used in the income approach included our forecast of revenue and expenses, a migration curve of developed and in-process technology, tax rate, discount rates, customer retention rates, useful lives, and contributory charge rates. These key inputs, for the income approach, are classified as Level 3 within the fair value hierarchy; see Note 3 Fair Value Measurements.

Q2 2012 goodwill impairment analysis

During the three months ended July 1, 2012, we changed the composition of key senior management at the reporting units and also changed our Chief Executive Officer. Additionally, we evaluated certain market trends and specific changes in our marketplace including, macro and micro economic conditions, expected government spending and industry data. As a result of the changes and evaluations, a review was performed over all areas in which we engage in business. Upon conclusion of the review, key operational and investment decisions were made which resulted in changes in the amount and timing of receipts and expenditures. Specifically, forecasts of revenue, research and development costs, capital expenditures, and other inputs to operations were revised, and the result was reduced cash flow forecasts across the three reporting units with goodwill. Consequently, a triggering event occurred to evaluate impairment of goodwill, specific to facts and circumstances during the three months ended July 1, 2012.

We prepared a Step 1 goodwill impairment analysis to determine the fair values of all three reporting units with goodwill (Intermec Global Solutions, Healthcare, and Supply Chain). To calculate the fair values we used the discounted cash flow method and market approach. We utilized the same methods listed above in Q1 2012 goodwill impairment analysis to perform our Step 1 analysis for the three months ended July 1, 2012. Once we had determined our assumptions we calculated the fair value of each reporting unit and compared it to the carrying value of the reporting unit.

After performing our Step 1 analysis, for the reporting units, we determined that the carrying value of the Healthcare reporting unit exceeded its fair value, so we then performed a Step 2 analysis. Based on our preliminary Step 2 analysis we determined we had an estimated goodwill impairment of $0.8 million associated with our Healthcare reporting unit. This impairment was primarily the result of a reduction in our long term business forecast specifically related to expected government spending in the skilled nursing area, the likely impact on capital investments in that market and the timing of the launch of new products for our Healthcare reporting unit. Due to the timing and complexity of this Step 2 analysis, we will finalize it in the third quarter of 2012 and the impairment amount may change at that time.

Determining the fair value of goodwill for the Healthcare reporting unit for Step 2 is judgmental in nature and involves the use of significant estimates and assumptions to perform a hypothetical fair value of the assets and liabilities within the reporting unit. Our analysis utilized the income approach to calculate the implied fair value of goodwill of the Healthcare reporting unit. The key inputs we used in the income approach included our forecast of revenue and expenses, a migration curve of developed and new technology, tax rate, discount rates, customer retention rates, useful lives, and contributory charge rates. These key inputs, for the income approach, are classified as Level 3 within the fair value hierarchy. See Note 3 Fair Value Measurements to our Condensed Consolidated Financial Statements for further detail.

Future goodwill impairments that may be material could be recognized should the recent economic uncertainty continue, our equity price declines on a sustained basis, global economies enter in another recession, or industry growth stagnates further. Our fair value estimates for event-driven impairment tests assume the achievement of future financial results contemplated in our forecasted cash flows and there can be no assurance that we will realize that value. The estimates and assumptions used are subject to significant uncertainties, many of which are beyond our control, and there is no assurance that anticipated financial results will be achieved.

Valuation of Long-Lived Assets

Long-lived assets, such as property, plant, and equipment, and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of asset groups to be held and used is measured by a comparison of the carrying amount of an asset group to estimated undiscounted future cash flows expected to be generated by the asset group. If the carrying amount of an asset group exceeds its estimated future cash flows, an impairment charge is recognized in our statement of operations and as a reduction to the asset group to the extent that the fair market value of the asset group is less than its carrying value. Due to the same circumstances that required the interim goodwill impairment test above, we evaluated our long lived assets for impairment for the quarters ended April 1, 2012 and July 1, 2012. We determined that the carrying amount of our long-lived assets did not exceed their estimated undiscounted future cash flows, and thus our long-lived assets are not impaired as of April 1, 2012 and July 1, 2012.

XML

Acquisitions (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Allocation Of Purchase Price To Assets Acquired And Liabilities Assumed

The allocation of the purchase price to Vocollect’s assets acquired and liabilities assumed, net of cash acquired, is as follows (in thousands):

	At Acquisition March 3, 2011 (Adjusted)
Accounts receivable (gross contractual receivables total of $21,461)	$	20,569
Inventories		7,520
Net deferred tax assets		7,880
Other current assets		7,353
Goodwill (including $7.9 million for assembled workforce)		140,162
Intangible assets		67,500
Property, plant and equipment		9,123
Other assets		137
Accounts payable		(6,818	)
Payroll and related expenses		(8,812	)
Deferred revenue		(10,936	)
Accrued expenses		(8,739	)
Deferred tax liabilities		(22,570	)
Long-term deferred revenue		(4,282	)
Other long-term liabilities		(1,370	)
Total net assets acquired	$	196,717

Schedule Of Unaudited Pro Forma Financial Information

The pro forma financial information presented below is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisitions and any borrowings undertaken to finance the acquisition had taken place at the beginning of fiscal 2011.

(in thousands)	Three Months Ended July 3, 2011			Six Months Ended July 3, 2011
Total revenues	$	221,082		$	417,911
Net loss		(3,796	)		(7,006	)

XML

Accumulated Other Comprehensive Loss

6 Months Ended

Jul. 01, 2012

Accumulated Other Comprehensive Loss

Note 18. Accumulated Other Comprehensive Loss

At July 1, 2012 and December 31, 2011, accumulated other comprehensive income comprised the following (in thousands):

	July 1, 2012			December 31, 2011
Foreign currency translation adjustment	$	(6,563	)	$	(4,546	)
Unamortized benefit plan costs		(78,861	)		(74,623	)
Unrealized loss on investments		(317	)		(308	)
Accumulated other comprehensive loss	$	(85,741	)	$	(79,477	)

XML

Acquisitions - Additional Information (Detail) (USD $)	3 Months Ended	6 Months Ended
	Jul. 03, 2011	Jul. 03, 2011	Mar. 03, 2011
Business Acquisition [Line Items]
Aggregate purchase price of business acquisition			$ 197,000,000
Acquisition and related costs	373,000	5,211,000
Total business acquisition costs	$ 5,200,000	$ 5,200,000

XML

Basis of Presentation

6 Months Ended

Jul. 01, 2012

Basis of Presentation

Note 1. Basis of Presentation

Our interim financial periods are based on a thirteen-week internal accounting calendar. In our opinion, the accompanying balance sheets, statements of operations, statements of cash flows and statements of comprehensive income (loss) include all adjustments, consisting mainly of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated financial statements include the accounts of Intermec and its subsidiaries. Intercompany transactions and balances have been eliminated. Preparing our financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and financial data included in the accompanying notes to the financial statements. Actual results and outcomes may differ from our estimates and assumptions.

Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2011 (the “2011 Form 10-K”).

Recently Adopted Accounting Pronouncements

Fair Value Measurement - In May 2011, the Financial Accounting Standards Board (“FASB”) issued guidance which generally provides a consistent definition of fair value and ensures that the fair value measurement and disclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. The guidance changes certain fair value measurement principles and enhances the disclosure requirements, particularly for Level 3 fair value measurements. This guidance was effective for interim and annual reporting periods beginning after December 15, 2011 and was applied on a prospective basis. The Company adopted the guidance on January 1, 2012, as required. There was no material impact on the Consolidated Financial Statements resulting from the adoption, see Note 3 Fair Value Measurements for additional disclosures related to this pronouncement.

Comprehensive Income - In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income,” (“ASU 2011-05”). ASU 2011-05 eliminates the option to report other comprehensive income (loss) and its components in the statement of changes in equity and requires that all nonowner changes in stockholders’ equity be presented in either a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB issued ASU 2011-12, “Comprehensive Income — Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in ASU 2011-05,” to defer the effective date to present items that are reclassified out of accumulated other comprehensive income to net income alongside their respective components of net income and other comprehensive income. All other provisions of this update, which are to be applied retrospectively, are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. We adopted this guidance in the first quarter of 2012 and applied it retrospectively. To implement this standard we have added a separate statement labeled Condensed Consolidated Statement of Comprehensive Income (Loss).

Intangibles – Goodwill and Other - In September 2011, the FASB issued ASU No. 2011-08, “Intangibles – Goodwill and Other (Topic 350) (“ASU 2011-08”). The amendments in this update will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendments include a number of events and circumstances for an entity to consider in conducting the qualitative assessment. This new guidance was adopted and applied in January 2012. The adoption of this accounting standard update did not have an impact on our financial position, results of operations, cash flows, or comprehensive income as it is intended to potentially simplify the assessment for goodwill impairment.

Reclassification

Certain reclassifications have been made to prior periods to conform to the present year presentation. Specifically, for the three and six months ended July 3, 2011 we have reclassified certain costs that were in cost of service revenues to cost of product revenues in the amount of $0.8 and $1.7 million, respectively. This reclassification has no impact on previously reported earnings from operations or net income. In addition, we have reclassified change in pension and other postretirement plans, net, previously reported in other operating activities into its own line item on the condensed consolidated statement of cash flows.

Offsetting of Financial Assets and Financial Liabilities

The Company has taken out policy loans from an insurance company on life insurance policies it owns and offsets these loans against the cash surrender values associated with the company owned life insurance policies. There is no intention to repay the loans prior to maturity or cancellation, and the company owned life insurance policies allow the right to offset the loan against the proceeds received on maturity or cancellation of the policies. The gross amount of the cash surrender values was $22.9 and $26.1 million at July 1, 2012 and December 31, 2011 respectively. The gross amount of the policy loans was $21.4 million and $16.0 million at July 1, 2012 and December 31, 2011 respectively. The net amounts of $1.5 million and $10.1 million at July 1, 2012 and December 31, 2011 respectively are included in our condensed consolidated balance sheets in Other assets, net.

XML

Condensed Consolidated Balance Sheets (Parenthetical) In Thousands, unless otherwise specified	Jul. 01, 2012	Dec. 31, 2011
Common stock, shares authorized	250,000	250,000
Common stock, shares issued	63,419	62,956
Common stock, shares outstanding	60,113	59,717

XML

Segment Reporting

6 Months Ended

Jul. 01, 2012

Segment Reporting

Note 11. Segment Reporting

Our chief operating decision maker is our Chief Executive Officer. Based on the evaluation of our financial information our reportable segments are comprised of Intermec-branded products, Intermec-branded services and Voice solutions. The Intermec-branded product segment generates revenue from the design, development, manufacture, sale and resale of mobile computing products, bar code scanners, wired and wireless bar code printers and label media products, and RFID products and license fees. Our Intermec-branded service segment generates revenue from managed services, customer support, product maintenance and professional services related to products and systems integration. The Voice solutions segment is comprised of voice data, collection terminals and professional services related to these products. Our statements of operations separately disclose revenues and costs related to our products and services on a consolidated basis.

Our chief operating decision maker evaluates revenue performance of product lines, both domestically and internationally. However, operating, strategic and resource allocation decisions are based primarily on the overall performance of our operating segments. The accounting policies of our three reportable segments are the same as those used to prepare our consolidated financial statements. Performance and resource allocation are primarily measured by sales and standard gross profit. All other earnings, costs and expenses are aggregated and reported on a consolidated basis. It is not practicable to segregate total assets by segment. Total assets at July 1, 2012 and December 31, 2011 were $566.6 and $869.3 million, respectively.

The following table sets forth our revenues and gross profit by reportable segment (in thousands):

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Revenues:
Intermec-branded products	$	135,618	$	153,329	$	252,951	$	287,183
Intermec-branded services		34,747		37,301		69,696		72,162
Voice solutions		30,586		30,452		57,982		40,255
Total	$	200,951	$	221,082		380,629	$	399,600
Gross profit:
Intermec-branded products	$	47,348	$	60,998	$	84,162	$	112,467
Intermec-branded services		14,237		13,234		28,017		25,814
Voice solutions		17,612		17,084		32,943		21,328
Total	$	79,197	$	91,316	$	145,122	$	159,609

The following table sets forth our revenues by product lines (in thousands):

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Revenues:
Intermec branded:
Systems and solutions	$	96,924	$	108,664	$	178,730	$	199,045
Printer and media		38,694		44,665		74,221		88,138
Service		34,747		37,301		69,696		72,162
Voice solutions		30,586		30,452		57,982		40,255
Total	$	200,951	$	221,082	$	380,629	$	399,600

XML

Document and Entity Information	6 Months Ended
	Jul. 01, 2012	Aug. 01, 2012
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jul. 01, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q2
Trading Symbol	IN
Entity Registrant Name	INTERMEC, INC.
Entity Central Index Key	0001044590
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		60,237,626

XML

Product Warranties

6 Months Ended

Jul. 01, 2012

Product Warranties

Note 12. Product Warranties

The following table summarizes our warranty liability activity included in current liabilities, for the six month period ended July 1, 2012 and the year ended December 31, 2011, respectively (in thousands):

	July 1, 2012			December 31, 2011
Beginning balance	$	4,853		$	2,555
Vocollect addition at acquisition		—			948
Payments or parts usage		(2,645	)		(5,867	)
Additional provision		3,060			7,217
Ending balance	$	5,268		$	4,853

XML

Condensed Consolidated Statements of Operations (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Revenues:
Product	$ 158,357	$ 177,751	$ 294,828	$ 319,487
Service	42,594	43,331	85,801	80,113
Total revenues	200,951	221,082	380,629	399,600
Costs and expenses:
Cost of product revenues	99,973	106,441	191,312	194,239
Cost of service revenues	21,781	23,325	44,195	45,752
Research and development	20,431	22,858	40,440	40,674
Selling, general and administrative	61,412	66,052	127,419	120,295
Impairment of goodwill	26,589		41,514
Gain on sale of assets	(1,255)		(2,655)
Acquisition costs		373		5,211
Restructuring costs	5,598	5,111	5,598	5,111
Total costs and expenses	234,529	224,160	447,823	411,282
Operating loss	(33,578)	(3,078)	(67,194)	(11,682)
Interest income	80	306	201	403
Interest expense	(882)	(883)	(1,632)	(1,393)
Loss before income taxes	(34,380)	(3,655)	(68,625)	(12,672)
Income tax expense (benefit)	3,142	141	210,987	(2,798)
Net loss	$ (37,522)	$ (3,796)	$ (279,612)	$ (9,874)
Loss per common share:
Basic loss per share	$ (0.62)	$ (0.06)	$ (4.65)	$ (0.16)
Diluted loss per share	$ (0.62)	$ (0.06)	$ (4.65)	$ (0.16)
Shares used in computing:
Basic loss per share	60,251,466	59,784,479	60,140,033	60,070,394
Diluted loss per share	60,251,466	59,784,479	60,140,033	60,070,394

XML

Inventories

6 Months Ended

Jul. 01, 2012

Inventories

Note 6. Inventories

Inventories consisted of the following (in thousands):

	July 1, 2012		December 31, 2011
Raw materials	$	27,739	$	30,485
Service parts		14,651		13,412
Work in process		550		316
Finished goods		55,004		59,409
Inventories	$	97,944	$	103,622

In addition to the inventories described above, we have service parts inventories totaling $4.3 and $4.3 million at July l, 2012 and December 31, 2011, respectively, which are included in our condensed consolidated balance sheets in Other assets, net.

XML

Accounts Receivable, Net

6 Months Ended

Jul. 01, 2012

Accounts Receivable, Net

Note 5. Accounts Receivable, Net

Accounts receivable, net, consisted of the following (in thousands):

	July 1, 2012		December 31, 2011
Accounts receivable, gross	$	138,132	$	146,682
Less:
Allowance for sales returns		4,185		4,423
Allowance for doubtful accounts		1,775		2,522
Accounts receivable, net	$	132,172	$	139,737

Our allowance for sales returns includes estimated customer returns and other incentives that are recorded as a reduction of sales. Price exceptions globally are recorded directly to the customers’ accounts instead of an allowance to gross receivables. One customer, ScanSource, our largest distributor, accounted for 26% and 19% of our accounts receivable as of July 1, 2012 and December 31, 2011, respectively.

One distributor, ScanSource Inc., accounted for more than 10% of our revenues. Total sales to this distributor were $41.1 and $71.9 million for the three months and six months ended July 1, 2012, respectively, and $28.1 and $68.7 million for the three and six months ended July 3, 2011, respectively

XML

Restructuring

6 Months Ended

Jul. 01, 2012

Restructuring

Note 17. Restructuring

After revising our 2012 business forecast to reflect current economic and other expectations, we committed to a business restructuring plan on June 12, 2012 that was intended to better align our cost structure with our current and anticipated needs by lowering costs primarily in North America and Europe. These reductions were primarily intended to lower our service and supply chain overhead and general and administrative support costs, with lesser impacts to Research and Development and Sales and Marketing. Under the business restructuring plan, we are reducing our work force primarily in the United States and Europe by approximately 160 employees, which represent approximately 7% of our current total global work force. We implemented this restructuring plan beginning in June of 2012 and expect to complete it over the remainder of fiscal year 2012.

The total restructuring costs for this plan are expected to be $6.4 million, including employee termination costs of $5.9 million and $0.5 million of other associated costs. We recorded $5.9 million of these charges in the second quarter of 2012. We expect to record the majority of the remaining charge throughout 2012. We anticipate that substantially all of the severance-related and periodic other associated costs will be cash expenditures. These costs are recorded on our condensed consolidated statement of operations in restructuring charges.

The reconciliation of accrued restructuring charges as of July 1, 2012 is summarized in the table below (in millions):

	Accrued Employee Termination Costs per Contract			Accrued Other Costs			Total Accrued Restructuring Charges
Balance at December 31, 2011	$	1.0		$	1.2		$	2.2
Restructuring charges for 2012 plan		5.9			—			5.9
Utilization of restructuring plans		(1.1	)		(0.2	)		(1.3	)
Reversal of prior year restructuring charges		(0.3	)		—			(0.3	)
Balance at July 1, 2012	$	5.5		$	1.0		$	6.5

XML

Commitments and Contingencies

6 Months Ended

Jul. 01, 2012

Commitments and Contingencies

Note 13. Commitments and Contingencies

We have entered into a variety of agreements with third parties that include indemnification clauses, both in the ordinary course of business and in connection with our divestitures of certain product lines. These clauses require us to compensate these third parties for certain liabilities and damages that may be incurred by them. Fair value of guarantees is required to be recorded as a liability. We do not believe that we have any significant exposure related to such guarantees and therefore have not recorded a liability as of July 1, 2012 or December 31, 2011. We have not made any significant indemnification payments as a result of these clauses.

In the three and six months ended July 1, 2012, we recorded $0.5 and $1.9 million in engineering fees related to take or pay purchase commitment agreements. We expect to make these payments by the end of 2012.

We currently, and from time to time, are subject to disputes, claims and lawsuits arising in the ordinary course of business. With the exception of certain cases involving intellectual property described below, the external legal costs incurred in these matters are expensed. These matters include claims by third parties against us for amounts allegedly owed to them as well as counterclaims against us in cases where we have made claims against third parties. Resolution of these disputes could result in the write down or write off of accounts receivable or the payment of damages. The ultimate resolution of such matters is inherently subject to uncertainty. An adverse outcome in certain of these matters could result in a material charge in the period in which the matter is resolved. However, we currently do not expect the ultimate resolution of pending proceedings and disputes to have a material effect on our business, financial condition, results of operations or liquidity. In the second quarter of 2012, we settled a pending lawsuit against us in the amount of $1.2 million. This amount is recorded in Selling, general and administrative expenses on our condensed consolidated statement of operations.

One of our pending lawsuits involves the defense of our patents; the external legal costs incurred in this matter are capitalized. We capitalize external legal costs incurred in the defense of our patents when we believe that there is an evident increase in the value of the patent and that the successful outcome of the legal action is probable. During the course of any legal action, the court where the case is pending makes decisions and issues rulings of various kinds, which may be favorable or unfavorable. We monitor developments in the legal action, the legal costs incurred and the anticipated outcome of the legal action, and assess the likelihood of a successful outcome based on the entire action. If changes in the anticipated outcome occur that reduce the likelihood of a successful outcome to less than probable, the capitalized costs would be charged to expense in the period in which the change is determined. As of July 1, 2012 and December, 31, 2011, $7.5 and $7.4 million of legal patent costs have been capitalized, respectively. All of these amounts relate to the case Alien Technologies Corporation v. Intermec, Inc., et al., Civil Action No. 3:06-cv-0051, United States District Court for the District of North Dakota, Southeastern Division (the “Alien Case”). The capitalized legal patent costs are recorded in other assets on our condensed consolidated balance sheets.

XML

Shares Used in Computing Earnings (Loss) per Share

6 Months Ended

Jul. 01, 2012

Shares Used in Computing Earnings (Loss) per Share

Note 9. Shares Used in Computing Earnings (Loss) per Share

Basic earnings (loss) per share are calculated using the weighted average number of common shares issued and outstanding for the applicable period. Diluted loss per share is computed using basic weighted average shares issued and outstanding plus the dilutive effect of unvested restricted stock and outstanding stock options using the “treasury stock” method.

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Weighted average shares - basic		60,251,466		59,784,479		60,140,033		60,070,394
Dilutive effect of unvested restricted shares and stock options		—		—		—		—
Weighted average shares - diluted		60,251,466		59,784,479		60,140,033		60,070,394

Our employees and directors held options to purchase 3,950,272 and 3,844,272 shares of our common stock for the three and six months ended July 1, 2012, respectively, and 3,451,713 and 3,078,769 shares of our common stock for the three and six months ended July 3, 2011, respectively, that were not included in weighted average shares diluted calculation because they were anti-dilutive to the diluted loss per share computation. These options would become dilutive in future periods if the average market price of our common stock exceeds the exercise price of the outstanding options and we report net earnings.

XML

Segment Reporting - Additional Information (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jul. 01, 2012 Segment	Dec. 31, 2011
Segment Reporting Disclosure [Line Items]
Number of reportable segments	3
Total assets	$ 566,582	$ 869,290

XML

Intangibles

6 Months Ended

Jul. 01, 2012

Intangibles

Note 7. Intangibles

The following table presents the gross carrying amount and accumulated amortization of intangible assets as of July 1, 2012 (in thousands):

	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Weighted Average Useful Life
Developed technology	$	40,200	$	16,053	$	24,147		5 years
In-process research and development		1,900		138		1,762		7 years
Customer relationships		17,600		1,948		15,652		11 years
Trademarks		5,200		519		4,681		10 years
Lease agreements		2,600		463		2,137		8 years
Total acquired intangible assets from Vocollect acquisition:		67,500		19,121		48,379
Other intangibles		14,459		10,228		4,231		5 years
Total	$	81,959	$	29,349	$	52,610

The following table presents the gross carrying amount and accumulated amortization of intangible assets as of December 31, 2011 (in thousands):

	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Weighted Average Useful Life
Developed technology	$	40,200	$	9,416	$	30,784		5 years
In-process research and development		1,900		—		1,900		7 years
Customer relationships		17,600		623		16,977		11 years
Trademarks		5,200		303		4,897		10 years
Lease agreements		2,600		245		2,355		8 years
Total acquired intangible assets from Vocollect acquisition:		67,500		10,587		56,913
Other intangibles		14,459		9,376		5,083		5 years
Total	$	81,959	$	19,963	$	61,996

Total amortization expense on intangibles for the three and six months ended July 1, 2012 was $4.7 and $9.4 million, respectively, and $3.3 and $4.3 million, for the three and six months ended July 3, 2011, respectively. Estimated future amortization expense for intangible assets for the next five years is as follows (in thousands):

Year	Amount
2012	$	18,558
2013		16,367
2014		8,865
2015		6,005
2016		3,482

XML

Provision for Income Taxes

6 Months Ended

Jul. 01, 2012

Provision for Income Taxes

Note 8. Provision for Income Taxes

In the second quarter, we recorded a tax provision of $1.7 million on foreign earnings and no tax benefit for earnings in the United States, Singapore and Japan due to losses in those jurisdictions. We also provided $1.4 million for deferred taxes on projected future repatriation from certain foreign subsidiaries which are not permanently reinvested. The tax provision for the three months ended April 1, 2012 included a net $206.9 million non-cash charge to record a valuation allowance against our U.S. deferred tax assets.

Currently, we record valuation allowances in the following jurisdictions: United States, Singapore and Japan. Under GAAP, a valuation allowance against our deferred tax assets is appropriate if based on the available evidence, it is more likely than not (defined as a likelihood of more than 50%) that the value of such assets will not be realized in the future. The valuation of deferred tax assets requires judgment in assessing a number of factors, including the likely future tax consequences of events we expect to recognize in our financial statements and tax returns, as well as our historical performance. Key factors we considered include our results for the quarter ended April 1, 2012; we recorded a pre-tax loss and significantly underperformed relative to our forecast. We also revised our forecast downward in the first quarter of 2012 for our U.S. and global operations for the remainder of 2012. We concluded that it was more likely than not that the value of such assets would not be realized, and we recorded a valuation allowance for our U.S. entities representing the full balance of these assets.

A sustained period of profitability in our U.S. operations is required before we would change our judgment regarding the need for a full valuation allowance against our U.S. deferred tax assets. In the event that we determine in the future that we expect to benefit from our deferred income tax assets in excess of the net balance at that time, we will make an adjustment to the deferred tax asset valuation allowance. This will reduce the provision for income taxes in that period. Until such time, we will offset U.S. profits against our deferred tax assets and will reduce the overall level of deferred tax assets subject to valuation allowance as a result.

For the jurisdictions where we did not record a valuation allowance, our tax provision includes an estimated annual effective tax rate from continuing operations of approximately 31%. Our effective tax rate from continuing operations in those jurisdictions is lower than the U.S. statutory rate of 35% due primarily to lower tax rates and tax incentives in those jurisdictions.

XML

Stock-Based Compensation

6 Months Ended

Jul. 01, 2012

Stock-Based Compensation

Note 10. Stock-Based Compensation

A summary of stock-based compensation expense related to director and employee stock options, Restricted Stock Units (“RSU”), Performance Stock Units (“PSU”), and Employee Stock Purchase Plan (“ESPP”) for the three and six months ended July 1, 2012 and July 3, 2011 is as follows (in thousands):

	Three Months Ended				Six Months Ended
	July 1, 2012		July 3, 2011		July 1, 2012		July 3, 2011
Cost of revenue	$	63	$	63	$	126	$	126
Selling, general and administrative		421		2,152		2,999		4,299
Total	$	484	$	2,215	$	3,125	$	4,425

Stock compensation expense for the three and six months ended July 1, 2012 was reduced by $1.9 million primarily due to forfeitures related to the departure of our former CEO.

For the three and six months ended July 1, 2012, we granted 572,855 and 586,855 options, respectively, to employees with a weighted-average grant-date fair value of $2.71 and $2.72 per option, respectively, which will vest annually in substantially equal quantities over three years from the date of grant.

XML

Commitments and Contingencies - Additional Information (Detail) (USD $) In Millions, unless otherwise specified			6 Months Ended	3 Months Ended	6 Months Ended
	Jul. 01, 2012	Dec. 31, 2011	Jul. 01, 2012 Patents Selling, General and Administrative Expenses	Jul. 01, 2012 Purchase Commitment Agreement	Jul. 01, 2012 Purchase Commitment Agreement
Commitments and Contingencies Disclosure [Line Items]
Fair value of guarantees required to be recorded as a liability	$ 0	$ 0
Engineering fees				0.5	1.9
Settlement of lawsuit involving patent			1.2
Capitalized legal patent costs	$ 7.5	$ 7.4

XML

Schedule Of Pension And Other Postretirement Benefit Plan Contributions (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended	6 Months Ended
	Jul. 01, 2012	Jul. 01, 2012
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension and other postretirement benefit plan contributions	$ 4,165	$ 7,209
U.S. Defined Benefit Postretirement Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension and other postretirement benefit plan contributions	2,122	3,117
Matching Contributions To 401(k) Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension and other postretirement benefit plan contributions	1,087	2,322
Non U.S. Defined Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension and other postretirement benefit plan contributions	$ 956	$ 1,770

XML

Summary of Warranty Liability Activity (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended	12 Months Ended
	Jul. 01, 2012	Dec. 31, 2011
Product Warranties [Abstract]
Beginning balance	$ 4,853	$ 2,555
Vocollect addition at acquisition		948
Payments or parts usage	(2,645)	(5,867)
Additional provision	3,060	7,217
Ending balance	$ 5,268	$ 4,853

XML

Product Warranties (Tables)

6 Months Ended

Jul. 01, 2012

Summary Of Warranty Liability Activity

The following table summarizes our warranty liability activity included in current liabilities, for the six month period ended July 1, 2012 and the year ended December 31, 2011, respectively (in thousands):

	July 1, 2012			December 31, 2011
Beginning balance	$	4,853		$	2,555
Vocollect addition at acquisition		—			948
Payments or parts usage		(2,645	)		(5,867	)
Additional provision		3,060			7,217
Ending balance	$	5,268		$	4,853

XML

Inventories - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Jul. 01, 2012	Dec. 31, 2011
Inventory Disclosure [Line Items]
Service parts inventories not expected to be sold within next 12 months	$ 4.3	$ 4.3

XML

Acquisitions

6 Months Ended

Jul. 01, 2012

Acquisitions

Note 15. Acquisitions

On March 3, 2011, we completed our acquisition of Vocollect Inc. by acquiring all of the outstanding shares of capital stock of Vocollect and all in-the-money options to purchase shares of common stock of Vocollect for an aggregate purchase price of approximately $197 million in cash, net of cash acquired. Vocollect provides voice-centric solutions for mobile workers in distribution, warehouse and healthcare environments worldwide through design, manufacture and sale of voice data collection terminals and related software. This acquisition is part of our strategy to expand our warehouse and mobility solutions.

We have included the financial results of Vocollect in our condensed consolidated financial statements from the date of acquisition. Vocollect acquisition and related costs of approximately $0.3 and $5.2 million were recorded as an expense for the three and six months ended July 3, 2011, respectively, and are included in the total acquisition costs of $5.2 million in our condensed consolidated statement of operations. Acquisition related costs include direct integration costs, transaction fees and professional services.

The allocation of the purchase price to Vocollect’s assets acquired and liabilities assumed, net of cash acquired, is as follows (in thousands):

	At Acquisition March 3, 2011 (Adjusted)
Accounts receivable (gross contractual receivables total of $21,461)	$	20,569
Inventories		7,520
Net deferred tax assets		7,880
Other current assets		7,353
Goodwill (including $7.9 million for assembled workforce)		140,162
Intangible assets		67,500
Property, plant and equipment		9,123
Other assets		137
Accounts payable		(6,818	)
Payroll and related expenses		(8,812	)
Deferred revenue		(10,936	)
Accrued expenses		(8,739	)
Deferred tax liabilities		(22,570	)
Long-term deferred revenue		(4,282	)
Other long-term liabilities		(1,370	)
Total net assets acquired	$	196,717

Goodwill recognized is attributable primarily to the expected synergies and the assembled workforce of Vocollect and is not deductible for income tax purposes. Goodwill associated with the Vocollect acquisition has been allocated to the Voice solutions reportable segment.

Unaudited Pro Forma Financial Information

The unaudited pro forma financial information in the table below summarizes the combined results of operations for Intermec and Vocollect as though the acquisition occurred at the beginning of fiscal 2011. The pro forma financial information presented below is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisitions and any borrowings undertaken to finance the acquisition had taken place at the beginning of fiscal 2011.

(in thousands)	Three Months Ended July 3, 2011			Six Months Ended July 3, 2011
Total revenues	$	221,082		$	417,911
Net loss		(3,796	)		(7,006	)

XML

Revolving Credit Facility (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Long-Term Debt Principal Payments

At July 1, 2012, scheduled principal payments on long-term debt were as follows (in thousands):

	Total
2012-2013	$	—
2014		85,000
Total principal payments	$	85,000

XML

Accounts Receivable, Net - Additional Information (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012 ScanSource Inc	Jul. 03, 2011 ScanSource Inc	Jul. 01, 2012 ScanSource Inc	Jul. 03, 2011 ScanSource Inc	Jul. 01, 2012 ScanSource Inc Accounts Receivable Concentration Risk	Dec. 31, 2011 ScanSource Inc Accounts Receivable Concentration Risk
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of accounts receivable from largest customer									26.00%	19.00%
Total sales	$ 200,951	$ 221,082	$ 380,629	$ 399,600	$ 41,100	$ 28,100	$ 71,900	$ 68,700
Percentage of revenues from distributor, minimum					10.00%		10.00%

XML

Revolving Credit Facility - Additional Information (Detail) (USD $)	6 Months Ended			1 Months Ended		3 Months Ended	6 Months Ended
	Jul. 01, 2012 Second Quarter Of 2012	Jul. 01, 2012 Third Quarter Of 2012	Jul. 01, 2012 Subsequent Quarters	Mar. 03, 2011 Secured Revolving Credit Facility	Dec. 21, 2011 Revolving Facility	Jul. 01, 2012 Revolving Facility	Jul. 01, 2012 Revolving Facility	Jul. 01, 2012 Revolving Facility Minimum	Jul. 01, 2012 Revolving Facility Maximum	Jul. 01, 2012 Revolving Facility Libor Plus Applicable Margin Minimum	Jul. 01, 2012 Revolving Facility Libor Plus Applicable Margin Maximum	Jul. 01, 2012 Revolving Facility Bank's Prime Rate, Less Applicable Margin Minimum	Jul. 01, 2012 Revolving Facility Bank's Prime Rate, Less Applicable Margin Maximum
Line of Credit Facility [Line Items]
Maturity period				3 years
Maximum amount available under the Revolving Facility				$ 100,000,000	$ 150,000,000
Maturity date				Mar. 03, 2014	Dec. 31, 2014
Current borrowing capacity						7,300,000	7,300,000
Borrowings under the Revolving Facility						85,000,000	85,000,000
Letter of credit outstanding						1,500,000	1,500,000
Variable interest rate								1.25%	1.75%	1.25%	1.75%	0.25%	1.00%
Weighted average interest rate						2.23%	2.26%
Increase of interest rate on all obligations under the revolving facility in the event of default							2.00%
Fee on the maximum amount available to be drawn under each letter of credit								0.60%	1.00%
Percentage of fee to be paid on unused portion of the New Facility								0.15%	0.25%
Maximum funded debt to EBITDA							2.5
Asset coverage ratio								1
Minimum adjusted EBITDA allowed for the trailing twelve months	$ 25,000,000	$ 35,000,000	$ 45,000,000

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Net loss:	$ (37,522)	$ (3,796)	$ (279,612)	$ (9,874)
Other comprehensive loss:
Foreign currency translation adjustments	(5,525)	2,716	(2,014)	7,636
Unrealized gain (loss) on investment	(9)	(1)	(9)	(3)
Amortization of benefit plan costs	(2,119)	562	(4,237)	1,182
Income tax on other comprehensive income	(4)	(202)	(4)	(425)
Total other comprehensive income	(7,657)	3,075	(6,264)	8,390
Total comprehensive loss	$ (45,179)	$ (721)	$ (285,876)	$ (1,484)

XML

Derivative Instruments

6 Months Ended

Jul. 01, 2012

Derivative Instruments

Note 4. Derivative Instruments

Due to our global operations, we are exposed to foreign currency exchange rate fluctuations in the normal course of our business. Our treasury policies provide for risk mitigation of the effects of certain foreign currency exposures through the purchase of foreign exchange forward contracts. Our policy prohibits speculation in financial instruments for profit on the exchange rate price fluctuation. We enter into foreign exchange forward contracts primarily to economically hedge the impact of fluctuations of foreign exchange arising from intercompany inventory sales made to our subsidiaries that are denominated primarily in Euros or British Pounds, customer receivables of our foreign subsidiaries denominated primarily in U.S. Dollars and Euros and intercompany loans denominated in Euros, Swedish Krona, Norwegian Kroner, Danish Krone and Canadian Dollar. Our foreign exchange forward contracts are not designated as hedging instruments for accounting purposes; accordingly, we record these contracts at fair value on our consolidated balance sheets, with changes in fair value recognized in earnings in the period of the change. The aggregate notional amounts of the forward contracts we held for foreign currencies were $129.0 million as of July 1, 2012. Principal currencies we economically hedged include the Euro, British Pound, Brazilian Real, Canadian Dollar, Mexican Peso, Singapore Dollar, Swedish Krona, Norwegian Kroner and Danish Krone. These contracts do not contain any credit-risk-related contingent features.

We attempt to manage the counterparty risk associated with these foreign exchange forward contracts by limiting transactions to counterparties with which we have an established banking relationship. In addition, these contracts generally settle in approximately 30 days. See Note 3, Fair Value Measurements, for information on the fair value of these contracts.

The net loss (gain) resulting from these contracts recorded in selling, general and administrative expense was approximately $2.4 and $1.5 million for the three and six months ended July 1, 2012, and $0.5 and $1.1 million for the three and six months ended July 3, 2011, respectively. We recorded a net (liability) asset of $0.7 and $(0.8) million in other current assets or accounts payable and accrued expenses as of ended July 1, 2012 and December 31, 2011, respectively.

XML

Summary Of Stock-Based Compensation Expense (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011	Jul. 01, 2012	Jul. 03, 2011
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 484	$ 2,215	$ 3,125	$ 4,425
Cost Of Revenue
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	63	63	126	126
Selling, General And Administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 421	$ 2,152	$ 2,999	$ 4,299

XML

Schedule Of Allocation Of Purchase Price To Assets Acquired And Liabilities Assumed, Net of Cash Acquired (Detail) (Adjusted Purchase Price, USD $) In Thousands, unless otherwise specified	Mar. 03, 2011
Adjusted Purchase Price
Schedule of Business Acquisitions, Purchase Price Allocation [Line Items]
Accounts receivable (gross contractual receivables total of $21,461)	$ 20,569
Inventories	7,520
Net deferred tax assets	7,880
Other current assets	7,353
Goodwill (including $7.9 million for assembled workforce)	140,162
Intangible assets	67,500
Property, plant and equipment	9,123
Other assets	137
Accounts payable	(6,818)
Payroll and related expenses	(8,812)
Deferred revenue	(10,936)
Accrued expenses	(8,739)
Deferred tax liabilities	(22,570)
Long-term deferred revenue	(4,282)
Other long-term liabilities	(1,370)
Total net assets acquired	$ 196,717

XML

Fair Value Measurements (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Financial Assets And Liabilities Subject To Fair Value Measurement Provisions

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Our financial assets and liabilities subject to fair value measurement provisions as of July 1, 2012 comprised the following (in thousands):

	Level 1		Level 2			Level 3		Fair Value at July  1, 2012
Money market funds	$	39,561	$	—		$	—	$	39,561
Stock		181		—			—		181
Derivative instruments – assets		—		1,317			—		1,317
Total assets at fair value	$	39,742	$	1,317		$	—	$	41,059
	Level 1		Level 2			Level 3		Fair Value at July 1, 2012
Derivative instruments – liabilities	$	—	$	(575	)	$	—	$	(575	)
Total liabilities at fair value	$	—	$	(575	)	$	—	$	(575	)

Our financial assets and liabilities subject to fair value measurement provisions as of December 31, 2011 comprised the following (in thousands):

	Level 1		Level 2			Level 3		Fair Value at December 31, 2011
Money market funds	$	15,275	$	—		$	—	$	15,275
Certificates of deposit		—		3,555			—		3,555
Stock		170		—			—		170
Derivative instruments – assets		—		985			—		985
Total assets at fair value	$	15,445	$	4,540		$	—	$	19,985
	Level 1		Level 2			Level 3		Fair Value at December 31, 2011
Derivative instruments – liabilities	$	—	$	(1,801	)	$	—	$	(1,801	)
Total liabilities at fair value	$	—	$	(1,801	)	$	—	$	(1,801	)

Schedule Of Goodwill Assets That Were Measured At Fair Value On Non-Recurring Basis

The following fair value hierarchy table presents information about our goodwill assets that were measured at fair value on a non-recurring basis at July 1, 2012 (in thousands):

Goodwill	Level 1		Level 2		Level 3		Fair Value at July 1, 2012
Voice solutions supply chain reporting unit	$	—	$	—	$	89,993	$	89,993
Voice solutions healthcare reporting unit		—		—		8,655		8,655
Intermec global solutions reporting unit		—		—		3,348		3,348
Total goodwill at fair value	$	—	$	—	$	101,996	$	101,996

The following fair value hierarchy table presents information about our goodwill assets that were measured at fair value on a non-recurring basis at December 31, 2011(in thousands):

Goodwill	Level 1		Level 2		Level 3		Fair Value at December 31, 2011
Voice solutions supply chain reporting unit	$	—	$	—	$	130,682	$	130,682
Voice solutions healthcare reporting unit						9,480		9,480
Intermec global solutions reporting unit						3,348		3,348
Total goodwill at fair value	$	—	$	—	$	143,510	$	143,510

Fair Value Measurements of Assets and Liabilities Measured at Fair Value on Non Recurring basis

The following table presents qualitative information with respect to Level 3 fair value measurements for assets and liabilities measured at fair value on a non-recurring basis at July 1, 2012:

Reporting Unit	Fair Value		Valuation Technique(s)	Unobservable Input(s)
Voice Solutions Supply Chain
Goodwill	$	89,993	Income Approach	Financial Forecast
				Terminal Growth Rate
				Weighted Average Cost of Capital
				Expected Cash Flow
			Market Approach	Public Company Multiples
Voice Solutions Healthcare
Goodwill	$	8,655	Income Approach	Financial Forecast
				Terminal Growth Rate
				Weighted Average Cost of Capital
Intermec Global Solutions
Goodwill	$	3,348	Income Approach	Financial Forecast
				Terminal Growth Rate
				Weighted Average Cost of Capital
Total Goodwill	$	101,996

XML

Restructuring - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended
	Jul. 01, 2012	Jul. 01, 2012 Employee
Effects on Future Earnings and Cash Flows Resulting from Exit Plan [Line Items]
Reduction in number of employees		160
Percent of workforce related to restructuring		7.00%
Total charges expected to be incurred		$ 6.4
Employee termination costs		5.9
Other transitional cost		0.5
Total restructuring charges incurred to date	$ 5.9

XML

Restructuring (Tables)

6 Months Ended

Jul. 01, 2012

Schedule Of Reconciliation Of Accrued Restructuring Charges

The reconciliation of accrued restructuring charges as of July 1, 2012 is summarized in the table below (in millions):

	Accrued Employee Termination Costs per Contract			Accrued Other Costs			Total Accrued Restructuring Charges
Balance at December 31, 2011	$	1.0		$	1.2		$	2.2
Restructuring charges for 2012 plan		5.9			—			5.9
Utilization of restructuring plans		(1.1	)		(0.2	)		(1.3	)
Reversal of prior year restructuring charges		(0.3	)		—			(0.3	)
Balance at July 1, 2012	$	5.5		$	1.0		$	6.5

XML

Pension and Other Postretirement Benefits Liabilities

6 Months Ended

Jul. 01, 2012

Pension and Other Postretirement Benefits Liabilities

Note 14. Pension and Other Postretirement Benefits Liabilities

The components of net pension and postretirement periodic benefit cost (income) for the three and six months ended July 1, 2012 and July 3, 2011, were as follows (in thousands):

	U.S. Defined Benefit Plans						Non U.S. Defined Benefit Plans						Other Postretirement Benefit Plans
	2012			2011			2012			2011			2012			2011
Three Months Ended July 1, 2012, and July 3, 2011:
Interest cost	$	2,983		$	3,029		$	495		$	528		$	34		$	40
Expected return on plan assets		(2,592	)		(2,689	)		(532	)		(517	)		—			—
Amortization and deferrals:
Transition asset		—			—			(34	)		(33	)		—			—
Actuarial loss		888			563			163			163			—			—
Prior service cost		—			—			—			—			(41	)		(40	)
Net pension and postretirement periodic benefit cost (income)	$	1,279		$	903		$	92		$	141		$	(7	)	$	—

	U.S. Defined Benefit Plans						Non U.S. Defined Benefit Plans						Other Postretirement Benefit Plans
	2012			2011			2012			2011			2012			2011
Six Months Ended July 1, 2012, and July 3, 2011:
Interest cost	$	5,965		$	6,059		$	994		$	1,057		$	69		$	80
Expected return on plan assets		(5,183	)		(5,377	)		(1,069	)		(1,035	)		—			—
Amortization and deferrals:
Transition asset		—			—			(68	)		(66	)		—			—
Actuarial loss		1,776			1,126			328			326			—			—
Prior service cost		—			—			—			—			(83	)		(79	)
Net pension and postretirement periodic benefit cost (income)	$	2,558		$	1,808		$	185		$	282		$	(14	)	$	1

Our pension and other postretirement benefit plan contributions for the three and six months ended July 1, 2012, were as follows (in thousands):

	Three Months Ended July 1, 2012		Six Months Ended July 1, 2012
U.S. defined benefit postretirement benefit plans	$	2,122		3,117
Matching contributions to 401(k) plan		1,087		2,322
Foreign pension plans		956		1,770
Total	$	4,165		7,209

Benefits paid pertaining to our other postretirement benefit plans were not material for the three and six months ended July 1, 2012.

We expect to contribute an additional $10.7 million to these plans during the remainder of 2012, including $4.8 million of contributions to our U.S. pension plan, $2.3 million of benefit payments for our unfunded U.S. defined benefit plans, $1.9 million in matching contributions to our 401(k) plan, and $1.7 million in contributions to our foreign pension plans.